This #worlddiabetesday, we're highlighting the importance of early action on diabetes.
Learn more about our work in diabetes care here: www.sanofi.com/en/patients/understanding-diseases-conditi…
#worlddiabetesday #diabetes #wdd2026 #actearlyondiabetes
Sanofi
Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. It changed its name back to Sanofi in May 2011. The company trades as "SAN" on Euronext Paris and "SNY" on Nasdaq in the United States, and is a component of the Euro Stoxx 50 stock market index. In 2023, the company was ranked 89th in the Forbes Global 2000. More on Wikipedia
-
Sanofi
@sanofi
-
Sanofi
@sanofi
Our Q3 2026 results are now available.
Read the full press release for detailed insights: www.sanofi.com/en/media-room/press-releases/2026/2026-10-…
#sanofiresults $SAN $SNY -
Sanofi
@sanofi
Following our acquisition of Blueprint Medicines, we're uniting our teams, knowledge, and capabilities to improve the lives of people with systemic mastocytosis. Read the full letter from Maria Roche: www.sanofi.com/assets/dotcom/pages/docs/miscellaneous/blu…
-
Sanofi
@sanofi
#news: Positive phase 2b long-term data in ulcerative colitis and Crohn's disease, shared at UEG Week. Read more: www.sanofi.com/en/media-room/press-releases/2026/2026-10-…
@Teva #uegweek2026 -
Sanofi
@sanofi
NEWS: We’ve officially started construction on our new state-of-the-art insulin production facility. It will strengthen our ability to reliably supply insulin to millions of people living with #diabetes in Europe and worldwide.
Read more here: www.sanofi.com/en/media-room/press-releases/2026/2026-10-… -
Sanofi
@sanofi
We're proud to announce our major partnership with @LeTour de France and @LeTourFemmes as the official sponsor of the white jersey for the best young rider.
For both men's and women's categories, the white jersey represents progress, a value at the heart of Sanofi's quest for innovation. The #raceforhealth Is On! 🚴♂️🚴♀️
#tdf2027 #sanofitdf #tourdefranceThis media couldn't be displayed. See it on the original post. -
Sanofi
@sanofi
See you on the most iconic roads.
The #raceforhealth Is On -
Sanofi
@sanofi
#news: We’ve announced an expansion of our global Alliance with @Regeneron to add multiple next-generation, long-acting antibodies to our joint immunology portfolio.
Read more here: www.sanofi.com/en/media-room/press-releases/2026/2026-10-… -
Sanofi
@sanofi
Our Q2 2026 results are now available.
Read the full press release for detailed insights: www.sanofi.com/en/investors/financial-results-and-events/…
#sanofiresults $SAN $SNY -
Sanofi
@sanofi
#news: Update on our phase 3 program in moderate-to-severe #atopicdermatitis.
Learn more ⬇️
www.sanofi.com/en/media-room/press-releases/2026/2026-07-… -
Sanofi
@sanofi
#news: Our phase 3 results show our medicine met its primary and secondary endpoints in treatment-naïve infants with infantile-onset Pompe disease (IOPD). Read more: www.sanofi.com/en/media-room/press-releases/2026/2026-06-…
-
Sanofi
@sanofi
#news: The Japan Ministry of Health, Labour and Welfare has approved the first oral, reversible BTK inhibitor to treat adults with immune thrombocytopenia (ITP) who are refractory to other treatments. Read more ⬇️: www.sanofi.com/en/media-room/press-releases/2026/2026-06-…
-
Sanofi
@sanofi
#news: The @EU_Commission has approved our medicine for the treatment of certain people with secondary progressive #multiplesclerosis , reinforcing our commitment to advancing scientific innovation that address unmet patient needs.
Learn more ⬇️
www.sanofi.com/en/media-room/press-releases/2026/2026-06-… -
Sanofi
@sanofi
Sanofi appoints Paulo Fontoura as Global Head of R&D Pharma, starting September 1, 2026.
With 25+ years in pharmaceutical innovation, he brings a track record of 60+ new molecular entities and 20+ FDA/EMA approvals.
Read more: www.sanofi.com/en/media-room/press-releases/2026/2026-06-…
#sanofi -
Sanofi
@sanofi
We're chasing the miracles of science to improve people's lives. Last week, the world saw exactly how.
2026 marked our 8th consecutive year at #vivatech, and we came to show, not tell, with operational AI delivering real impact for patients, today. Learn more:This media couldn't be displayed. See it on the original post. -
Sanofi reposted
-
Sanofi
@sanofi
The Ministry of Health, Labour and Welfare in Japan has approved our subcutaneous therapy in combination with approved standard-of-care regimens for the treatment of multiple myeloma. Read the full announcement here: www.sanofi.com/en/media-room/press-releases/2026/2026-06-…
-
Sanofi
@sanofi
What a start at #vivatech! Visit us at Booth 1D01 through June 20 to experience how we’re reinventing AI across the value chain.
Learn more: www.sanofi.com/en/magazine/ai-in-healthcare/viva-tech-2026
#sanofi @VivaTechThis media couldn't be displayed. See it on the original post. -
Sanofi
@sanofi
We’re back at #vivatech 2026, and we’re raising the bar on what AI can do for global health.
Visit us June 17 – 20 at Booth 1D01 to see how our teams are accelerating breakthroughs across everything from research and development to manufacturing and supply, driving faster, smarter impact for patients. -
Sanofi
@sanofi
The @US_FDA granted accelerated approval for a treatment for #type1diabetes. Learn more: www.sanofi.com/en/media-room/press-releases/2026/2026-06-…
-
Sanofi
@sanofi
#news: Update on our phase 3 clinical study in chronic inflammatory demyelinating polyneuropathy (CIDP).
Learn more ⬇️
www.sanofi.com/en/media-room/press-releases/2026/2026-06-… -
Sanofi
@sanofi
With the approval from the @EU_Commission, our subcutaneous multiple myeloma (MM) therapy is now authorized across all existing IV indications for MM in the EU.
Read more: www.sanofi.com/en/media-room/press-releases/2026/2026-06-… -
Sanofi reposted
-
Sanofi
@sanofi
#news: The @US_FDA has granted priority review to our new drug application for an investigational oral molecule for type 3 Gaucher disease. Learn more: www.sanofi.com/en/media-room/press-releases/2026/2026-05-…
-
Sanofi
@sanofi
Phase 2 data for our investigational treatment for #aatd presented for the first time at #ats; These findings demonstrate our commitment to advancing innovation for people living with this rare disease. Learn more: www.sanofi.com/en/media-room/press-releases/2026/2026-05-…
-
Sanofi reposted
-
Sanofi
@sanofi
#news: The @EMA_News CHMP has recommended for approval our new investigational treatment for secondary progressive #multiplesclerosis without relapses, reinforcing our commitment to advance scientific innovation that address unmet patient needs.
Learn more ⬇️www.sanofi.com/en/media-room/press-releases/2026/2026-04-… -
Sanofi
@sanofi
Our Q1 2026 results are now available.
See the press release for more details: www.sanofi.com/en/media-room/press-releases/2026/2026-04-…
#sanofiresults $SAN $SNY -
Sanofi
@sanofi
The @US_FDA has approved our medicine for certain children aged 2-11 years with uncontrolled chronic spontaneous urticaria (CSU). ➡️ Read more: www.sanofi.com/en/media-room/press-releases/2026/2026-04-…
CC: @Regeneron -
Sanofi
@sanofi
The @US_FDA has approved a treatment for eligible young children with #type1diabetes. With this approval, we hope to better support these young T1D patients and their families. Learn more: www.sanofi.com/en/media-room/press-releases/2026/2026-04-…
-
Sanofi
@sanofi
#news: COMPARE study presented at #escmidglobal2026: head-to-head tolerability comparison of a protein-based and an mRNA COVID-19 vaccine
Read our press release: www.sanofi.com/en/media-room/press-releases/2026/2026-04-… -
Sanofi
@sanofi
The @EU_Commission has approved our medicine in the EU for the treatment of chronic spontaneous urticaria (CSU) in certain children aged 2 to 11 years. More information here ➡️: www.sanofi.com/en/media-room/press-releases/2026/2026-04-…
CC: @Regeneron -
Sanofi
@sanofi
#news: Positive results from two Phase 2 studies evaluating our investigational treatment in #asthma and #crswnp, demonstrating potential for people living with chronic respiratory conditions.
Learn more ⬇️
www.sanofi.com/en/media-room/press-releases/2026/2026-04-… -
Sanofi
@sanofi
The @EU_Commission has approved our medicine for the treatment of chronic graft-versus-host disease (GVHD) in certain adults and children aged 12 years and older, providing a new treatment mechanism for eligible patients with limited therapeutic options. Learn more:
-
Sanofi
@sanofi
We presented late-breaking research on our investigational medicine for moderate-to-severe atopic dermatitis patients at #aad2026. Learn more about our findings: www.sanofi.com/en/media-room/press-releases/2026/2026-03-…
-
Sanofi
@sanofi
The @EMA_News CHMP recommended approval of our subcutaneous therapy administered via an innovative delivery method for patients across the #multiplemyeloma (MM) spectrum in the EU.
If approved, this therapy would represent a significant step for the MM community.
Read more: -
Sanofi
@sanofi
Japan’s Ministry of Health, Labour and Welfare has approved our medicine for certain adults with bullous pemphigoid (BP). Read more: www.sanofi.com/en/media-room/press-releases/2026/2026-03-…
CC: @Regeneron -
Sanofi
@sanofi
The @US_FDA has granted breakthrough therapy designation to our investigational treatment for type 3 Gaucher disease (GD3). Learn more: www.sanofi.com/en/media-room/press-releases/2026/2026-03-…
-
Sanofi
@sanofi
The European Medicines Agency's CHMP has recommended the approval of our medicine in the EU to treat chronic spontaneous urticaria (CSU) in certain children aged 2 to 11 years. ️
Learn more: www.sanofi.com/en/media-room/press-releases/2026/2026-02-…
CC: @Regeneron -
Sanofi
@sanofi
Together with @DNDi and FoundationS, we’re proud to receive a positive CHMP (Committee for Medicinal Products for Human Use) opinion from the European Medicines Agency for our new treatment for adults and adolescents with early and advanced stage gambiense sleeping sickness.
This recommendation paves the way to bring innovative treatment to people affected by this deadly disease and aligns with the World Health Organization’s goal of eliminating gambiense sleeping sickness by 2030.
We remain committed to advancing scientific innovation to address unmet patient needs, particularly vulnerable communities.
Read our press release ➡️ www.sanofi.com/en/media-room/press-releases/2026/2026-02-…
#actforpatients #foundations #dndi #globalhealth #sleepingsickness -
Sanofi
@sanofi
The @US_FDA has approved our medicine for allergic fungal rhinosinusitis (AFRS) in certain adults and children. Learn more about this milestone: www.sanofi.com/en/media-room/press-releases/2026/2026-02-…
CC: @Regeneron -
Sanofi
@sanofi
New phase 2b maintenance results evaluating an investigational treatment for ulcerative colitis and Crohn’s disease, highlighting our commitment to scientific innovation for patients with inflammatory bowel disease. Read our press release. www.sanofi.com/en/media-room/press-releases/2026/2026-02-…
-
Sanofi
@sanofi
GVHD is a serious complication affecting up to 1 in 2 patients who undergo a stem cell transplant.
Today, February 17, marks #gvhdday - an opportunity to recognize and empower those living this devastating disease.
Learn more ➡️ www.gvhdalliance.org
#protectingthepromise #gvhd -
Sanofi
@sanofi
We're pleased to announce that we have completed the acquisition of @DynavaxCorp
This strengthens our presence in adult immunization by bringing together Dynavax's vaccines with Sanofi's commercial reach, global scale and development capabilities.
Read our press release ➡️ -
Sanofi
@sanofi
Our investigational BTK inhibitor for the potential treatment of wAIHA was granted Breakthrough Therapy Designation by @US_FDA and Orphan Drug by @MHLWitter_en in Japan, validating our commitment to helping address unmet needs for people living with rare diseases.
Learn more: -
Sanofi
@sanofi
New results from two phase 3 studies of our investigational oral therapy in type 3 Gaucher disease and Fabry disease are now available.
Learn more about this #raredisease research. www.sanofi.com/en/media-room/press-releases/2026/2026-02-… -
Sanofi
@sanofi
The @EMA_News CHMP has recommended the approval of our therapy to treat patients aged 12+ with chronic graft-vs-host disease cGVHD, a life-threatening complication that affects up to 1 in 2 people who undergo a stem cell transplant.
Learn more ➡️ www.sanofi.com/en/media-room/press-releases/2026/2026-01-… -
Sanofi
@sanofi
Our Q4 and full-year 2025 results are now available.
Learn more: www.sanofi.com/en/investors/financial-results-and-events/…
#sanofiresults $SAN $SNY -
Sanofi
@sanofi
#news: New data confirms potential in #atopicdermatitis
These results demonstrate the potential of OX40-ligand as an important #new mechanism in #ad.
Learn more: www.sanofi.com/en/media-room/press-releases/2026/2026-01-…
#dermatology #clinicalresearch #innovation -
Sanofi
@sanofi
#news: The National Medical Products Administration in China has approved treatments for obstructive hypertrophic cardiomyopathy (oHCM), and familial chylomicronaemia syndrome (FCS).
Learn more ➡️ www.sanofi.com/en/media-room/press-releases/2026/2026-01-… -
Sanofi
@sanofi
#news: The @EU_Commission has approved our medicine to delay the onset of stage 3 type 1 diabetes in patients aged eight years and older with stage 2 #t1d marking the first disease-modifying treatment option in the EU for early T1D.
Learn more: www.sanofi.com/en/media-room/press-releases/2026/2026-01-… -
Sanofi
@sanofi
The @US_FDA accepted for Priority Review our sBLA for children between one and eight years of age with stage 2 #type1diabetes. Learn more about this milestone ➡️ www.sanofi.com/en/media-room/press-releases/2026/2026-01-…
-
Sanofi
@sanofi
#news: We've entered into an agreement to acquire @DynavaxCorp, adding an adult hepatitis B vaccine and shingles candidate to our adult #vaccine portfolio and pipeline.
Learn more➡️www.sanofi.com/en/media-room/press-releases/2025/2025-12-… -
Sanofi
@sanofi
Update on the @FDA review of our investigational treatment in non-relapsing secondary progressive multiple sclerosis (nrSPMS).
Read our press release: www.sanofi.com/en/media-room/press-releases/2025/2025-12-… -
Sanofi
@sanofi
#news: The @EU_Commission has approved the first BTK inhibitor to treat adults with immune thrombocytopenia (#itp) who are refractory to other treatments.
Learn more: www.sanofi.com/en/media-room/press-releases/2025/2025-12-… -
Sanofi
@sanofi
The Ministry of Health, Labour and Welfare in Japan has approved our medicine for the treatment of certain children aged 6 to 11 years with asthma. Read our release: www.sanofi.com/en/media-room/press-releases/2025/2025-12-…
CC: @Regeneron -
Sanofi
@sanofi
.@EMA_NEWS has granted orphan designation to our investigational therapy for AATD related emphysema, validating our commitment to pursuing medicines for #rarediseases with significant unmet medical need.
Learn more ➡️ www.sanofi.com/en/media-room/press-releases/2025/2025-12-… -
Sanofi
@sanofi
#news: Phase 3 update on our clinical study for primary progressive multiple sclerosis. Read our press release ➡️ www.sanofi.com/en/media-room/press-releases/2025/2025-12-…
-
Sanofi
@sanofi
#news: Update on our phase 3 investigational medicine studying multiple sclerosis. Read our press release ➡️ www.sanofi.com/en/media-room/press-releases/2025/2025-12-…
-
Sanofi
@sanofi
#news: The National Medical Products Administration in China has approved treatments for hemophilia A or B with or without inhibitors, and acquired thrombotic thrombocytopenia purpura (aTTP).
Learn more ⬇️
www.sanofi.com/en/media-room/press-releases/2025/2025-12-… -
Sanofi
@sanofi
Older adults had the highest rates of flu-related hospitalization compared to the total population in multiple countries, and these were costly.
Our #flunomics report reveals where the protection of older adults needs stronger measures.
➡️ See the data: www.sanofi.com/en/magazine/your-health/flunomics-assessin… -
Sanofi
@sanofi
The European Commission has approved our medicine in the EU for certain adults and adolescents with moderate-to-severe chronic spontaneous urticaria (CSU), marking the first targeted treatment option in over a decade. Read more ⬇️
CC: @Regeneron -
Sanofi
@sanofi
The @WHO set a flu vaccination coverage target of 75% for older adults.
Our #flunomics report reveals where countries fell short and where better, more tailored approaches to vaccination can protect both people and health systems.
🔗Read more: www.sanofi.com/en/magazine/your-health/flunomics-assessin… -
Sanofi
@sanofi
At #acaai25, we’re presenting phase 3 results in allergic fungal rhinosinusitis (AFRS) in people aged 6 years and older, underscoring our commitment to advancing care for chronic respiratory diseases.
CC: @Regeneron -
Sanofi
@sanofi
Again and again, we see older adults hospitalized at higher rates than the general population.
Our #flunomics report shows why we shouldn’t underestimate flu each season, and why tailored protection for older adults is key.
➡️ www.sanofi.com/en/magazine/your-health/flunomics-assessin… -
Sanofi
@sanofi
Our Q3 2025 Results are now available. Read the press release. ⬇️
#sanofiresults $SAN $SNY -
Sanofi
@sanofi
Results from a phase 2 study evaluating an investigational treatment for alpha-1 antitrypsin deficiency (#aatd), achieved all primary and key secondary endpoints.
Read our press release to learn more about our research on this #raredisease. -
Sanofi
@sanofi
#news: The @US_FDA accepted the filing of our sBLA for recently diagnosed stage 3 #type1diabetes for expedited review through the FDA Commissioner’s National Priority Voucher (CNPV) pilot program. Learn more ⬇️
-
Sanofi
@sanofi
We have presented Phase 2 data at #esmo25 supporting the potential of our investigational therapy for gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
Read more ⬇️
CC: @OranoMed @RadioMedix -
Sanofi
@sanofi
#news: FLUNITY-HD study in @TheLancet assessed the effectiveness of our high-dose #influenza vaccine against hospitalizations in 65+ vs standard-dose.
Learn more ⬇️ -
Sanofi
@sanofi
#news: The @EMA_News CHMP has recommended the approval of our new treatment for adults with immune thrombocytopenia (#itp), reinforcing our commitment to advance scientific innovation that addresses unmet patient needs in #rarediseases.
Learn more ⬇️ -
Sanofi
@sanofi
Data from our phase 4 head-to-head study in people with chronic rhinosinusitis with nasal polyps (#crswnp) and coexisting asthma has been published in @LancetRespirMed. Learn more about the findings.
CC: @Regeneron -
Sanofi
@sanofi
The @US_FDA has granted Fast Track designation to our investigational gene therapy for the treatment of #myotonicdystrophytype 1, reinforcing our dedication to developing new medicines that address unmet needs for people living with #rarediseases.
Learn more ⬇️ -
Sanofi
@sanofi
The CHMP recommended the approval of our medicine for certain adults and adolescents in the EU with #chronicspontaneousurticaria (CSU), potentially providing a new option for people with this debilitating skin disease.
CC: @Regeneron -
Sanofi
@sanofi
#news: At #eadvcongress 2025, we’re presenting results from a phase 2a study evaluating our investigational therapy in moderate-to-severe #hidradenitissuppurativa – a chronic and debilitating inflammatory skin disease.
Learn more about our data ⬇️ -
Sanofi
@sanofi
#news: At #ectrims2025, we’re sharing new data in #multiplesclerosis as we continue to test the bounds of clinical possibility across the spectrum of disease.
Learn more about our MS research and innovation ⬇️ -
Sanofi
@sanofi
#news: At #erscongress 2025, we’re presenting new data across #asthma, #copd, and #crswnp, reinforcing our breadth of innovation in chronic respiratory conditions and commitment to helping patients breathe better.
Read about our data ⬇️
CC: @Regeneron -
Sanofi
@sanofi
#news: Phase 3 study evaluating our investigational treatment in #atopicdermatitis met its primary endpoints, demonstrating potential as a new treatment option for people with moderate-to-severe disease.
Learn more ⬇️ -
Sanofi
@sanofi
#news: New data at #eadvcongress 2025 underscores the potential of novel platforms and technologies across chronic inflammatory skin conditions, including atopic dermatitis and hidradenitis suppurativa.
Read about our data ⬇️
CC: @Regeneron -
Sanofi
@sanofi
Our CEO, Paul Hudson, on Q2 2025: continued pipeline progress, key approvals, and milestones.
Read more: www.sanofi.com/en/investors/financial-results-and-events/…
#sanofiresults $SAN $SNYThis media couldn't be displayed. See it on the original post. -
Sanofi
@sanofi
Our second quarter 2025 results are now available. Read the press release: www.sanofi.com/en/investors/financial-results-and-events/…
#sanofiresults $SAN $SNY -
Sanofi
@sanofi
📢 #news: The @US_FDA has granted Orphan Drug Designation to our investigational IgG1-based, GPRC5D-targeting antibody treatment for patients with relapsed or refractory #multiplemyeloma.
Learn more ⬇️ -
Sanofi
@sanofi
#news: The @EU_Commission has approved our combination therapy for adult patients with newly diagnosed #multiplemyeloma eligible for transplant.
Learn more ⬇️
www.sanofi.com/en/media-room/press-releases/2025/2025-07-… -
Sanofi
@sanofi
We’ve entered into an agreement to acquire Vicebio. This brings an early-stage combination vaccine candidate for RSV and hMPV, both respiratory viruses, and expands capabilities in vaccine design and development with ‘Molecular Clamp’ technology. Read more ⬇️
-
Sanofi
@sanofi
We have completed the acquisition of @BlueprintMeds expanding our portfolio in rare immunological disease and adding early-stage pipeline in immunology.
-
Sanofi
@sanofi
#news: The @EMA_News CHMP has recommended the approval of our combination therapy to treat people with newly diagnosed #multiplemyeloma (MM) eligible for transplant. The decision represents a significant step for the MM community.
Learn more ⬇️ -
Sanofi
@sanofi
The @US_FDA approved our medicine as the first and only treatment specifically indicated for adults with #bullouspemphigoid (BP), a chronic and debilitating skin disease. Read more ⤵️
CC: @Regeneron -
Sanofi
@sanofi
At #eaaci2025, we’re presenting new late-breaking data from our phase 4 head-to-head study in patients with chronic rhinosinusitis with nasal polyps (#crswnp) and coexisting asthma.
Find out more about the results ⬇️
CC: @Regeneron -
Sanofi
@sanofi
#news: At #eular2025, we presented new data evaluating our investigational therapy in active IgG4-related disease, a progressive immune-mediated rare disease.
Read about our data ⬇️ -
Sanofi
@sanofi
We’re sharing results from phase 4 research in patients with skin of color diagnosed with #atopicdermatitis at #rad2025. Read more about the data. 📣
CC: @Regeneron -
Sanofi
@sanofi
#news: At ISTH 2025, we’re sharing new data in immune thrombocytopenia (#itp) and #hemophilia that demonstrate our commitment to supporting the varied needs of people living with #rareblooddisorders.
Learn more about our research and scientific innovation ⬇️ -
Sanofi
@sanofi
#news: New data at #asco25 published in @JCO_ASCO analyzed the potential of an investigational delivery method to administer our investigational subcutaneous #multiplemyeloma combination therapy.
Learn more ⬇️ -
Sanofi
@sanofi
The @US_FDA has granted Orphan Drug Designation to our investigational therapy for the treatment of #sicklecelldisease, reinforcing our dedication to developing new medicines that address unmet needs for people living with #rarediseases.
Learn more ⬇️ -
Sanofi
@sanofi
We announced an agreement to acquire Blueprint Medicines, a biopharmaceutical company specializing in systemic mastocytosis, a rare immunological disease, and other KIT-driven diseases.
-
Sanofi
@sanofi
We’re providing an update on our phase 3 studies in adults with COPD: www.sanofi.com/en/media-room/press-releases/2025/2025-05-…
CC: @Regeneron -
Sanofi
@sanofi
#news: First real-world comparison of infant and maternal respiratory syncytial virus (#rsv) immunization programs to be presented at #espid2025.
Read more ⬇️ -
Sanofi
@sanofi
We’re acquiring Vigil Neuroscience, adding a potential first-in-class neuroinflammation treatment to our R&D pipeline. A Phase 2 Alzheimer’s study is planned—because patients urgently need new options.
Learn more. ⤵️ -
Sanofi reposted
-
Sanofi
@sanofi
We’re proud to be teaming up with @McLarenF1 Racing on the legendary 24 Hours of Le Mans – carrying not just speed and innovation, but a powerful message. 💛💜💙
Read more ➡️ www.sanofi.com/en/media-room/press-releases/2025/2025-04-…
#defeatmeningitis #meningitisflag @M_R_FThis media couldn't be displayed. See it on the original post. -
Sanofi
@sanofi
Our first quarter 2025 results are now available. Read the press release. ⤵️
#sanofiresults $SAN $SNY -
Sanofi
@sanofi
#news: Our medicine with @Regeneron has been approved by the @US_FDA for certain patients aged 12 years and older with #chronicspontaneousurticaria (CSU), a chronic inflammatory skin disease. Read more ⤵️
-
Sanofi
@sanofi
#news: Phase 3 data from three studies of our investigational treatment for adults with #multiplesclerosis have been published by @NEJM and presented during a plenary session at #aanam
Learn more ⬇️ -
Sanofi
@sanofi
Almost half of the world’s population lives in an area sensitive to climate change.
This #worldhealthday, learn how we’re tackling environmental challenges to improve global health ⤵️ -
Sanofi
@sanofi
#news: The Ministry of Health, Labor and Welfare in Japan approved our medicine for adults living with uncontrolled #copd, a first-of-its-kind medicine for this progressive respiratory disease.
Read more below 👇
CC: @Regeneron -
Sanofi
@sanofi
#news: The @US_FDA has granted fast track designation to our #chlamydia vaccine candidate for the prevention of chlamydia infection.
Learn More ⬇️ -
Sanofi
@sanofi
NEWS: @US_FDA accepted our application with priority review for an investigational treatment in adults living with non-relapsing secondary progressive #multiplesclerosis (nrSPMS).
Learn more ⬇️ -
Sanofi
@sanofi
We announced entering into an agreement to acquire DR-0201, Dren Bio’s bispecific myeloid cell engager for deep B-cell depletion.
The acquisition, subject to closing conditions including receipt of regulatory approval, will broaden our immunology pipeline. -
Sanofi
@sanofi
We’re spotlighting #myelomamilestone moments to raise awareness and amplify the stories of the myeloma community. Learn more about how to get involved during Myeloma Action Month from @IMFmyeloma.
International Myeloma Foundation
@IMFmyeloma
What was a major #myelomamilestone moment for you? Tell us in the comments!
Take action this #myelomaactionmonth! Tag and share with your circle and use the #myelomamilestone hashtag to spread knowledge of multiple myeloma. ❤️ -
Sanofi
@sanofi
At #aad2025, we shared late-breaking data from our pivotal trial in adults with #bullouspemphigoid. Learn more about the results presented with @Regeneron ⬇️
-
Sanofi
@sanofi
#news: Today, Japan’s Ministry of Health, Labour and Welfare approved our combination regimen for patients with newly diagnosed #multiplemyeloma.
Learn more ⬇️ -
Sanofi
@sanofi
#news: The application of our investigational medicine for #bullouspemphigoid (BP) has been accepted for priority review by the @US_FDA. Learn more about the news. ⬇️
CC: @Regeneron -
Sanofi
@sanofi
#gvhdday makes this the ideal time to learn the ABCs of Graft-Versus-Host-Disease.
Sometimes severe, this complication is experienced by about half those transplanted with donor cells.
Visit to find out more and show your support. ⤵️
#gvhdalliance #gvhdconnectforhope -
Sanofi
@sanofi
#news: China’s National Medical Products Administration has approved our combination therapy for adult patients with newly diagnosed #multiplemyeloma ineligible for transplant.
Learn more ⬇️ -
Sanofi
@sanofi
Our CEO, Paul Hudson, reflects on the pivotal role innovation plays in driving our growth.
Learn more: www.sanofi.com/en/media-room/press-releases/2025/2025-01-…
#sanofiresults $SAN $SNY -
Sanofi
@sanofi
Our Q4 & Full-Year 2024 results are now available. Learn more. ⤵️
#sanofiresults $SAN $SNY -
Sanofi
@sanofi
#news: @EU_Commission has approved our combination therapy for adult patients with newly diagnosed #multiplemyeloma ineligible for transplant in the EU.
Learn more ⬇️ -
Sanofi
@sanofi
The biopharma industry is entering a transformative era.
In an article with the @wef, our CEO Paul Hudson discusses four key areas that can power the progress of medicine 2025.
Read more 👇
#wef25 #worldeconomicforum #biopharma -
Sanofi
@sanofi
#news: China’s National Medical Products Administration has approved our combination therapy for adult patients with relapsed or refractory #multiplemyeloma.
Learn more ⬇️ -
Sanofi
@sanofi
#news: Latest phase 3 study evaluating our investigational subcutaneous #multiplemyeloma combination therapy met key endpoints in relapsed or refractory patients.
Learn more ⬇️ -
Sanofi
@sanofi
Here’s to health, progress and achievements in 2025. Let’s make the new year amazing – together! 🧬 #happynewyear #2025 #weneversettle
-
Sanofi
@sanofi
#news: We launched the phase 3 clinical program for our 21-valent #pneumococcal conjugate vaccine candidate and expanded our partnership with SK bioscience to develop next-generation vaccines.
Together, we’re pushing boundaries to help protect more lives.
Learn more ⬇️ -
Sanofi
@sanofi
#news: The @US_FDA granted Breakthrough Therapy designation to our investigational treatment for non-relapsing secondary progressive #multiplesclerosis, an area of unmet need for the community. Read our press release ➡️ www.sanofi.com/en/media-room/press-releases/2024/2024-12-…
-
Sanofi
@sanofi
#news: Today the @US_FDA granted Fast Track designation for our two combination vaccine candidates to prevent #influenza and #covid19 infections.
Learn More ⬇️ -
Sanofi
@sanofi
#news: At #ash24, we shared pivotal data about our investigational treatment for #immunethrombocytopenia (ITP), and new phase 3 data evaluating our combination regimens in newly diagnosed #multiplemyeloma.
-
Sanofi
@sanofi
How are we ensuring transparency in #ai? 🧠
We prioritize transparency in AI systems with risk assessments, guidelines, and training to ensure reliable outputs. Our approved AI tools support our Digital R&D team in analyzing #clinicaltrial data to predict patient risk factors. -
Sanofi
@sanofi
Last week, we hosted our first global Hackathon on AI agents with 250 top users from France, USA and China. 💡 They designed AI Agents to revolutionize decision intelligence across our organization. Over 31,000 Sanofians upskilled in AI through a masterclass and quizzes.
-
Sanofi
@sanofi
#news: The resubmission of our application for an investigational medicine for chronic spontaneous urticaria (#csu) has been accepted for review by the @US_FDA.
Learn more ⬇️ @Regeneron -
Sanofi
@sanofi
#news: The @EMA_News CHMP recommended the approval of our combination therapy, making strides towards a potential new treatment option for people in the EU with newly diagnosed #multiplemyeloma who are transplant-ineligible.
Learn more ⬇️ -
Sanofi
@sanofi
Today is #worlddiabetesday.💙 We join the global community to raise awareness about this global health challenge.
Our Global Health Unit partners with @IntDiabetesFed to provide online training in 40 countries which has benefited over 1,450 healthcare professionals to-date. -
Sanofi
@sanofi
How can we harness the immune system to fight type 1 #diabetes?
Learn more about how Sanofi is using #immunoscience to develop new treatments that stop the immune system from attacking insulin-producing cells, possibly before symptoms even appear. -
Sanofi
@sanofi
We’re harnessing the power of #ai to unlock the immune system’s potential in treating complex diseases. Our R&D leaders share how AI-driven #immunoscience could bring potentially life-changing therapies to patients faster in a recent @WIRED article.
-
Sanofi
@sanofi
Climate change is taking a toll on our health. In @ProSyn, our CEO Paul Hudson proposes strategies we must implement to protect human health ⬇️
Read more: www.project-syndicate.org/commentary/health-care-sector-m… -
Sanofi
@sanofi
The @EU_Commission approved our medicine for children aged 1-11 with eosinophilic esophagitis (#eoe).
As the first and only treatment for children in the region with this devastating condition, this medicine provides an important new option for patients.
CC: @Regeneron -
Sanofi
@sanofi
Our CEO, Paul Hudson, reflects on our strong Q3, pushed forward by the momentum of our launches of innovative medicines and vaccines.
Learn more: www.sanofi.com/en/investors/financial-results-and-events/…
#sanofiresults $SAN $SNY -
Sanofi
@sanofi
Our Q3 2024 results are now available. Learn more. ⤵️
#sanofiresults $SAN $SNY -
Sanofi
@sanofi
#news: At #acaai24, new late-breaking positive results from our phase 3 study in chronic spontaneous urticaria (CSU) are being presented. Learn more ⬇️
CC: @Regeneron -
Sanofi
@sanofi
Mariette Yang's dream was to become a doctor and help people. ✨
At Sanofi, she's making that dream come true!
Now, as part of our #manufacturing & #supply team, she thrives working alongside a passionate and diverse group of Sanofians.
Learn more: www.youtube.com/watch?v=ZGZItZKPnMo -
Sanofi
@sanofi
Our Global Health Unit addresses critical #healthcare gaps in vulnerable populations through a not-for-profit model, focusing on enhancing access to medicine, strengthening health systems, and driving impactful investments.
Discover our actions in our 2024 Impact Report ⬇️ -
Sanofi
@sanofi
#news: at #idweek2024, new real-world effectiveness data on our respiratory syncytial virus (#rsv) immunization for infants will be presented. Learn More ⬇️
-
Sanofi
@sanofi
The @US_FDA has approved our medicine as an add-on maintenance treatment of adult patients with inadequately controlled chronic obstructive pulmonary disease (COPD) and an eosinophilic phenotype. This marks the first-ever biologic approved for COPD.
CC: @Regeneron -
Sanofi
@sanofi
China’s National Medical Products Administration has approved our treatment for uncontrolled #copd. With this approval, we hope to address a major public health concern and help more people living with this progressive respiratory disease worldwide. For more👇
CC: @Regeneron -
Sanofi
@sanofi
🚨 News from #unga79! Foundation S and The Collective MindS Climate x Health Council just released their Action Report. 🌍
It outlines key steps to boost #healthcare resilience and secure flexible funding for local health adaptation. Learn more 👇
#climatefinance -
Sanofi
@sanofi
Jane Pavlik is part of our #manufacturing & #supply teams. While turning R&D ideas into reality for patients comes with its challenges, she believes that diversity brings fresh perspectives and enhances problem-solving.
Learn more: www.youtube.com/watch?v=bgh91z6Z7E8 -
Sanofi
@sanofi
New data at the #eadvcongress reinforce our commitment to advancing care across immune-mediated skin diseases, including #atopicdermatitis and #csu. Read about our presentations, including select data in partnership with @Regeneron 👇
-
Sanofi
@sanofi
#news: Today, the @US_FDA approved our #multiplemyeloma combination therapy for certain adults who are newly diagnosed.
Read more about the news ⬇️ -
Sanofi
@sanofi
The @EMA_News CHMP recommended the approval of our medicine for children aged 1-11 with eosinophilic esophagitis (#eoe), a chronic and progressive disease that can damage the esophagus: www.sanofi.com/en/media-room/press-releases/2024/2024-09-…
CC: @Regeneron -
Sanofi
@sanofi
#news: At #ectrims2024, we presented phase 3 results for our investigational #multiplesclerosis treatment, a critical step towards reaching the unmet needs of people living with #ms.
Learn more ⤵️ -
Sanofi
@sanofi
#news: Today, we’ve entered into an exclusive licensing agreement with @OranoMed and @RadioMedix, to advance a next-generation medicine, now in Phase 2, in the expanding field of radioligand therapies.
Learn more ⬇️ -
Sanofi
@sanofi
Phase 3 data shows positive results of our investigational medicine in people aged 6 years and older with chronic spontaneous urticaria (CSU) uncontrolled on antihistamines. Learn about our efforts to advance care for this debilitating skin disease:
CC: @Regeneron -
Sanofi
@sanofi
Pivotal data demonstrate the potential for our investigational treatment in adults with bullous pemphigoid, a chronic and relapsing skin disease, characterized by intense itch and blisters.
CC: @Regeneron -
Sanofi
@sanofi
Now that we’ve brought the #paris2024 Paralympic Games to a close, we want to say a huge thank you to our 2,024 volunteers that helped to make both the #olympic and #paralympic Games Paris 2024 a reality! 💜 🙌
#ignitingpotential #weneversettle @Paris2024This media couldn't be displayed. See it on the original post. -
Sanofi
@sanofi
#news: At #erscongress, we’re sharing new pooled data from two landmark phase 3 studies in #copd. We remain committed to chasing the miracles of science for people with this respiratory disease ⤵️
-
Sanofi
@sanofi
#paris2024 Paralympic Games was a blast! We’re so proud of our #teamsanofi athletes and Sanofi volunteers for putting in the hard work every step of the way 🙌
#weneversettle #ignitingpotential #paralympics
@Paris2024This media couldn't be displayed. See it on the original post. -
Sanofi
@sanofi
Our #volunteers are bringing incredible energy to the #paralympics! Thanks for bringing out the magic of the Games and making them unforgettable! We couldn’t be prouder of our amazing Sanofians 💜✨
#paris2024 #ignitingpotential #weneversettle -
Sanofi
@sanofi
#news: New ground-breaking positive Phase 3 results in non-relapsing secondary progressive #multiplesclerosis. Update on relapsing MS results. ⤵️
-
Sanofi
@sanofi
Ready, set, GO! The #paris2024 #paralympic Games are here!
The Games are kicking off strong for Team Sanofi! After carrying the Olympic Flame Paris 2024 in its final meters, Nantenin Keita, shines as a flag bearer & torchbearer at the Paralympic Opening Ceremony! 🌟
Our #volunteers are set to make the Games a reality and we're so ready to cheer on our #teamsanofi athletes!
Last but not least, let’s make a difference by flying the #meningitisflag high during these Games! 💛💜💙
#ignitingpotential #weneversettle -
Sanofi
@sanofi
What a magical start! ✨Here are the highlights 👇
🐎 Our Metal Horse from the #paris2024 Olympic Games Opening Ceremony is now on display at the Paris mayor’s office.
🌍 Sanofi volunteers have traveled across the globe, ringing in plenty of energy and motivation, for a kick-off at the UNESCO House in Paris!
🔥 The Paris 2024 #paralympicflame made a stop at La Maison Sanofi, with our CEO Paul Hudson & our EVP Corporate Affairs @DerveloyA proudly carrying it to our HQ.
#paralympics
@paris2024 -
Sanofi
@sanofi
At #erscongress, we’re presenting 24 abstracts united by a singular goal: to advance care for people with immune-mediated respiratory diseases such as #copd, #asthma, and #crswnp. Learn more about our presentations, including select data in partnership with @Regeneron ⬇️
-
Sanofi
@sanofi
Week 2 of the Olympic Games Paris 2024 is in the books 💜 💜
We're so proud of our #teamsanofi Athletes, Volunteers, and Igniters for their dedication and hard work🥇
#weneversettle #ignitingpotential #paris2024 @Paris2024This media couldn't be displayed. See it on the original post. -
Sanofi
@sanofi
That's a wrap for the Olympic Games Paris 2024 🤩
Our Team Sanofi dazzled us by winning 4 medals! Also THANK YOU to the 1,000+ Sanofians who volunteered during the Olympics 🫶
We're ready to cheer on our Team Sanofi at the Paris 2024 #paralympics Games!
#olympics #paris2024 -
Sanofi
@sanofi
#news: Latest phase 3 data in #multiplemyeloma study shows investigational combination regimen meets key survival endpoint in newly diagnosed, transplant-eligible patients.
Learn more ⬇️ -
Sanofi
@sanofi
Our amazing #teamsanofi athletes, @BubucheOfficiel and @Yul_Shin0122 stopped by La Maison Sanofi ✨ They had a blast meeting our Sanofians and exploring our exhibition that highlights the link between science and sports.
-
Sanofi
@sanofi
Week 1 of the Olympic Games Paris 2024 ✅
Check out our highlights! Spoiler, there is a LOT! 🥇
Stay tuned! We’re excited for the days ahead as our #teamsanofi athletes Valériane Ayayi & Dany Dann compete. Go Team Sanofi! 💜
@Paris2024This media couldn't be displayed. See it on the original post. -
Sanofi
@sanofi
As part of our partnership with @Paris2024, we’re very proud to become the home of the “Metal Horse” from the #openingceremony of the #olympicgames Paris 2024.
Learn more: www.sanofi.com/en/magazine/our-science/paris-2024-opening…
#ignitingpotential #weneversettle -
Sanofi
@sanofi
Just a few hours left until the #olympicgames Paris 2024 begin! 🔥
Our volunteers for the Games are arriving from all around the world and they’ve just kicked off Games Time at the UNESCO House in Paris!
Just like athletes, they've been gearing up for months to bring the spirit of the Games to life.
Stay tuned, this is only the beginning✨
#weneversettle #ignitingpotential #paris2024 @Paris2024 -
Sanofi
@sanofi
Our Q2 2024 results are now available. Learn more. ⤵️
#sanofiresults $SAN $SNY -
Sanofi
@sanofi
#news: Pivotal data published in @NEJM demonstrate effective bleed protection in children under 12 living with severe #hemophilia A. Learn how these results can transform the standard of care: www.sanofi.com/en/media-room/press-releases/2024/2024-07-…
-
Sanofi
@sanofi
For #teamsanofi athlete @BubucheOfficiel and Arnaud Dourlens, our first torchbearer for the Olympic Torch Relay Paris 2024, their supporters make sure they never settle when it comes to their success 🌟🤝
#ignitingpotential #weneversettle @Paris2024 -
Sanofi
@sanofi
Whether in sports or in science, we’re as committed as the team of people who stand behind us. 🤝💪
Ask #teamsanofi member Ezra Frech and Youxin Kong, a Sanofi senior scientist and volunteer for the Olympic Games #paris2024. -
Sanofi
@sanofi
It’s more important than ever to ensure that #ai is designed and developed to minimize bias. For us, tech doesn't work, unless it works for everyone. Read more: www.sanofi.com/en/magazine/ai-in-healthcare/all-in-ai-bia…
This media couldn't be displayed. See it on the original post. -
Sanofi
@sanofi
We have been named No. 7 on @TIME's list of the World's Most #sustainable Companies!
Learn more about how we’re minimizing our environmental impact ➡️ www.sanofi.com/en/our-company/sustainability/environmenta… -
Sanofi
@sanofi
The @EU_Commission approved our medicine for adults with uncontrolled #copd. As the first-ever targeted therapy for COPD, this treatment offers new hope for those who previously had little options for this burdensome disease in the EU.
CC: @Regeneron
Learn more ⬇️ -
Sanofi
@sanofi
24 days to go 🔜 @Paris2024! 🔥
Our #teamsanofi athletes and Sanofians are gearing up for this once-in-a-lifetime moment! 🌟
Learn more about Sanofi x #paris2024: www.sanofi.com/en/paris-2024-partnership -
Sanofi
@sanofi
At Sanofi, AI isn't just a tool—it's interwoven into every step of our drug development journey. The use of virtual patient populations, or "digital twins," is a standout example of how we are accelerating R&D for asthma and other immune-mediated diseases.
-
Sanofi
@sanofi
#news: Phase 2 data presented at #ean2024 in multiple sclerosis. There is still so much we can learn about neurological diseases and we’re committed to advancing our understanding of the underlying science behind them. #multiplesclerosis.
Learn more ⤵️: -
Sanofi
@sanofi
Want a #bts look into the Olympic Torch Relay? 🔥 We captured all the most incredible moments from when the #olympic Flame stopped by our site in Neuville-sur-Saône, France 🙌
#ignitingpotential #paris2024 #weneversettle @paris2024This media couldn't be displayed. See it on the original post. -
Sanofi
@sanofi
Positive Phase 3 data evaluating our medicine with @Regeneron for eosinophilic esophagitis (#eoe) in pediatric patients aged 1 to 11 years has been published in @NEJM. Learn more about the results: www.sanofi.com/en/media-room/press-releases/2024/2024-06-…
-
Sanofi
@sanofi
Only 1 month left until the Olympic and Paralympic Games #paris2024, we wanted to thank the family, friends and mentors who taught us to never settle, in our pursuit of what’s next. 🔥
@Paris2024 #ignitingpotential #weneversettle #teamsanofi #olympics #paralympicsThis media couldn't be displayed. See it on the original post. -
Sanofi
@sanofi
#news: At #isth2024, we’re sharing seven oral presentations from across our #hemophilia portfolio, which reinforce our commitment to bring treatments that could be first- and best-in-class to the rare blood disorder community.
-
Sanofi
@sanofi
#news: Today we announced a manufacturing partnership with @Biovac_inst, a South African biopharmaceutical company, to produce inactivated #polio vaccines in Africa.
Read more 👇 -
Sanofi
@sanofi
We are tackling the climate crisis with a holistic approach that includes focusing on addressing the research gap that exists, allowing for better informed strategies and solutions. 🤝🍃
Learn more about our approach and findings here: www.sanofi.com/en/magazine/social-impact/climate-health-n… -
Sanofi
@sanofi
We believe that with #ai, we'll better chase the miracles of science to improve people’s lives: chasing faster and solving sooner.
Watch our recap from @VivaTech, where we shared the next chapter of our journey to becoming the first biopharma powered by AI at scale, responsiblyThis media couldn't be displayed. See it on the original post. -
Sanofi
@sanofi
That’s a wrap on the Sanofi Cup Final! More than just a competition, this was the first time we’ve gathered thousands of Sanofians from around the world to explore what science and sports have in common. 🔥
#paris2024 #ignitingpotential #weneversettle @Paris2024This media couldn't be displayed. See it on the original post. -
Sanofi
@sanofi
Meet Amber, one of our inspiring women making a difference at Sanofi. ✨
Leading our Gender+ WISE ERG program in North America, she empowers her colleagues to build the skills they need to grow and develop professionally. Discover her story 👇
#inspireinclusion #womenintech -
Sanofi
@sanofi
Make your passion your purpose ✨
On our brand-new careers site, our Sanofians show you how you can chase the miracles of science to improve people’s lives.
Learn more ⤵️
#pursueprogress #discoverextraordinary -
Sanofi
@sanofi
In our moments of self-doubt, it’s the people who believe in us that pick us back up. For Arnaud Dourlens, our first Olympic Games #paris2024 torchbearer, that person is his mentor, Catherine Lentgen.
#ignitingpotential @Paris2024 #weneversettle #olympictorchrelay -
Sanofi
@sanofi
The Sanofi Cup Final was legendary! Almost 300 Sanofi athletes from across the world. 24 teams. 5 sports. And as One Sanofi, we came together to channel the spirit of the Olympic and Paralympic Games Paris 2024: our determination and teamwork taking center stage 💪
-
Sanofi
@sanofi
NEWS: We’re exploring areas of high unmet need in #multiplemyeloma. Our phase 3 data at #asco24 demonstrates the potential of our investigational therapy in newly diagnosed transplant-ineligible patients. Learn more ⬇️
www.sanofi.com/en/media-room/press-releases/2024/2024-06-… -
Sanofi
@sanofi
#news: The CHMP has recommended the approval of our #copd medicine, paving the way for a new treatment option for adults with uncontrolled COPD with raised blood eosinophils in the European Union. Read more about the latest news 👇
@Regeneron -
Sanofi
@sanofi
#news update on the @FDA priority review of our investigational medicine for certain adults living with uncontrolled COPD. Read our press release 👇
@Regeneron -
Sanofi
@sanofi
We’re rethinking the role of the immune system across diseases. Learn about how we are redefining therapeutic R&D with #immunoscience.
-
Sanofi
@sanofi
Experience the next chapter in our journey to becoming the first biopharma company powered by AI at scale this week at #vivatech
Learn more about our innovations: www.sanofi.com/en/magazine/our-science/viva-technology-20…
📍 Join us on Stand J24 to meet our experts and discover the next generation of healthcare -
Sanofi
@sanofi
Today, hours from the opening of #vivatech, we’re excited to announce our collaboration with @FormationBio & @OpenAI to build first-in-class AI-powered software. Join us at VivaTech for more on our AI innovations. ⤵️
-
Sanofi
@sanofi
#news: Late-breaking data from our replicate Phase 3 trial in COPD were presented at #ats2024 and published in @NEJM. Explore the latest results for this complex respiratory disease. @Regeneron ⬇️
Read our press release: www.sanofi.com/en/media-room/press-releases/2024/2024-05-… -
Sanofi
@sanofi
To mark the 100 days to the @Paris2024 Paralympic Games the #meningitisflag is spreading its colors across the French capital! Sport goes beyond medals; it ignites change beyond its realms. If only it could help change #meningitis awareness. AI-Generated images by IfOnlyAI
@M_R_F -
Sanofi
@sanofi
AI is a powerful tool, but it’s our role as innovators to be accountable to its outcomes. We believe this goes beyond legal compliance and uphold our Responsible AI Standards from design through to use. Read more: www.sanofi.com/en/magazine/our-science/ai-accountable-to-…
This media couldn't be displayed. See it on the original post. -
Sanofi
@sanofi
Who pushes you to go for gold? 🥇 For #teamsanofi athlete @BubucheOfficiel, it’s her best friend Julia.
Watch to learn more about Amandine’s story of resilience as she takes on the Olympic Games #paris2024 💪
#ignitingpotential #weneversettleThis media couldn't be displayed. See it on the original post. -
Sanofi
@sanofi
The Olympic Flame just passed through our R&D site in Montpellier, France! 🔥
The journey is not over, the relay goes on with lots of key stops coming up. Stay tuned ✨
#ignitingpotential #paris2024 @Paris2024 -
Sanofi
@sanofi
Yesterday, 4 Sanofians carried the Olympic Torch in @marseille, France 🇫🇷
Over the next few weeks, the Torch will travel to several Sanofi sites across France, with nearly 300 Sanofians participating as official Torchbearers. Stay tuned! 🔥
#ignitingpotential #paris2024 -
Sanofi
@sanofi
Watching the Olympic torch arrive from Greece was such an inspiring moment for our Sanofians 🔥
We're excited to continue the torch relay tomorrow in @marseille for this once in a lifetime event.
#paris2024 #ignitingpotential -
Sanofi
@sanofi
.@TheLancet has recently published new data from Galicia, Spain, showing real-world impact on respiratory syncytial virus (#rsv) hospitalizations in infants after the introduction of our #immunization.
-
Sanofi
@sanofi
At #ats2024 we’re presenting 25 abstracts across respiratory diseases, including #copd and #asthma. We’re committed to further understanding patient needs in these complex conditions. Learn more ⬇️
www.sanofi.com/en/media-room/press-releases/2024/2024-04-… -
Sanofi
@sanofi
Our CEO Paul Hudson reflects on our strong start of the year, driven by launches and the transformation of our portfolio of medicines and vaccines.
Learn more about our first quarter 2024 results: www.sanofi.com/en/investors/financial-results-and-events/…
#sanofiresults $SAN $SNY -
Sanofi
@sanofi
Our first quarter 2024 results are now available. Read the press release: www.sanofi.com/en/investors/financial-results-and-events/…
#sanofiresults $SAN $SNY -
Sanofi
@sanofi
Who inspires you to push the limits? For Youxin, senior scientist and volunteer for the #olympic Games #paris2024, it’s her mentor Alexey. 💫 #ignitingpotential #weneversettle
This media couldn't be displayed. See it on the original post. -
Sanofi
@sanofi
#news: Positive Phase 3 data demonstrate the potential of a new first-in-class treatment for immune thrombocytopenia (#itp). Learn more about the results and how we’re committed to transforming the standard of care for people with ITP: www.sanofi.com/en/media-room/press-releases/2024/2024-04-…
-
Sanofi
@sanofi
Sometimes we need someone who believes in us more than we believe in ourselves. 🔥
For #teamsanofi athlete @TeamEzra05, the person who ignites his potential 24/7 is his mum.
Find out more about his story 👇
#ignitingpotential #paris2024This media couldn't be displayed. See it on the original post. -
Sanofi
@sanofi
NEWS: We chase the latest science to address unmet needs facing the #multiplesclerosis community. Our new data at #aan for our investigational anti-CD40L illustrates our progress. ⤵️ www.sanofi.com/en/media-room/press-releases/2024/2024-04-…
-
Sanofi
@sanofi
We’re proud to announce that the #meningitisflag has received the #impact2024 label from @Paris2024 💛💙💜
This label is all about reinforcing the important place that sport holds in society. Curious to read more? Check out below 👇
@M_R_F @COMOmeningitis -
Sanofi
@sanofi
We’re one team working in relay for one purpose—every single day.
We chase the miracles of science to improve people’s lives.
Learn how we turn the impossible into possible: www.sanofi.com/en/our-company
#sanofi #weneversettleThis media couldn't be displayed. See it on the original post. -
Sanofi
@sanofi
We’re all in on AI. In a conversation with @TEDTalks, our CEO Paul Hudson shared it’s time for businesses to harness AI to achieve the extraordinary.
Watch to learn more: www.ted.com/talks/paul_hudson_and_lindsay_levin_leadershi…
#repsonsibleai #innovation #tedtalks -
Sanofi
@sanofi
We’re thrilled to announce that @sanofi has been named to @FastCompany's Most Innovative Companies of 2024! Read more about this year’s #fcmostinnovative. ⬇️ www.fastcompany.com/91042045/sanofi-most-innovative-compa…
-
Sanofi
@sanofi
The countdown to the #olympic and #paralympic Games @Paris2024 continues! Watch the February Play It Back to catch up on our celebrations, and stay tuned for more next month 🏆
#ignitingpotentialThis media couldn't be displayed. See it on the original post. -
Sanofi
@sanofi
The women of Sanofi inspire us today and every day.
On this International Women's Day, Join us as we celebrate the journeys of four Sanofian women who chase the miracles of science to improve people's lives.
#iwd #inspireinclusion -
Sanofi
@sanofi
Who ignites your potential? For @Yul_Shin0122, #teamsanofi artistic gymnast, his father has been there from the start, encouraging him to never settle.
Together, we can always push the limits of what's possible! That's why we believe in #ignitingpotential
#paris2024 @Paris2024 -
Sanofi
@sanofi
#dyk that multiple myeloma is the second most common blood cancer in the world? During #myelomaactionmonth, we’re partnering with @imfmyeloma to amplify the voices of those living with multiple myeloma. Learn more: myelomaactionmonth.org
International Myeloma Foundation
@IMFmyeloma
TAKE ACTION: What is one thing you wish people knew about myeloma? Share your answer in a social post along with #myelomaactionmonth Learn more ways to take action at www.myelomaactionmonth.org
-
Sanofi
@sanofi
#news: We’re presenting late-breaking Phase 2 data for a novel investigational oral BTK inhibitor in chronic spontaneous urticaria at #aaaai24. Learn more: www.sanofi.com/en/media-room/press-releases/2024/2024-02-…
-
Sanofi
@sanofi
Late-breaking Phase 4 data will be presented at #aaaai24. Explore the latest results in adults with uncontrolled moderate-to-severe asthma. Learn more: www.sanofi.com/en/media-room/press-releases/2024/2024-02-…
-
Sanofi
@sanofi
Our application for an investigational COPD medicine has been accepted by the @US_FDA for priority review. Learn what this means for hundreds of thousands of patients in the U.S. living with this serious, progressive disease.
CC: @Regeneron
Learn more ⬇️ -
Sanofi
@sanofi
We’re leveraging #ai to drive faster breakthroughs.
In @FortuneMagazine, our CEO Paul Hudson covers how the technology could spark a new era of discovery and the challenges the industry must overcome to unlock its potential.
Read more: fortune.com/2024/02/19/sanofi-ceo-ai-promises-great-era-d… -
Sanofi
@sanofi
The 2023 Impact Report of our Foundation S is here! Find out more about our various initiatives around: Climate & Health, Childhood Cancer, Sleeping Sickness, and Humanitarian Aid.
-
Sanofi
@sanofi
#news: Our medicine for chronic spontaneous urticaria has received its first global approval by the Ministry of Health, Labor and Welfare in Japan. This milestone offers a new treatment option for those with unmet needs. @Regeneron
Learn more: www.sanofi.com/en/media-room/press-releases/2024/2024-02-… -
Sanofi
@sanofi
#news: Positive data for our investigational anti-CD40L antibody were published in @NEJM. Read more about how we’re exploring potential treatment options for the MS community: www.sanofi.com/en/media-room/press-releases/2024/2024-02-…
-
Sanofi
@sanofi
This #valentinesday, we’re celebrating our 1-year anniversary with #teamsanofi 💜 our team of 14 inspiring athletes and coaches.
Take a look back at our first year together 👇This media couldn't be displayed. See it on the original post. -
Sanofi
@sanofi
2️⃣0️⃣0️⃣ days until the @Paris2024 Paralympic Games!
As para-athletes are gearing up to fly their country’s flag, a new flag will also be flying: the #meningitisflag to unite the world in the fight against #meningitis.
Watch Vaskange’s amazing video to learn more 👇 💛💙💜 -
Sanofi
@sanofi
Time to Play it Back! Discover last month's highlights of our partnership with the Olympic and Paralympic Games @Paris2024.
Ready for a glimpse of January? 🔥 #ignitingpotential #paris2024This media couldn't be displayed. See it on the original post. -
Sanofi
@sanofi
We’re committed to the continuous improvement of care for people living with #pompe disease. Learn more about our latest data across a wide range of patient groups and clinical circumstances presented this week at #worldsymposia: www.sanofi.com/en/media-room/press-releases/2024/2024-02-…
-
Sanofi
@sanofi
#news: we're launching our 'Cancer & Work: Acting Together' Global Program, supporting Sanofians impacted by cancer and critical illness. Learn more: www.sanofi.com/en/media-room/press-releases/2024/2024-02-…
-
Sanofi
@sanofi
Our CEO, Paul Hudson, reflects on how we begin the year as a development-driven, science-led, tech-powered biopharma company: www.sanofi.com/en/investors/financial-results-and-events/…
#sanofiresults $SAN $SNY -
Sanofi
@sanofi
Our Q4 2023 Financial Results are now available. Read the press release: www.sanofi.com/en/investors/financial-results-and-events/…
#sanofiresults $SAN $SNY -
Sanofi
@sanofi
Sleeping sickness is one of 20 neglected tropical diseases. On #worldntdday, we spotlight the impact that can be achieved by working together, across sectors, to deliver innovative therapies.
@DNDi @WHO @Collective_FS #sanofiactsThis media couldn't be displayed. See it on the original post. -
Sanofi
@sanofi
The @US_FDA has approved an age expansion for medicine for people living with eosinophilic esophagitis (#eoe). @Regeneron Learn more ⬇️
www.sanofi.com/en/media-room/press-releases/2024/2024-01-… -
Sanofi
@sanofi
Together, we’re leading the science relay 🔥 We’re proud to partner with the Paris 2024 Olympic and Paralympic Torch Relays, symbolizing unity and the pursuit of excellence. #ignitingpotential #paris2024
-
Sanofi
@sanofi
The second season of #nojargon is coming soon 🔬✨
Let’s continue to discover scientific notions translated by our scientists into accessible and understandable content 🔎
Didn't get to see season 1? Check it out here 👉 www.sanofi.com/en/magazine/your-health/nojargon-dive-into… -
Sanofi
@sanofi
Our CEO Paul Hudson joined @SquawkCNBC today in @Davos to highlight how we are using our #ai at-scale ambition to advance science for patients. #wef24
Squawk Box
@SquawkCNBC
"We could have ahead of us a golden generation of science born out of AI," says @Sanofi CEO Paul Hudson.
This media couldn't be displayed. See it on the original post. -
Sanofi
@sanofi
Who ignites your potential? For Paralympic gold medalist @itslaurenrowles, it’s her mum.
Like Lauren, we believe in #ignitingpotential to chase the miracles of science to improve people’s lives, recognizing the people who stood by us every step of the way.This media couldn't be displayed. See it on the original post. -
Sanofi
@sanofi
The @US_FDA has updated the label for our medicine to add data in patients living with #atopicdermatitis with hand and foot involvement, a particularly difficult-to-treat form of the disease. @Regeneron Learn more ⬇️ www.sanofi.com/en/media-room/press-releases/2024/2024-01-…
-
Sanofi
@sanofi
With respiratory viruses circulating this winter, vaccination is important for older adults. But vaccine fatigue is real.
Read the full article by our medical expert Bogdana Coudsy to learn more about how flu vaccine hesitancy can impact public health 👇 www.sanofi.com/en/magazine/your-health -
Sanofi
@sanofi
New patient-reported outcomes data on Late-onset #pompe disease in Molecular Genetics and Metabolism 👉 For decades, we’ve focused on advancing care for this community, which includes listening to and incorporating their individual voices into research. www.sanofi.com/en/our-science/therapeutic-areas/rare-dise…
-
Sanofi
@sanofi
And just like that, it’s finally here…2024! We’re kicking off the new year with highlights from 2023 of our partnership with the Olympic and Paralympic Games Paris 2024 👀
This media couldn't be displayed. See it on the original post. -
Sanofi
@sanofi
Here’s to 2024 and the journey ahead ✨. Happy New Year!
#happynewyear -
Sanofi
@sanofi
Enfants de Sanofi has provided support to over 3,820 children of Sanofi employees around the 🌍. On its 30-year anniversary, learn more about the program 👉 www.sanofi.com/en/magazine/sustainability/30-years-3820-c…
This media couldn't be displayed. See it on the original post. -
Sanofi
@sanofi
Only 2-16% of clinical trial participants identify as racial and ethnic minorities. Watch more to learn about the importance of diversity in #clinicaltrials and our collaboration with @TriNetX: www.youtube.com/watch?v=LOqzTK1oVb8
-
Sanofi
@sanofi
CHMP gives positive opinion to new therapy, paving the way for local approval for HCPs to now treat the T.b. rhodesiense form of #sleepingsickness, an #ntd found in Africa, with an effective, safe alternative.
-
Sanofi
@sanofi
Are you FLUent yet?
Let's improve your scientific knowledge with our latest #nojargon minute on #flustrains 👇 -
Sanofi
@sanofi
#news: Phase 3 trial data was presented in collaboration with @EMN_EuMMnet at #ash23 on an investigational treatment for newly diagnosed transplant-eligible multiple myeloma patients. Read more: www.sanofi.com/en/media-room/press-releases/2023/2023-12-…
-
Sanofi
@sanofi
Ready for a full rundown of November? Let’s Play It Back!
Spoiler alert: #teamsanofi ignited their potential with @Yul_Shin0122 winning gold 🥇 and @BubucheOfficiel officially qualifying for the Olympic Games Paris 2024 🏆This media couldn't be displayed. See it on the original post. -
Sanofi
@sanofi
#news: Our Phase 3 trial investigating a combination regimen in newly diagnosed #multiplemyeloma met its primary endpoint. Read more: www.sanofi.com/en/media-room/press-releases/2023/2023-12-…
-
Sanofi
@sanofi
Today, we're hosting an investor R&D Event in New York providing updates and insight into our innovative pipeline and new growth drivers. Learn more. ⤵️
-
Sanofi
@sanofi
We’re going all in on AI, responsibly 🚀. Through a robust governance & 5 guiding principles, we commit to harnessing the full potential of AI whilst keeping patients and customers safe.
#aiethics #responsibleai
Read more: www.sanofi.com/en/our-science/digital/ai-across-sanofi -
Sanofi
@sanofi
🏅 On International Day of Persons with Disabilities, we honor the resilience of #teamsanofi para-athletes.
🦾 Read more about the remarkable stories of @TeamEzra05, @NantoKeita223 and @davide_morana: www.sanofi.com/en/magazine/paris-2024-partnership/fightin…
#idpd #ignitingpotential -
Sanofi
@sanofi
How can we break the impact ceiling in #inflammation and #immunology (I&I) therapeutics? Our very own Head of Global I&I Development, Naimish Patel, shares his vision. ⬇️
-
Sanofi
@sanofi
Lab coats off 🥼, running shoes on 👟. The Sanofi Cup is a celebration of teamwork, resilience, and challenge.
Watch how Sanofians from around the 🌍 ignite their potential. #ignitingpotentialThis media couldn't be displayed. See it on the original post. -
Sanofi
@sanofi
#news: Chasing the miracles of science often requires a bold approach. Alongside @Regeneron, we’ve been bold every step of the way in #copd. Read our latest news to learn what it could mean for the COPD community ⬇️
-
Sanofi
@sanofi
2023 marks 10 years of KiDS, Kids & Diabetes in Schools. We’re proud of our partnership with @IntDiabetesFed and @ispad_org on this initiative which has reached 340K+ children and is now seeing a 50% increase in participating countries, driving better understanding of diabetes.
-
Sanofi
@sanofi
Vaccines help protect not only our health but also our future, making it possible for @ingridsilva to pursue her big dream.
Ingrid followed her passion to become a professional ballerina in New York. Today, her dream is to continue pursuing her love for dance. ⬇ -
Sanofi
@sanofi
#diabetes education is not just for people living with the condition, in many cases type 2 diabetes can be delayed or prevented.
Read more from Olivier Charmeil, Executive Vice President, Sanofi General Medicines on the importance of knowing your risk #worlddiabetesday -
Sanofi
@sanofi
The @IntDiabetesFed estimates 212 million people living with #diabetes are undiagnosed. On #worlddiabetesday, take the IDF risk assessment to know your risk of developing type 2 diabetes & know your response.Visit tinyurl.com/2p8jeeh to take the test today #wddknowyourrisk
-
Sanofi
@sanofi
Less than a year until the Paris 2024 Olympic and Paralympic Games, and we're thrilled to share our monthly highlights with you. 🔥 Ready for a glimpse of October? Let's Play It Back! #ignitingpotential @nmahut @DanyDann97
This media couldn't be displayed. See it on the original post. -
Sanofi
@sanofi
Watch this fascinating peek behind the scenes as the Meningitis Flag’s designer, @LauraSpring1, explains how feedback from the meningitis community @M_R_F @COMOmeningitis influenced the symbolism of the shapes and colors. 💛💜💙 #meningitisflag
-
Sanofi
@sanofi
Respiratory Syncytial Virus #rsv can impact any infant even when they are healthy and born at term. In severe cases, it could cause lung infections.
Help us raise awareness this #rsvawarenessweek and support @EFCNIwecare 👀
Find out more 👉 www.gfcni.org/campaigns/rsv-all-infants -
Sanofi
@sanofi
Respiratory Syncytial Virus #rsv is the most common cause of lower respiratory tract infection in babies. However, many parents haven’t even heard of it.
Silke Mader, Chair of @EFCNIwecare, explains how families can learn about RSV.
#togetheragainstrsv #rsvawarenessweek -
Sanofi
@sanofi
It's 300 days before the Paralympic games Paris 2024 🦾! Sanofians took on the challenge of para-sports during our Sanofi Cup events 🏀 #ignitingpotential
-
Sanofi
@sanofi
Yes ✔ That’s right! All babies entering their first Respiratory Syncytial Virus season are at risk of #rsv.
This includes those born healthy, and at term.1,2
Find out more about RSV 👉: www.sanofi.com/en/your-health/vaccines/respiratory-syncyt… -
Sanofi
@sanofi
The history of changemaking in the bleeding disorder community can be harnessed to empower and equip the
next generation. Explore today’s innovations and co-create tomorrow’s change with @RE_Pharma 👇
Reuters Events Pharma
@RE_Pharma
Explore fundamental change for people living with #bleedingdisorders in your region. Co-create long-term impact using data, storytelling, education and inspiration. Register for Hemophilia Changemakers 2023 now events.reutersevents.com/pharma/hemophilia-virtual/utm_so…
#hemophilia #haemophilia -
Sanofi
@sanofi
Our CEO Paul Hudson reflects on our Q3 Results and the next chapter of our strategy. Read more: www.sanofi.com/en/investors/financial-results-and-events/…
-
Sanofi
@sanofi
Today we share our Q3 2023 Results and details on the next chapter of our Play to Win strategy: www.sanofi.com/en/investors/financial-results-and-events/…
-
Sanofi
@sanofi
We're proud to be included in @TIME's Best Inventions of 2023 list. #timebestinventions
TIME
@TIME
TIME's new cover: Introducing the Best Inventions of 2023 ti.me/3FuI2Qp
-
Sanofi
@sanofi
We're presenting late-breaking results from our clinical trial for children aged 1-11 with eosinophilic esophagitis (#eoe) at #acg2023. @Regeneron
-
Sanofi
@sanofi
Thank you @ispad_org for hosting us in Rotterdam! As the meeting comes to an end, we are grateful to everyone who joined our scientific activities. We are already looking forward to the 50th Annual Conference in Lisbon, Portugal.
#seeyouthere #ispad2023 #ispad2024 -
Sanofi
@sanofi
As the Olympic and Paralympic Games Paris 2024 are getting closer, we reflect on the social legacy the Games will leave behind. Read more 👇
-
Sanofi
@sanofi
#ispad2023 is well on its way! Building on 100 years of expertise in #diabetes and our growing capabilities in immunology, we are continuing to chase the miracles of science to improve outcomes for those living with autoimmune #type1diabetes.
-
Sanofi
@sanofi
We’re proud to announce the first shipments of our Impact brand medicines have arrived in the Republic of Djibouti and are en route to Tanzania, marking a significant step in our work to address healthcare access and inequity globally. Read more ⤵️
#actwithimpact -
Sanofi
@sanofi
We are pleased to share new Phase 3 clinical trial data in autoimmune #type1diabetes at #ispad2023.
At Sanofi, we remain committed to developing innovative treatments with the goal of improving the lives of those living with #t1d. ⤵️ -
Sanofi
@sanofi
We’re excited to be attending #ispad2023, where we will be sharing our latest scientific breakthroughs for autoimmune #type1diabetes. At Sanofi, we remain focused on working with the #diabetes community in our aim to improve the lives of people living with this condition.
-
Sanofi
@sanofi
Today we’re presenting late-breaking data from our Ph. 2b trial of a novel investigational anti-OX40-ligand medicine in atopic dermatitis at #eadvcongress.
Read our press release: www.sanofi.com/en/media-room/press-releases/2023/2023-10-… -
Sanofi
@sanofi
“Understanding atopic dermatitis as a complex immunologic disease helps us explore new, disruptive pathways.”
Learn more from our scientists about research to address individual needs for people with inflammatory skin conditions: www.sanofi.com/en/magazine/our-science/tackling-atopic-de…
#eadvcongress -
Sanofi
@sanofi
Join us at #uegweek where we’re sharing our latest eosinophilic esophagitis (#eoe) research. Check out our abstracts: ueg.eu/week/programme
-
Sanofi
@sanofi
We’ll share research from 28 abstracts across atopic dermatitis, prurigo nodularis, chronic spontaneous urticaria plaque psoriasis and hidradenitis suppurativa at #eadvcongress. Explore the latest findings.
-
Sanofi
@sanofi
#icymi Findings from our recent Hemophilia Life Stages and Changes Global Survey were presented at #ehc2023. Understanding what it’s like to live or care for someone with a rare condition, like #hemophilia, is critical to assessing unmet needs. Read more: www.sanofi.com/en/magazine/your-health/global-hemophilia-…
-
Sanofi
@sanofi
How many people worldwide are estimated to be living with hemophilia?
Sanofi
@sanofi
Over 1 million. To better understand the challenges of the #hemophilia community, we partnered with @HarrisPoll to conduct The Hemophilia Life Stages Survey. Stay tuned for the results at #ehc2023.
-
Sanofi
@sanofi
We are proud to present the results from our Hemophilia Life Stages and Changes Global Survey at #ehc2023. The survey was developed with @HarrisPoll and provides important insights into the experience of the #hemophilia community across 11 countries.
-
Sanofi
@sanofi
At a special event, Paris 2024 volunteers met #teamsanofi athlete @TCurin and "Rising Phoenix" movie producer @nugentgreg. Our speakers shared how the Paralympic Games 2024 can promote inclusivity and break down barriers for people with disabilities.
#ignitingpotential -
Sanofi reposted
Paris 2024
@Paris2024
💛💜💙
-
Sanofi
@sanofi
300 days to go 🔥! Sanofians around the world are in the starting blocks for the Olympic & Paralympic Games Paris 2024. Yoga, volleyball and wheelchair basketball, they all got an opportunity to ignite their potential during our Sanofi Cup events 🤸♀️. #ignitingpotential
-
Sanofi
@sanofi
Young people will change the world. So today at @OneYoungWorld, Sanofi NextGen Scholars Chaima, Krystal and Dominick will join our #amillionconversations Workshop to explore how we can build a more inclusive healthcare system.
#oyw23 -
Sanofi
@sanofi
Learn more about our latest data in #pompe disease across a wide range of patient characteristics and clinical circumstances at this year’s @WorldMuscleSoc. #wms2023
-
Sanofi
@sanofi
WOW! Just one month old but already the Meningitis Flag is raising awareness across the world. 💛💜💙
They all fly the flag, will you?
#worldmeningitisday #meningitisflag #paris2024 #paris2024paralympicgames -
Sanofi
@sanofi
Around 180 daily health-related decisions are made by someone who requires insulin to manage their diabetes. No wonder why #diabetesburnout might sometimes be unavoidable.
Hear what Maja Bujas-Bobanovic, Global Medical Head of Franchise, General Medicines, Sanofi says on this! -
Sanofi
@sanofi
We aim to be an industry-leading company in Immunology. We are announcing today that we have entered into a collaboration with Teva to strengthen our commitment to advancing innovative treatment options for inflammatory conditions.
-
Sanofi
@sanofi
“#rsv is unpredictable, nerve wracking and complicated” describes nurse Melody.
Nurses Melody and Alejandro discuss the potentially devastating impact of Respiratory Syncytial Virus and how we can work together to fight against RSV in babies.
Watch below⬇️
#togetheragainstrsvThis media couldn't be displayed. See it on the original post. -
Sanofi
@sanofi
We’re halfway through #easd2023, but our commitment towards the #diabetes community never ends. We are empowered when we all come together with the purpose to chase the miracles of science to improve the lives of people living with diabetes. This is why at Sanofi #weneversettle
-
Sanofi
@sanofi
Congratulations to Pr @AkeLernmark who has been awarded with the 55th Claude Bernard Prize during this year’s #easd2023 for his lifetime achievements and contributions in the research of autoimmune #t1d 🎉.
-
Sanofi
@sanofi
We’re pleased to announce that we entered into an agreement with Janssen to develop & commercialize a vaccine candidate for extraintestinal pathogenic E. coli, now in Phase 3. This is in line with our commitment to design & deliver first- or best-in-class #medicines & #vaccines.
-
Sanofi
@sanofi
MS is a complex disease impacting 2.9M people worldwide. Our #multiplesclerosis data at #msmilan2023 could be key to unlocking new treatments. www.sanofi.com/en/media-room/press-releases/2023/2023-10-…
-
Sanofi
@sanofi
At Sanofi, we believe that everyone living with #diabetes should get a personalized care plan that suits them. Optimal treatment for their needs and the use of digital health solutions can help!
Read more from @Oxanamonge Global Head of Franchise, General Medicines, Sanofi. -
Sanofi
@sanofi
#worldheartday, a moment for your ❤.
Addressing various factors can help improve your heart's health. Staying active, reducing bad cholesterol and not smoking are a few things that you can do for it. Ask your doctor how to care for your ❤.
Find more www.sanofi.com -
Sanofi reposted
ResearchAmerica
@ResearchAmerica
#icymi At #raforum, Elias Zerhouni, MD, had an engaging discussion with Dietmar Berger MD, PhD, CMO @Sanofi, about priorities in #ai, strengthening #clinicaltrials, and innovations across the drug discovery and development process. Watch it here: youtu.be/SKfF2iWNxJE
-
Sanofi
@sanofi
#worldheartday 2023 is almost here. Do you know how to give your ❤ a little extra love? Come back on the 29th September to find out.
-
Sanofi
@sanofi
Today, the @US_FDA accepted for Priority Review our application for medicine to treat children aged 1 – 11 with eosinophilic esophagitis (#eoe), a disease driven in part by type 2 inflammation. @Regeneron
-
Sanofi
@sanofi
The Ministry of Health, Labour and Welfare of Japan has approved our therapy for #hemophilia A. This moment marks a significant step in advancing care for people around the world with this #rareblooddisorder.
-
Sanofi
@sanofi
#nojargon alert 🚨#inflammation is often a source of pain and discomfort, but why is it such a frequent response to harm? Our scientists explain. 👇
-
Sanofi
@sanofi
What do breaking world records and making breakthrough drug discoveries have in common? Find out how scientists and athletes are #ignitingpotential with #teamsanofi @TeamEzra05 🔥.
This media couldn't be displayed. See it on the original post. -
Sanofi
@sanofi
As a proud global partner of @UN Secretary-General Special Envoy for #roadsafety, we #makeasafetystatement by signing the Responsibility Pledge at events hosted across the world. Recently, we were happy to welcome @JeanTodt in Brazil to introduce the Pledge to Sanofians.
-
Sanofi
@sanofi
As we attend the #unga, we focus on the importance of global health for vulnerable populations. Our Global Health Unit is working with local partners to ensure accessible and sustainable healthcare in Da es Salaam, Tanzania. #weneversettle #actwithimpact #climateweeknyc
This media couldn't be displayed. See it on the original post. -
Sanofi
@sanofi
Para-athlete @davide_morana shares his personal dream for the Meningitis Flag and the powerful potential of raising awareness in the goal to defeat meningitis. 💛💜💙
#meningitisflag #defeatmeningitis -
Sanofi
@sanofi
Quality of life is a key concern for individuals living with bleeding disorders. Here’s how we can close gaps in care when it comes to pain and mental health.
Reuters Events Pharma
@RE_Pharma
Advance quality of life in #bleedingdisorders by developing holistic approaches to measuring and managing pain, #mentalhealth and well-being. Sign up for Hemophilia Changemakers 2023 now events.reutersevents.com/pharma/hemophilia-virtual/utm_so…
#rehemophilia #hemophiliacare #blooddisorders -
Post not available here, view on X
Sanofi
@sanofi
Hi @missmayawolff, we’re unable to discuss products on social media but you can send us your questions via the contact form on our website: www.sanofi.com/en/contact
If you have questions or concerns about your health, please talk to your healthcare provider. -
Sanofi
@sanofi
In light of the impact of the earthquake in Morocco, Sanofi through @Collective_FS , committed €1 million in humanitarian aid. The needs for medicines and vaccines donations are currently assessed with local authorities
-
Sanofi
@sanofi
Representation in healthcare matters. We’re launching our NextGen Scholarship, a pioneering program supporting young people from marginalized communities to become healthcare leaders. Find out more about programs in Brazil, France, Japan, the UK and US. www.sanofi.com/en/magazine/sustainability/investing-in-ne…
-
Sanofi
@sanofi
Did you know that lipid nanoparticles or #lnps play an essential role in #mrna vaccines? 🧐
👇 Watch the video to learn more!This media couldn't be displayed. See it on the original post. -
Sanofi
@sanofi
Deeper understanding of chronic obstructive pulmonary disease (#copd) cannot come quickly enough for those living with the condition. Learn how we’re spearheading scientific efforts with @Regeneron to rethink what’s possible.
-
Sanofi
@sanofi
Because we all have a role to play to reduce traffic fatalities, we're partnering with @UN Secretary-General Special Envoy for #roadsafety.
Read the latest @wef article by @JeanTodt @UN Secretary-General’s Special Envoy for Road safety & @Sanofi CEO Paul Hudson: www.weforum.org/agenda/2023/09/road-traffic-fatalities-pr… -
Sanofi
@sanofi
The power of a symbol.
The #meningitis community is a force for progress, but it has never had a unifying symbol it can rally behind. Until now.
#meningitisflag #defeatmeningitis -
Sanofi
@sanofi
We announce changes to our Executive Committee. These new appointments bring three highly qualified global leaders with new insights and world-class expertise in their field.
-
Sanofi
@sanofi
With deep experience in rare disease research, we are thrilled to share compelling data at #ssiem2023.
Hear more from our leaders on our support for those living with inherited metabolic conditions. We will never stop pursuing better care for rare. -
Sanofi
@sanofi
Thank you #esccongress 2023! We leave Amsterdam inspired with a fresh sense of motivation to strive towards advancing solutions, moving away from a ‘one-size fits all’ approach to cardiovascular care.
See you next year at #esccongress in London. -
Sanofi
@sanofi
The #meningitisflag is a symbol to raise awareness of meningitis and help to defeat it.
Special thanks to @M_R_F, @COMOmeningitis, Laura Spring and #paris2024 Team Sanofi para-athletes: @TCurin, @davide_morana and @xxebobxx.
#defeatmeningitis -
Sanofi
@sanofi
With 1 year to the #paris2024 Paralympic Games, we’re pleased to unveil the #meningitisflag. Inspired by 3 para-athletes and co-created with @M_R_F @COMOmeningitis, this flag is the first ever global symbol to rally the meningitis community. #defeatmeningitis
-
Sanofi
@sanofi
We’re halfway through #esc2023 Congress. At Sanofi, #weneversettle. We are proud of our rich heritage with over 60 years experience in helping to manage various cardiovascular conditions. For decades, we have been spearheading innovation in this space, and we are not done yet.
-
Sanofi
@sanofi
Hello from Amsterdam! We’re proud to be here at the world’s biggest gathering of heart specialists at #esccongress to connect with the cardiology community, to share insights, and discuss multi-disciplinary care models.
If you’re here, feel free to stop by our booth! -
Sanofi
@sanofi
What does Respiratory Syncytial Virus (#rsv) mean to you?
We recently worked with @NickChaffe to create a giant doodle installation based on our discussions with Healthcare Professionals (HCPs) about RSV.
Watch the video to find out what they said! -
Sanofi
@sanofi
Can you guess what they’re looking at? Find out why athletes @davide_morana, @xxebobxx, @TCurin and @M_R_F, @COMOmeningitis have teamed up on August 28.
#defeatmeningitis -
Sanofi
@sanofi
By online vote 🗳️ our brave scientists attempt to define #genetherapy with absolutely #nojargon.
How does it work? Watch the video 👇 -
Sanofi
@sanofi
Today, the U.S. @CDCgov Advisory Committee on Immunization Practices unanimously recommended our monoclonal antibody to prevent respiratory syncytial virus (#rsv) disease in newborn and infants below 8 months of age through their first RSV season. CC: @AstraZeneca
-
Sanofi
@sanofi
For Henriette, one of the most challenging parts of living with a #rareblooddisorder like cold agglutinin disease (#cad) is not knowing what the next day or month may hold. Find out how she’s adapted to life with CAD. patient.understandcad.com/living-with-a-chronic-condition
-
Sanofi
@sanofi
Our CEO, Paul Hudson, reflects on our solid second quarter driven by a flow of positive readouts and regulatory achievements that match our best-in-class ambitions.
Learn more about our Q2 2023 results: www.sanofi.com/en/investors/financial-results-and-events/…
#sanofiresults $SAN $SNY -
Sanofi
@sanofi
Our Q2 2023 Financial Results are now available.
Learn more: www.sanofi.com/en/investors/financial-results-and-events/…
#sanofiresults $SAN $SNY -
Sanofi
@sanofi
It’s officially 365 days until @Paris2024 🎉
Thank you @Yul_Shin0122 for kicking off the countdown with us, and to all members of #teamsanofi for your passion, values, and for inspiring us beyond sport.
We can’t wait to see the Sanofi community in Paris!
#ignitingpotential -
Sanofi
@sanofi
Curious about the science behind #mrna?
Discover here how our #scientists at the mRNA Center of Excellence are pushing the boundaries to develop new #therapeutics and #vaccines.
#weneversettle -
Sanofi
@sanofi
Today, we’re marking #internationalselfcareday, reflecting on our commitment to bring health in your hands, and our responsibility to create a healthier society and planet for all through our global partnership with @SavetheChildren.
Read more here: www.savethechildren.net -
Sanofi
@sanofi
Breaking news: @US_FDA approved our long-acting antibody to protect newborns and infants against respiratory syncytial virus (#rsv) disease. CC: @AstraZeneca
-
Sanofi
@sanofi
Our new Patient Charter describes Sanofi’s commitment to people-driven healthcare. It is a core set of principles and behaviors that drives our engagement with patients and the healthcare community, enabling us to take patient engagement to the next level across Sanofi.
-
Sanofi
@sanofi
And just like that, we bagged our first @Cannes_Lions award! The pinnacle of recognition for creatives🦁. Our Ready Player Mom campaign, developed for probiotic brand #enterogermina won a Bronze Lion in the Entertainment for Gaming category. Congrats to all involved! #cannes2023
-
Sanofi
@sanofi
At #reaix2023 this weekend, our CEO Paul Hudson spoke with @BloombergTV about the progress of @Sanofi's strategy to bring forward innovative, best-in-class medicines and the use of #ai to accelerate drug discovery and development.
-
Sanofi
@sanofi
On its 30-year anniversary, #enfantsdesanofi, posted its 2022 annual report.
Eve, Bach and Héloïsa’s testimonials highlight how Enfants de Sanofi supports access to healthcare, education, and inclusion for children with disabilities.
#actwithimpact -
Sanofi
@sanofi
This year at @VivaTech, our digital experts took us on the journey of a molecule, showcasing the #ai-powered tools we use to chase the miracles of science and deliver faster breakthroughs for patients. #vivatech
Discover more: www.sanofi.com/en/media-room/press-releases/2023/2023-06-…This media couldn't be displayed. See it on the original post. -
Sanofi
@sanofi
What happens when you ask a generative AI platform about chronic, inflammatory skin conditions? See dermatologist Dr. Mark Tang put the latest AI technology to the test and visit us at #wcd23singapore to learn more. @Regeneron @ILDSDerm @wcd2023sg
-
Sanofi
@sanofi
Understanding what it’s like to live with a rare condition, like #pompe, is critical to assessing unmet needs and models of care. At #ean2023, we share patient-reported outcomes and real-world patient evidence to better understand. Learn more - meet Juan: www.youtube.com/watch?v=NJx2uZiXxQw&list=PLJ3snXOLamPhWnU…
-
Sanofi
@sanofi
Live from London at our #vaccinesinvestorevent, where CEO Paul Hudson shares our ambition: “With 27 earlier-stage readouts from assets with potential first- or best-in-class profiles, we’re ready to transform the practice of medicine.”
Follow this thread for more live tweets 👇Post not available here, view on X
Sanofi
@sanofi
Sally Mossman, Head of Research Portfolio Strategy, is explaining how we’re pushing the frontiers of science and vaccinology. “We're making rapid progress in #acne and #chlamydia by identifying the most adapted vaccine technology to meet this challenge. Science leads the way."
Sanofi
@sanofi
Thomas Triomphe concludes our event: “We strive to innovate and deliver a pipeline of first- or best-in-class vaccines to improve people’s lives and address significant unmet medical needs.”
Thanks for following our #vaccinesinvestorevent! -
Sanofi
@sanofi
Today, at our #vaccinesinvestorevent, we are delighted to share our progress in accelerating #vaccines R&D. Our #mrna platform has played a pivotal role, enhancing our industry-leading toolbox of R&D platforms.
-
Sanofi
@sanofi
Together with @Regeneron, we’re transforming the world of dermatology with our industry-leading research approach. Hear more from Dr. Paul Rowe, Head of Global Medical Immunology, and join us at #wcd2023singapore to discuss advances in inflammatory skin diseases.
-
Sanofi
@sanofi
Today we announced topline data from our investigational medicine for atopic dermatitis. The data support our Immunology strategy built around exploring disruptive mechanisms of action. Learn more here: www.sanofi.com/en/media-room/press-releases/2023/2023-06-…
-
Sanofi
@sanofi
Eager to use her skills in engineering to improve patients‘ lives, Micaela joined Sanofi as a Senior Research Scientist. She brings unrivaled expertise to the role and cutting-edge approaches to antibody discovery and the use of nanotechnology.
#teamsanofi #ignitingpotential -
Sanofi
@sanofi
We’re presenting late-breaking Phase 3 data for children under 12 with severe #hemophilia A at #isth2023. Learn more about these results and how we’re breaking barriers in hemophilia. www.sanofi.com/en/media-room/press-releases/2023/2023-06-…
-
Sanofi
@sanofi
We’re in San Diego ready for #ada2023. We’re looking forward to connecting with our peers from the US, and around the world, to discuss the latest advances in #diabetes research and care. If you’re at @ADA_DiabetesPro stop by our booth!
-
Sanofi
@sanofi
Why do we chase the miracles of science?
To help redefine what it means to live life to the fullest for people living with #rareblooddisorders, like hemophilia, ITP, CAD, and aTTP. Learn how we’re advancing innovation at #isth2023. -
Sanofi
@sanofi
In @Techonomy, our CEO Paul Hudson and Owkin CEO @TClozel discuss what the next generation workforce is looking for when it comes to a company’s digital capabilities and how it will impact attracting and retaining talent.
-
Sanofi
@sanofi
Time is critical for patients who need new medicines. Learn how Diane Wuest and her team are leveraging #digital to accelerate #innovation for patients.
-
Post not available here, view on X
Sanofi
@sanofi
Estamos pendientes de que nos compartas toda la información pertinente de la situación mencionada el 18 de abril en nuestro canal de quejas técnicas CHC_CO_quejastecnicas@sanofi.com para poder acompañar tu situación a la brevedad.
Sanofi
@sanofi
.@claulambra Estamos pendientes de que nos compartas toda la información pertinente de la situación mencionada el 18 de abril en nuestro canal de quejas técnicas CHC_CO_quejastecnicas@sanofi.com para poder acompañar tu situación a la brevedad.
-
Sanofi
@sanofi
Join us at @VivaTech in Paris to discover the #ai-powered tools we use across our value chain to chase the miracles of science: www.sanofi.com/en/media-room/press-releases/2023/2023-06-…
#vivatech #weneversettle -
Sanofi
@sanofi
Our 2023 Planet Care Challenge pledges €3 million to turn employee-generated #sustainability ideas into real solutions. 🌎
Congratulations to the winning teams: www.sanofi.com/assets/dotcom/content-app/articles/social-…
#actwithimpact -
Sanofi
@sanofi
Together with @Regeneron, we’re presenting 26 abstracts with data across five different chronic diseases with underlying type 2 inflammation at #eaacicongress2023. Explore the latest findings:
-
Sanofi
@sanofi
For too many people living with #rareblooddisorders, treatment options remain limited. In honor of #eha2023, we asked our team how they’re chasing the miracles of science to bring forth advances in care. Hear what they had to say ⬇️
-
Sanofi
@sanofi
A @US_FDA Advisory Committee voted in support of our investigational long-acting antibody, the first immunization designed to protect all infants against respiratory syncytial virus (#rsv) disease through their first RSV season. CC: @AstraZeneca
-
Sanofi
@sanofi
Many barriers are yet to be broken down to ensure equitable and accessible care for women and girls living with, or carriers of, hemophilia around the world. Learn more 👇
Reuters Events Pharma
@RE_Pharma
Raise awareness of gender bias and data disparities in #hemophilia to demand equal treatment opportunities for women and girls in your region. Register for the 1st free event in the Hemophilia Changemakers 2023 Series, in partnership with @sanofi now events.reutersevents.com/pharma/hemophilia-virtual/utm_so…
-
Sanofi
@sanofi
At Sanofi, we’re changing scale with the installation of larger solar power plants to produce our own renewable electricity and meet part of our consumption needs.
#worldenvironmentday #actwithimpactThis media couldn't be displayed. See it on the original post. -
Sanofi
@sanofi
#amillionconversations aims to build trust in healthcare for under-represented groups, including LGBTQ+ people.
We’re listening, learning and working to champion greater equity. -
Sanofi
@sanofi
On #worldenvironmentday, learn more about how #ecodesign allows us to optimize the full environmental performance of our products.
#worldenvironmentday #actwithimpact -
Sanofi
@sanofi
The @US_FDA has granted fast track designation for our investigational medicine for people living with hematologic malignancies. #investors
-
Sanofi
@sanofi
Raj Verma, our Chief Diversity, Culture and Experience Officer, shares our first-ever Diversity, Equity and Inclusion report to reflect on the progress of our global #dei strategy.
Explore the report: diversity-equity-inclusion.sanofi.com/article/1/
#diversity #inclusion -
Sanofi
@sanofi
Late-breaking Phase 2 data are being presented at #cmsc2023 on our investigational anti-CD40L antibody for #multiplesclerosis.
Learn more about our innovative MS research: www.sanofi.com/en/media-room/press-releases/2023/2023-05-… -
Sanofi
@sanofi
This #worldmsday, we’re proud to partner with @Upworthy to amplify the voices of these incredible women living with #multiplesclerosis. Read more 👇
Upworthy
@Upworthy
For those living with multiple sclerosis, navigating life is different for each individual, but change is a constant for all. Learn more about #ms through the lens of these three women. #worldmsday
www.upworthy.com/three-women-three-ms-journeys-how-multip… @sanofi #sponsored -
Sanofi
@sanofi
Ready for a new dose of knowledge? 🧐
We’re back with an episode of our #nojargon series where our #scientists explain what a #monoclonalantibody is in simple terms.
Mission accomplished? -
Sanofi
@sanofi
We make the impossible possible by chasing the miracles of science to improve people’s lives.
Discover how in our 2022 Integrated Report: www.sanofi.com/en.
#weneversettle -
Sanofi
@sanofi
As part of our commitment to ensuring comprehensive #diabetes care is accessible in low- and middle-income countries and underserved communities worldwide, we are teaming up with @MoHGhana for a three-year program. Check out this short video about our shared ambition
This media couldn't be displayed. See it on the original post. -
Sanofi
@sanofi
Meet Naimish Patel, Therapeutic Area Head for Immunology & Inflammation. Naimish admits he would have loved to have become a professional musician, but instead he channeled his curiosity to chase the miracles of science to improve people’s lives.
#weneversettleThis media couldn't be displayed. See it on the original post. -
Sanofi
@sanofi
#icymi: We’re building on our scientific advancements for patients living with chronic respiratory diseases. Earlier today, Dietmar Berger spoke more about our strategy at our #ats2023 investor call: www.sanofi.com/en/investors/financial-results-and-events/…
#investors -
Sanofi
@sanofi
Late-breaking data from our Phase 3 COPD trial with @Regeneron were presented for the first time at #ats2023 and published in @NEJM. Explore the latest results for this potentially life-threatening respiratory disease: www.sanofi.com/en/media-room/press-releases/2023/2023-05-…
-
Sanofi
@sanofi
As part of our continued commitment to the respiratory community, we’re rethinking the science of chronic obstructive pulmonary disease (COPD), a life-threatening condition. Read more: www.sanofi.com/en/chasing-miracles/miracles-of-science/wo…
#ats2023 -
Sanofi
@sanofi
Behind every medicine, there stands a group of patient heroes. As we celebrate #clinicaltrialsday, learn more about the important role clinical trial volunteers play in R&D, in this video produced for us by @BBCStoryWorks Commercial Productions.
#naturesbuildingblocks #ctd2023 -
Sanofi
@sanofi
Now a Paralympic medalist, @xxebobxx was just 16 months old when she contracted meningitis, resulting in the amputation of her limbs. Today, Ellie is preparing for #paris2024 while driving positive change for meningitis awareness.
#teamsanofi #ignitingpotential -
Sanofi
@sanofi
All #clinicaltrials at Sanofi should reflect the diversity of patients who live with the disease.
Thank you @Citeline_Awards for naming us your 2023 Champion of Diversity & Inclusion in Clinical Research!
#citelineawards #dei -
Sanofi
@sanofi
At #espid2023, we’re presenting positive results from our study investigating the effect of our immunization on the prevention of respiratory syncytial virus (#rsv) hospitalizations.
-
Sanofi
@sanofi
Positive results from two pivotal Phase 3 trials of our medicine for prurigo nodularis, a chronic inflammatory skin disease characterized by intense itch and painful skin lesions, were published in @NatureMedicine. Learn more: www.sanofi.com/en/media-room/press-releases/2023/2023-05-…
-
Sanofi
@sanofi
We’re proud to share data at #ispor2023 showing improved outcomes for people living with late-onset #pompe disease. We are one step closer to addressing unmet needs for the Pompe community. www.youtube.com/watch?v=NJx2uZiXxQw
-
Sanofi
@sanofi
We’re sharing new, late-breaking #respiratory data at #ats2023. Learn more about our research in asthma and
chronic obstructive pulmonary disease (COPD): www.sanofi.com/en/media-room/press-releases/2023/2023-05-… -
Sanofi
@sanofi
We’re sharing new atopic dermatitis data at #espd2023, including findings in infants and throughout various stages of childhood. Explore our latest research: www.espd.info/espd2023/programme @Regeneron
-
Sanofi
@sanofi
In a new article from @HarvardChanSPH, our CEO Paul Hudson and @HarvardChanDean share our poll results, which shows an urgent need to build back societal trust in the institutions delivering health information and medical care: www.hsph.harvard.edu/deans-office/2023/05/01/institutions…
#amillionconversations -
Sanofi
@sanofi
Did you know #whoopingcough affects adults as well as children? Especially those with #asthma. Tanya thought she had a cold but was hospitalized for 10 days. She wants others to know the risks about this vaccine-preventable disease.
-
Sanofi
@sanofi
“If we’re going to close the gap in health disparities, we have to have conversations,” Michelle A. Williams @HarvardChanSPH.
We’ve launched #amillionconversations - a global initiative to spark honest discussions with underrepresented communities. -
Sanofi
@sanofi
We’re delighted to have completed the acquisition of @ProventionBio. This U.S.-based biopharma company is focused on delaying the onset and impact of immune-mediated diseases, such as type 1 diabetes.
Read more: www.sanofi.com/en/media-room/press-releases/2023/2023-04-…
#immunology #diabetes #weneversettle -
Sanofi
@sanofi
Our CEO Paul Hudson reflects on our strong start of the year, driven by growth across our Specialty Care, Vaccines and Consumer Healthcare businesses.
Learn more about our first quarter 2023 results: www.sanofi.com/en/investors/financial-results-and-events/…
#sanofiresults $SAN $SNY #weneversettle -
Sanofi
@sanofi
Our first quarter 2023 results are now available. Read the press release: www.sanofi.com/en/media-room/press-releases/2023/2023-04-….
#sanofiresults $SAN $SNY
Sanofi
@sanofi
For better accessibility, we've made the contents of this video available in PDF format here: www.sanofi.com/dam/jcr:288e1626-dd2e-488f-8c4c-8ba3d656e0…
-
Sanofi
@sanofi
We’re in Paris, where #ebmt23 is in full swing—just a few minutes’ walk from our headquarters! If you are attending @TheEBMT, stop by our symposium or booth 35 to learn how we are chasing the miracles of science.
Post not available here, view on X
Sanofi
@sanofi
Acute and chronic autoimmune responses to a bone marrow #transplant can have a major impact on quality of life. We remain committed to building on our tradition of helping those living with transplant complications. #weneversettle #ebmt23
Sanofi
@sanofi
Thank you to everyone who stopped by during @TheEBMT. We look forward to returning next year! In the meantime, we’ll continue working to help address the unmet needs of the bone marrow #transplant community at every step of their treatment journey.
-
Sanofi
@sanofi
We’re partnering with @novonordisk, @LillyPad and @Merck to pioneer the world's first cross-industry solution for recycling materials from injection pens ♻.
#planetcare #actwithimpact #circulareconomy #plasticwaste -
Sanofi
@sanofi
Congratulations to @GovCanHealth on accelerating their efforts to prevent #rsv in all infants for the upcoming season.
Sanofi Canada
@SanofiCanada
Today marks a historic milestone as the @GovCanHealth has approved our first and only single-dose immunization designed for the prevention of #rsv disease in newborns and infants, developed with our partner @AstraZeneca. sanoficanada.mediaroom.com/2023-04-24-Health-Canada-appro…
#weneversettle -
Sanofi
@sanofi
.@handsolooficial built his 1st prosthetic arm with #lego at 9. Today, he dreams of making prosthetics more accessible to all. 🦾
#vaccines help protect us from many life-threatening diseases, making it possible for David to pursue his big dream. 👇
#vaccinesfordreams #wiw2023 -
Sanofi
@sanofi
Attending #eado2023? Hear from a panel of non-melanoma skin cancer (NMSC) experts led by Prof. Axel Hauschild about their perspectives on treatment strategies, optimizing treatment options, and future treatment directions in advanced NMSC. web.cvent.com/event/93fcbbe1-8bcb-4a98-af9a-c697535f4c0d/…
-
Sanofi
@sanofi
As @TheEBMT Annual Meeting approaches, we’re looking forward to connecting with the #transplant community to discuss therapeutic advancements. We hope to see you at Europe’s largest annual conference in blood and marrow transplantation and cellular therapies! #ebmt23
-
Sanofi
@sanofi
Our EVP for Vaccines Thomas Triomphe was invited this week by Reuters Events Pharma to share insights on how #vaccines can help address health inequities. Could an “immunity community” be the key to solving this problem? Check out his thoughts: www.linkedin.com/pulse/looking-close-gap-health-inequitie…
#repharma23 -
Sanofi
@sanofi
#yellowfever, the next climate-induced health threat? Changing climates, deforestation and extreme weather events are all factors that could affect the threat of yellow fever. Our @Devex article explores how innovation can help prepare for the future.
Read more 👇
Devex
@devex
Global health experts expect a drastic rise in yellow fever cases as the disease spreads to new areas in the coming years, fueled in part by climate change. Can innovation help to halt its spread? Explore this new visual story.
#sponsored by @Sanofi #p... devex.shorthandstories.com/yellow-fever-the-next-big-clim… -
Sanofi
@sanofi
The stories of people living with rare diseases like #hemophilia inspire us to push the boundaries of what science can do.
This #worldhemophiliaday, learn how we are working to transform the future of care for people with this #rareblooddisorder. www.sanofihemophilia.com -
Sanofi
@sanofi
Only 500 days to go until the #paris2024 Paralympic Games!
Let's go #teamsanofi 🔥
@bubucheofficiel @danydann97 @davide_morana @xxebobxx @TeamEzra05 @itslaurenrowles @nantokeita223 @NicolaiZeltinge @nmahut @bareksarah @SarahFarhoud @tcurin @valeriane_ayayi @Yul_Shin0122 -
Sanofi
@sanofi
500 days to go until the Paris 2024 Paralympic Games!
We’re proud to support Team Sanofi athletes and all para-athletes as they prepare for #paris2024 🔥.
@davide_morana, @TeamEzra05 and @nantokeita223 share what it means to be part of #teamsanofi.
#ignitingpotential -
Sanofi
@sanofi
Our scientists are investigating CEACAM5 as a potential biomarker for several types of cancers. Read more about the early-stage CEACAM5 research that will be presented at #aacr23. www.abstractsonline.com/pp8/
-
Sanofi
@sanofi
Our colleague Alexandre has learned to push himself beyond his limits, like an athlete has to do in order to win gold. As a scientist in our immuno-oncology team, his finish line is finding cures for blood cancers.
#ignitingpotential -
Sanofi
@sanofi
Today is Worth Health Day and we are raising awareness of the importance of health for all. Around the world, 2.5 billion people still have limited access to healthcare.
Learn how we address access inequities: www.sanofi.com/en/our-company/sustainability -
Sanofi
@sanofi
Two recently published studies in @TheLancet and @TheLancetHaem show the potential of our science to transform care and address unmet needs for all types of #hemophilia.
Learn more: www.sanofi.com/en/media-room/press-releases/2023/2023-04-… -
Sanofi
@sanofi
It's been a little over a year since we've launched our new brand identity and purpose. Proud that our hard work - and teamwork - has paid off with 3 wins at this year’s Sabre Awards and Transform Europe Awards. 1/3
Sanofi
@sanofi
🏆 Sabre Awards 2023: Best Brand Film in “Employee Communications”
🏆 Transform Europe Awards 2023: Highly Commended in “Best Brand Evolution”
🏆 Transform Europe Awards 2023: Bronze in “Best Visual Identity From the Healthcare and Pharmaceutical Sector”
2/3
Sanofi
@sanofi
Thanks @Provoke_News and @TransformEvents for sharing the brand love!
Learn more about our purpose and identity: www.sanofi.com/en/our-company/our-strategy
3/3 -
Sanofi
@sanofi
We chase the miracles of science to improve people’s lives, and sometimes that means starting over. Sanofians find inspiration from loved ones, motivation from families, and a united strength to push harder until we turn a corner.
#weneversettleThis media couldn't be displayed. See it on the original post. -
Sanofi
@sanofi
Our CEO Paul Hudson recently visited our brand new head office in Spain, home to 800 Sanofians and our Global Innovation Center.
Equipped with the latest technology, this new site enables our teams to work seamlessly to chase the miracles of science. -
Sanofi
@sanofi
We’re announcing positive results from a Phase 3 trial of our medicine in adults with chronic obstructive pulmonary disease (COPD), a life-threatening disease that irreversibly damages the lungs. CC: @Regeneron
www.sanofi.com/en/media-room/press-releases/2023/2023-03-… -
Sanofi
@sanofi
.@danydann97 discovered break-dancing at 15 & left French Guiana to build his career in mainland France. When his best friend died of a sudden heart attack, break-dancing helped him cope with his grief & pushed him to perform at the highest level.
#teamsanofi
#ignitingpotential -
Sanofi
@sanofi
What’s the role of #allyship in advancing a more inclusive workplace? In this video, our DE&I board member Rohini Anand talks with Sanofians Folake and Pedro about the importance of bringing everyone together in the fight for equity.
www.sanofi.com/en/our-company/sustainability/inclusion
#embraceequity -
Sanofi
@sanofi
The @EU_Commission approved our medicine as the first and only targeted treatment for eligible patients with severe atopic dermatitis from infancy to adulthood. CC: @Regeneron
www.sanofi.com/en/media-room/press-releases/2023/2023-03-… -
Sanofi
@sanofi
We’re presenting late-breaking results at #aad2023 from our clinical trial in patients with #atopicdermatitis of the hands and feet, a particularly difficult-to-treat form of the disease. @Regeneron Read more: www.sanofi.com/en/media-room/press-releases/2023/2023-03-…
-
Sanofi
@sanofi
Sustainable businesses need sustainable supply chains. We're proud to have been recognized by @CDP for engaging our suppliers to tackle #climatechange for a second year in a row.
#actwithimpact #cdpsupplychain -
Sanofi
@sanofi
Behind every medicine, there stands a group of patient heroes. Learn more about the important role #clinicaltrial volunteers play in R&D, in this video produced for us by @BBCStoryWorks Commercial Productions: www.bbc.com/storyworks/natures-building-blocks-2/sanofi-g…
#naturesbuildingblocks -
Sanofi
@sanofi
We’re celebrating the 500 days countdown to the #paris2024 Olympics with a throwback to our launch film for the Games.
Go behind the scenes with Sanofians & #teamsanofi’s @DanyDann97 & @xxebobxx as they get ready to help us ignite the potential in everyone.
#ignitingpotentialThis media couldn't be displayed. See it on the original post. -
Sanofi
@sanofi
Only 500 days to go until the #paris2024 Olympic Games!
Let's go #teamsanofi 🔥 🔥 🔥
@bubucheofficiel @danydann97 @davide_morana @xxebobxx @TeamEzra05 @itslaurenrowles @nantokeita223 @NicolaiZeltinge @nmahut @bareksarah @SarahFarhoud @tcurin @valeriane_ayayi @Yul_Shin0122 -
Sanofi
@sanofi
We’re pleased to announce that we’ve entered into an agreement to acquire @ProventionBio, a U.S.-based #biopharmaceutical company focused on intercepting and preventing #immunemediateddiseases.
-
Sanofi
@sanofi
This #internationalwomensday, @SarahFarhoud reflects on the importance of role models to inspire and empower women to ignite their own potential. We’re proud to have Sarah as a #teamsanofi Ignitor!
#iwd2023 #ignitingpotential #embraceequity -
Sanofi
@sanofi
As a former practicing physician, Zsuzsanna Devecseri, Head, Global Oncology Medical Affairs, shares her #myelomastory and recounts the progress we’ve made in the blood cancer space over the past decade. www.linkedin.com/pulse/myeloma-action-month-individual-co…
#myelomaawarenessmonth -
Sanofi
@sanofi
Our application for our medicine for people living with chronic spontaneous urticaria (CSU) has been accepted for review by the US FDA. CSU is an inflammatory skin disease that can cause hives on the skin and/or swelling deep under the skin. www.sanofi.com/en/media-room/press-releases/2023/2023-03-…
@Regeneron -
Sanofi
@sanofi
Today we’re announcing positive topline results from the pivotal phase 3 study of our #hemophilia A treatment in children under 12. Learn more: www.sanofi.com/en/media-room/press-releases/2023/2023-03-…
-
Sanofi
@sanofi
🧐 Get ready to learn the difference between #antigens and #antibodies in a fun way!
Our scientists and #chatgpt teamed up to explain the difference without jargon. While ChatGPT provides its unique take, our scientists bring their expertise, personal touch, and humor to the mix. -
Sanofi
@sanofi
Emotional support can truly make a difference when dealing with life’s difficulties. With the help of her friends, our colleague Jane has learned to embrace the impact of hemophilia A on her family, first as a daughter and then as a mother. #weneversettle
This media couldn't be displayed. See it on the original post. -
Sanofi
@sanofi
As #aaaai23 approaches, learn more about how we are harnessing #ai and #data to transform drug discovery in conditions such as #atopicdermatitis and #asthma.
www.linkedin.com/pulse/from-poetry-medicines-what-chatgpt… -
Sanofi
@sanofi
BREAKING NEWS: The US FDA approved our first-in-class, high-sustained factor VIII replacement therapy for #hemophilia A. This milestone marks a notable advancement in care for people living with this #rareblooddisorder. Learn more: www.sanofi.com/en/media-room/press-releases/2023/2023-02-…
-
Sanofi
@sanofi
We’re halfway through #attd2023! Our heritage and expertise from 100 years in #diabetes care keeps driving us forward. We’re true believers in the importance of technology and innovation to improve people’s lives, which is why #weneversettle
-
Sanofi
@sanofi
Meet our DE&I Board Member Rohini Anand, who reflects on her own experience of being an outsider, and how it shifted her perspective on making people feel like they belong.
Learn more about our DE&I board: www.sanofi.com/en/our-responsibility/equality-and-inclusi…
#diversityequityinclusion -
Sanofi
@sanofi
This year, we saw global spikes in respiratory syncytial virus (#rsv). At #rsvvw23 this week, top RSV experts will discuss this contagious virus, its true burden and possible preventative approaches.
Learn more about key data presentations: www.sanofi.com/en/media-room/press-releases/2023/2023-02-… -
Sanofi
@sanofi
We are continuing to champion the development of new therapeutic options for people living with #rarediseases like #hemophilia, #cad, and #multiplemyeloma. Dietmar Berger shares more on how we are translating innovation into improved outcomes. www.linkedin.com/pulse/how-rethinking-clinical-endpoints-…
-
Sanofi
@sanofi
Our suppliers are essential in helping us bring transformational medicines and vaccines to people all over the world. As part of our new #supplierdiversity strategy, Sanofi pledges to spend over €1.5 billion with small and diverse businesses by 2025. suppliers.sanofi.com/en/sustainable-procurement/supplier-…
-
Sanofi
@sanofi
The need for innovation in the fight against #childhoodcancer remains. We're committed to prioritize childhood cancer research that will move the needle on more targeted therapies and to provide access to effective care.
Learn more: www.ft.com/partnercontent/sanofi/why-we-must-prioritise-c…
#iccd2023 -
Sanofi
@sanofi
AI has the potential to transform R&D for the pharmaceutical industry. In a new article in @FastCompany, our CEO Paul Hudson shares his thoughts on how to break down barriers standing in the way of fully embracing this new technology: www.fastcompany.com/90842341/three-barriers-that-can-slow…
#innovation -
Sanofi
@sanofi
At Sanofi we run on purple, now everyone else can too 💜 #paris2024 #ignitingpotential
Cycling on TNT Sports
@cyclingontnt
For the first time 𝐞𝐯𝐞𝐫, the athletics track at the Olympics will be purple 😍
-
Sanofi
@sanofi
Thank you #teamsanofi Ignitors and @Paris2024 President @TonyEstanguet for visiting La Maison Sanofi. Your passion will inspire many to ignite their potential! 🔥 #ignitingpotential
This media couldn't be displayed. See it on the original post.
Sanofi
@sanofi
With @Danydann97, @Yul_Shin0122, @NantoKeita223, @TCurin, @BarekSarah, @NicolaiZeltinge, @SarahFarhoud, @TeamEzra05, @xxebobxx and @davide_morana
-
Sanofi
@sanofi
“aTTP is my story but it’s not me.” Learn how Anise is navigating life with acquired thrombotic #thrombocytopenic purpura (aTTP) and discover how she’s helping others impacted by #rareblooddisorders.
-
Sanofi
@sanofi
Proud to announce the first investment from our Global Health Impact Fund for SwipeRx, supporting expansion of their pharmacy tech platform in lower-income countries. #actwithimpact
Learn more: www.swiperxapp.com/swiperx-boosts-series-b-to-37-million-… -
Sanofi
@sanofi
In response to the devastating earthquakes, Sanofi through Foundation S, will make an initial donation of €3 million including vaccines and essential medicines and a €2 million in emergency funding to local and global humanitarian organizations.
-
Sanofi
@sanofi
In a @Fortune article, our CEO Paul Hudson and @HarvardChanDean discuss the trust gap that exists globally between minorities and healthcare systems, and what must be done to address this disparity.
www.sanofi.com/en/about-us/our-stories/three-steps-to-beg… -
Sanofi
@sanofi
#icymi In 2021, we joined @GustaveRoussy, @Inserm, @IP_Paris_ and others to create the Paris Saclay Cancer Cluster (PSCC) - a collaboration dedicated to revolutionary biomedical oncology research to improve cancer care.
Learn more: www.ip-paris.fr/en/news/paris-saclay-cancer-cluster-winne….
#worldcancerday -
Sanofi
@sanofi
Our CEO Paul Hudson reflects on our performance in 2022 and the progress we’ve made in R&D transformation.
Learn more about our fourth-quarter and full-year 2022 results: www.sanofi.com/en/investors/financial-results-and-events/….
$SAN $SNY #sanofiresults
#weneversettle -
Sanofi
@sanofi
Our Q4 and full-year 2022 results are now available. Read the press release: www.sanofi.com/en/media-room/press-releases/2023/2023-02-….
#sanofiresults $SAN $SNY -
Sanofi
@sanofi
Exciting day at La Maison Sanofi as we welcomed @Paris2024 President @TonyEstanguet and #teamsanofi Ignitors for a meet & greet with Sanofians to share ideas and ambitions for our journey towards the #paris2024 Games.
-
Sanofi
@sanofi
Up to 90% of children will contract #rsv by the age of two.
To raise awareness of this common, contagious virus, we have written a feature on RSV science now in @NaturePortfolio. -
Sanofi
@sanofi
Today, more than one billion people are still affected by #neglectedtropicaldiseases. With our partners @WHO and @DNDi, we remain #100percentcommitted to work together and move the science forward on NTDs, and to eliminate #sleepingsickness by 2030.
#worldntdday #actwithimpact -
Sanofi
@sanofi
The @EU_Commission approved our medicine as the first and only targeted treatment for eligible adults and adolescents 12 years and older with EoE, a chronic, progressive inflammatory disease that may damage the esophagus.
www.sanofi.com/en/media-room/press-releases/2023/2023-01-…
CC: @Regeneron -
Sanofi
@sanofi
The @EMA_News CHMP recommended our medicine for approval in eligible children in the EU with severe atopic dermatitis, a chronic skin condition with underlying type 2 inflammation that can majorly impact quality of life. www.sanofi.com/en/media-room/press-releases/2023/2023-01-…
CC: @Regeneron -
Sanofi
@sanofi
Positive Phase 3 data published in @NEJM underscores the importance of maintaining sustained factor activity levels for people living with #hemophilia A. Learn more: www.sanofi.com/en/media-room/press-releases/2023/2023-01-…
-
Sanofi
@sanofi
At #wef2023 our CEO Paul Hudson joined @ArthurSadoun from @PublicisGroupe to sign the #workingwithcancer pledge: a promise to bring much-needed visibility to the issues people with cancer face in the workplace.
Learn more at www.workingwithcancerpledge.com
#actwithimpact -
Sanofi reposted
World Economic Forum
@wef
Paul Hudson (@sanofi) highlights the need to decarbonize the delivery of #healthcare. #wef23
-
Sanofi
@sanofi
Healthcare that works for everyone starts with healthcare that listens to everyone equally.
That’s why we've launched #amillionconversations today: A global initiative to spark frank discussions between healthcare & marginalized communities.
Learn more: www.sanofi.com/en/our-responsibility/equality-and-inclusi… -
Sanofi
@sanofi
LIVE FROM #wef2023
Tune in to watch the launch of #amillionconversations: A global coalition between public, private and social sectors to build trust between healthcare and people who feel discriminated against.
💻 Livestream: www.sanofi.com/en/our-responsibility/equality-and-inclusi…
@WEF #actwithimpact -
Sanofi
@sanofi
Tune in tomorrow to watch our #wef2023 livestream about the launch of #amillionconversations: A new initiative aiming to create greater trust between underrepresented communities and healthcare by 2030.
📅 January 18, 3 PM CET
💻 www.sanofi.com/en/our-company/sustainability/inclusion/a-…
@WEF #actwithimpact -
Sanofi
@sanofi
Watch the launch of #amillionconversations at #wef2023 next week to learn about our new initiative that aims to create greater trust between underrepresented communities and healthcare stakeholders by 2030.
📅 January 18, 3 PM CET
💻 www.sanofi.com/en/our-company/sustainability/inclusion/a-…
@WEF #actwithimpact -
Sanofi
@sanofi
This week, our CEO Paul Hudson presented to investors at the @jpmorgan Annual Healthcare Conference, highlighting how our strategy is taking shape and what we'll achieve for patients in 2023.
#jpmhc23 #jpm2023 #innovation -
Sanofi
@sanofi
We’re excited to renew our commitment to Sanofi Ventures as the team continues to invest in top-tier #biotherapeutics & #digitalhealth companies focused on transforming the practice of medicine. Learn how Sanofi Ventures supports our #innovation ecosystem: www.sanofi.com/en/media-room/press-releases/2023/2023-01-…
-
Sanofi
@sanofi
We’re honored to receive @TheSMI's Terra Carta Seal for our efforts to help build a healthier, more resilient world.
We remain committed to ensuring access to healthcare and bringing focus to address unmet needs while reducing our environmental impact.
#actwithimpact -
Sanofi
@sanofi
Join Sasalet Kalulu, Digital Innovation Manager at Sanofi as he takes us on a guided tour of our new headquarters: www.youtube.com/watch?v=xA_iLXs9S98
-
Sanofi
@sanofi
We're kicking off the new year in our new Paris global headquarters: #lamaisonsanofi.
Designed with the highest standards for energy efficiency and state-of-art digital resources, our newest site enables Sanofians to better collaborate, connect, create and celebrate. -
Sanofi
@sanofi
As we get ready to wrap up 2022, we wish you Happy Holidays and a healthy New Year! ✨
-
Sanofi
@sanofi
Eosinophilic esophagitis (EoE) is a chronic and progressive disease that damages the esophagus, creating a substantial burden for patients in their everyday lives. Learn more about our latest #eoe news: www.sanofi.com/en/media-room/press-releases/2022/2022-12-… @NEJM
-
Sanofi
@sanofi
When Raimunda joined Sanofi, her colleagues were unsure how to even say hello. So she started teaching them sign language. Today, Raimunda doesn’t just have lasting friendships, but the courage and self-belief to evolve in her career.
#weneversettleThis media couldn't be displayed. See it on the original post. -
Sanofi reposted
WHO Foundation
@WHOFoundation
In our latest blog series, “The Conversation”, we met @vaninalala, the head of Foundation S – The Sanofi Collective; the new philanthropy engine of @Sanofi.
Together, we discussed the impact and the Why of philanthropy. ⤵️
who.foundation/latest-updates/the-conversation-with-vanin… -
Sanofi
@sanofi
We’re pleased to broaden our collaboration with @InnatePharma, adding an exciting new NK cell engager program to our growing pipeline of diverse and complementary #immunooncology approaches.
Learn more: www.sanofi.com/en/media-room/press-releases/2022/2022-12-… -
Sanofi
@sanofi
The @EMA_News CHMP recommended our medicine for approval in eligible EU patients 12 & older with #eoe, a chronic, progressive esophageal disease for which no specifically approved targeted drugs exist. www.sanofi.com/en/media-room/press-releases/2022/2022-12-…
CC: @Regeneron -
Sanofi
@sanofi
The @EU_Commission approved our medicine to treat eligible adults with moderate-to-severe prurigo nodularis, a debilitating chronic skin condition with underlying type 2 inflammation associated with extreme itch.
www.sanofi.com/en/media-room/press-releases/2022/2022-12-…
CC: @Regeneron -
Sanofi
@sanofi
.@CDP has recognized our leadership in taking actions against #climatechange for two consecutive years. See the full #cdpalist: www.cdp.net/en/data/scores
#actwithimpact -
Sanofi
@sanofi
We’re proud to be recognized on @CDP’s Climate Change A List for the second year in a row, for our leadership in #environmental transparency and continued progress in fighting #climatechange.
Learn more: www.sanofi.com/en/our-company/sustainability/environmenta…
#cdpalist #actwithimpact -
Sanofi
@sanofi
Highly contagious diseases such as polio and whooping cough can be particularly severe and even life-threatening for children. But there is something you can do. 👇 #vaccineswork #teamvaccines
IFPMA
@IFPMA
Parents know that babies are vulnerable to childhood diseases, like polio and whooping cough, and can benefit from the protection that routine vaccines can provide throughout their lives. teamvaccines.ifpma.org/vaccines-for-life #vaccinesforlife #teamvaccines
-
Sanofi
@sanofi
Introducing #teamsanofi! On our journey to @Paris2024, we’re proud to team up with inspiring athletes & coaches who share our love for sports & health. Meet the Ignitors who’ll help us inspire everyone to ignite their own potential. #ignitingpotential ⬇️ www.sanofi.com/en/paris-2024-partnership
-
Sanofi
@sanofi
We’re committed to advancing #protectionbeyondflu. Not all flu vaccines are created equal: our portfolio includes #flu vaccines that can help protect against flu but also against its potential complications. Read more 👇
World Heart Federation
@worldheartfed
Anyone can catch and spread flu, making it unpredictable and in some cases severe 🤧
You can reduce your risk of heart attack by 45% with the #fluvaccine.
Protect yourself and those around you.
Use Heart to Stop Flu.
@sanofi #protectionbeyondflu #usehearttostopflu #useheart -
Sanofi
@sanofi
Sanofians Andria and Daniel from Boston share their realities living with a hidden disability. As members of our Ability+ ERG, they’re using their experience to help us better understand our people and our patients, their needs, frustrations and hopes. #weneversettle
This media couldn't be displayed. See it on the original post. -
Sanofi
@sanofi
Cancer kills 1.3 million people annually in the EU alone, and this number is expected to increase by 25% by 2035. Finding new ways to tackle it is critical, and we’re making strides: www.ip-paris.fr/en/news/paris-saclay-cancer-cluster-winne…
Post not available here, view on X
Sanofi
@sanofi
🏆 This week, the French Ministry of Higher Education & Research named the PSCC laureate of the “France 2030” Biocluster plan.
Sanofi
@sanofi
“The Paris Saclay Cancer Cluster gives us the opportunity to strengthen France and Europe's strategic health autonomy, supporting the economy with high skilled jobs, and most importantly, improving the lives of millions of people impacted by cancer.” - Paul Hudson, CEO of Sanofi
-
Sanofi
@sanofi
"What does this mean in the long term? Am I going to be healthy?” Laura had questions when she was diagnosed with immune thrombocytopenia (#itp).
Hear more about her diagnosis journey: www.youtube.com/watch?v=mwIdu0C8gQc -
Sanofi
@sanofi
Sparked by the spirit of @Paris2024, we’re committed to #ignitingpotential in everyone.
Like Olympians and Paralympians, we spend every day challenging ourselves as we chase the miracles of science to improve people’s lives.
Learn more: www.sanofi.com/en/paris-2024-partnership
#paris2024
Sanofi
@sanofi
The Paris 2024 Olympic and Paralympic Games aren’t just about sports. They’re about inclusion, empowerment, teamwork, and what can be achieved when people from different backgrounds unite behind a common purpose. These are the values that drive us.
Sanofi
@sanofi
We’re harnessing #paris2024’s spirit of inclusivity to make science more available to all and reflect our purpose to chase the miracles of science to improve people’s lives.
Learn more: www.sanofi.com/en/paris-2024-partnership -
Sanofi
@sanofi
🚨 We’ve just signed a AUD$280 million partnership for a #translationalsciencehub, bringing together Australian researchers with our scientists to advance #mrna vaccine research.
Read more: www.sanofi.com/en/australia
Sanofi
@sanofi
Speaking of #translational science... we asked our scientists to explain it without jargon. 🧐 Did they make it crystal clear? #nojargon
-
Sanofi
@sanofi
We're proud to support #generationvaluable, a new leadership program created by Caroline Casey - founder of @Valuable500 and DE&I board member at Sanofi.
Ahead of #idpd2022, hear learn about her approach to end disability inequality through the power of business. -
Sanofi
@sanofi
We’re advancing our work with @DNDi to support the @WHO’s goal to eliminate #sleepingsickness by 2030. New phase 2/3 data from our investigational therapy are published in @TheLancetInfDis: www.sanofi.com/en/media-room/press-releases/2022/2022-11-…
#actwithimpact -
Sanofi
@sanofi
Earlier this week, Sanofi Global Health signed an agreement with healthcare leaders from Djibouti to improve access to medicines, medical training and capacity building. #actwithimpact
Learn more about Sanofi Global Health: www.sanofi.com/en/our-company/sustainability/global-healt… -
Sanofi
@sanofi
Sports and science aren’t all that different: in the end, it's about the results. Sanofian and former Olympic rower Chris Liwski shares how athletes and scientists walk similar paths, fueled by failure to get better and fiercely focused on achieving the end goal. #weneversettle
-
Sanofi
@sanofi
Meral’s story is not uncommon but often untold. Serious complications following #flu infection can occur at any age.
Watch and learn why Meral is a strong advocate for getting the #fluvaccine.
#vaccineswork -
Sanofi
@sanofi
We’re proud to have signed the #whclimatepledge at #cop27 and be recognized by @HHSGov officials as a leader in decarbonization and climate change resilience.
-
Sanofi
@sanofi
.@EU_Commission has given the green light for a new treatment for adults with #coldagglutinindisease (CAD), a #rareblooddisorder.
Learn about what this approval means for people with CAD here: www.sanofi.com/en/media-room/press-releases/2022/2022-11-… -
Sanofi
@sanofi
We want our people to show up to work feeling comfortable in their skin, confident to speak up and brave enough to speak out. Our ERGs are set up to do just that.
Sanofians Pedro Pittella and Bruno Araujo from Brazil share their experiences and emotions.
#weneversettle -
Sanofi
@sanofi
Over 380 million people live with chronic obstructive pulmonary disease (COPD) and many experience long-term decline in lung function as the disease worsens. Visit The Next Breath to learn more about COPD: www.thenextbreath.com/blog/World-COPD-Day
#worldcopdday -
Sanofi
@sanofi
Our CEO Paul Hudson attended #cop27 to meet peers, government representatives and environmental influencers and discuss the link between a healthy planet and the health of humanity.
Learn more about our commitment to the environment: www.sanofi.com/en/our-company/sustainability/environmenta…
#actwithimpactThis media couldn't be displayed. See it on the original post. -
Sanofi
@sanofi
The @EMA_News CHMP has recommended our medicine for approval for adults with prurigo nodularis, a chronic inflammatory skin disease for which there are no specifically approved medicines. www.sanofi.com/en/media-room/press-releases/2022/2022-11-… @Regeneron
-
Sanofi
@sanofi
Breaking news @EU_Commission has approved our next-generation protein-based adjuvanted #covid19 booster #vaccine in the EU.
#weneversettle -
Sanofi
@sanofi
Our CEO Paul Hudson spoke to a gathering of entrepreneurs about the metamorphoses of the modern workplace and the value of unlearning previous experience to clear a path for fresh thinking from the next generation.
-
Sanofi
@sanofi
Globally, an estimated 1.1 million children and adolescents live with #t1d. That’s why we have partnered with @IntDiabetesFed to ensure children have the access to diabetes education they need.
Watch below to learn more about the Kids and Diabetes in School support program. -
Sanofi
@sanofi
#rsv is a common and contagious virus contracted by ~90% of babies by age 2.
Today marks a historic milestone as the @EU_Commission has approved our new protective option against RSV disease for infants, developed with our partner @AstraZeneca.
#weneversettle -
Sanofi
@sanofi
With 6 other health companies in @TheSMI Health Systems Taskforce, we’re proud to unveil our shared commitments to accelerate the transition to #netzero health systems.
Ahead of #cop27, learn more about our taskforce and commitments.
#actwithimpact #patientearth -
Sanofi
@sanofi
Our Q3 2022 Financial Results are now available. Read the press release: www.sanofi.com/en/media-room/press-releases/2022/2022-10-…
#sanofiresults -
Sanofi
@sanofi
Our CEO Paul Hudson reflects on our Q3 2022 performance, the progress we’ve made on our social impact strategy and our key R&D achievements.
Learn more: www.sanofi.com/en/investors/financial-results-and-events/…
#sanofiresults $SAN $SNY -
Sanofi
@sanofi
The fight against #polio has made great progress over the last decade but it isn’t over. What measures could help bring polio to an end? Find out here: www.sanofi.com/en/magazine/your-health
#endpolio #worldpolioday #vaccineswork -
Sanofi
@sanofi
Access to healthcare is becoming increasingly complex, especially in countries with underdeveloped infrastructure & healthcare systems. In an article for @prosyn, our CEO Paul Hudson shares how our Global Health Unit is tackling these challenges from the ground up. #actwithimpact
-
Sanofi
@sanofi
Our colleague Mathilde gets vaccinated against #influenza every year, as #flu puts her at risk of an #asthma attack.
Hear Mathilde’s story in her own words. Learn more about the risks of flu here: www.sanofi.com/en/patients/understanding-diseases-conditi… -
Sanofi
@sanofi
#whs2022 is a wrap! We enjoyed meeting global health stakeholders to discuss health challenges created by the climate crisis, and our shared global responsibility to find solutions. #actwithimpact
-
Sanofi
@sanofi
With @NovoNordisk and @merckgroup we're proud to sign the #marseilledeclaration – our joint commitment to the implementation of high welfare standards for animals used in the research and production of medicines and vaccines.
Read more: www.sanofi.com/dam/jcr:64620ff7-dfa4-4a3f-a8b9-05982d52de… -
Sanofi
@sanofi
Last week, our CEO Paul Hudson joined the @BusinessatOECD 60th Anniversary Dinner to discuss #health #environment and #innovation. And how businesses and governments can work together to address the systemic challenges of #climatechange.
-
Sanofi
@sanofi
During today’s keynote speech at #repharma22, our CDO, Arnaud Robert, underlined the importance of embracing data to improve our company, our industry and people’s lives.
More on Data Science at Sanofi: www.sanofi.com/en/our-science/digital-artificial-intellig… -
Sanofi
@sanofi
With @Regeneron, we’re presenting late-breaking Phase 3 investigational data in children ages 1 to 11 with eosinophilic esophagitis (EoE).
Learn about these results at #uegweek: www.sanofi.com/en/media-room/press-releases/2022/2022-10-… -
Sanofi
@sanofi
We’ve been protecting travellers against infectious diseases for >60 years. We're continuously innovating our #vaccines and we’re developing new generation vaccines for #yellowfever and #rabies so people can continue to explore the world.
IFPMA
@IFPMA
Travel opens up a whole world of possibilities but also gives diseases other ways to spread. Vaccines can help keep people protected, wherever they are in the world. teamvaccines.ifpma.org/vaccines-for-life #vaccinesforlife #teamvaccines
-
Sanofi
@sanofi
Scientific discoveries don’t happen overnight or without hard work. But we’re determined to find the answers that will lead us to breakthrough medicines and vaccines for patients.
Meet a new cast of Sanofians who tell the story behind our purpose.
#weneversettle -
Sanofi
@sanofi
Everyone has a role to play in the race to #defeatmeningitis by 2030.
On #worldmeningitisday we’re teaming up with meningitis survivor and para swimmer @TCurin. Find out what you can do in the race to defeat this potentially devastating yet largely vaccine-preventable disease. -
Sanofi
@sanofi
Inspirational para-athlete @TCurin has been living with the some of the possible consequences of #meningitis since age 6.
For him, no challenge is too great. As we race to #defeatmeningitis, we all have a role to play.
Do your part this #worldmeningitisday.This media couldn't be displayed. See it on the original post. -
Sanofi
@sanofi
People living with #atopicdermatitis may question their self-confidence at critical moments in life.
This year’s 2022 ‘Agents of Change’ AD Challenge is focused on helping to improve ‘self-esteem’ for people with AD.
Learn more: agentsofchange-2022.hyvecrowd.com/contest/188/overview
#changead @Regeneron -
Sanofi
@sanofi
We’re pleased to announce that our Vaccines Good Manufacturing Practice Education Center of Excellence in the US won 2 coveted @BrandonHallGrp Silver Awards in the Best Advance category:
➡Competencies & Skill Development
➡Best Unique / Innovative Learning & Development Program -
Sanofi
@sanofi
Did you know that many cases of and deaths from #meningitis are vaccine preventable, but progress in defeating it lags behind other infectious diseases?
Read how we're supporting the progress that’s needed towards the race to #defeatmeningitis by 2030. -
Sanofi
@sanofi
Across all age groups, the risk of potential serious complications following a #flu infection exists.
❤ This #worldheartday, learn how protecting yourself against flu can also help prevent flu triggered cardiovascular events. -
Sanofi
@sanofi
Our medicine for #prurigonodularis has been approved by the FDA. Learn more about this important step for almost 75,000 patients who now have a new option: www.sanofi.com/en/media-room/press-releases/2022/2022-09-… @Regeneron
-
Sanofi
@sanofi
Last weekend, over 500 colleagues in France came together to run the Race for Children Without Cancer - an initiative organized by @ImagineForMargo and supported by our @Collective_FS. Together, the runners raised 2.16 million euros to help advance childhood cancer research!
-
Sanofi
@sanofi
On #worldrabiesday we’re joining the @rabiesalliance to spread awareness of this 100% #vaccine preventable disease! For over 45 years, we’ve been committed to the fight against #rabies, and we continue to invest in innovation to save lives. #vaccinatetoeliminate #endrabiesnow
-
Sanofi
@sanofi
This week at #unga22 & #climateweeknyc our social impact leaders met with peers & stakeholders who are transforming our approach to shared global responsibilities.
On their agendas: access to healthcare, environmental sustainability and the future of philanthropy. #actwithimpact
António Guterres
@antonioguterres
Our world is in big trouble.
Let’s develop common solutions to common problems — grounded in goodwill, trust, and the rights shared by every human being.
Let’s work as one, as a coalition of the world. As united nations. -
Sanofi
@sanofi
Our teams are working on projects to make our facilities more environment-friendly. Because our actions are our future, we #actwithimpact
-
Sanofi
@sanofi
We're constantly seeking to deliver positive impacts on local communities or co-benefits on the environment through our actions.
This year, we’re focusing on two projects in partnership with EcoAct.
#actwithimpact -
Sanofi
@sanofi
Here at Sanofi, we #actwithimpact and transform our ambitions into actions with our partners. #carbonneutrality #netzero
-
Sanofi
@sanofi
We’re focused on prioritizing the development of innovative, targeted treatments for children with #childhoodcancer.
Read more:
#nationalchildhoodcancerawarenessmonth -
Sanofi
@sanofi
In the race towards #netzero, our priority is to reduce emissions across our full value chain to the maximum.
#actwithimpact -
Sanofi
@sanofi
We’re tackling climate change in a way that aligns with our purpose: improving people’s lives.
www.sanofi.com/en/our-responsibility/environmental-sustai…
#climateweek #actwithimpact -
Sanofi
@sanofi
Breaking: the @EMA_News’s #chmp has recommended approval of our potential RSV immunization for the broad infant population.
Along with our partners @Astrazeneca, we’re proud of this latest milestone and look forward to contributing to the future in #rsv disease prevention. -
Sanofi
@sanofi
#atopicdermatitis is a chronic type 2 inflammatory skin disease with 85-90% of patients developing symptoms before 5 years of age. Find out more about today’s news: www.sanofi.com/en/media-room/press-releases/2022/2022-09-…
@Regeneron @TheLancet -
Sanofi
@sanofi
For #worldatopiceczemaday we’re calling on the public to help people with #atopicdermatitis feel more confident with their skin. Submit an idea to the 2022 ‘Agents of Change’ AD Challenge to help people with AD build self-esteem. #changead agentsofchange-2022.hyvecrowd.com/contest/188/overview
@Regeneron -
Sanofi
@sanofi
Today, we’re presenting late-breaking results at #eadv2022 from our second pivotal trial in adults with #prurigonodularis. Read the news: www.sanofi.com/en/media-room/press-releases/2022/2022-09-…
@Regeneron -
Sanofi
@sanofi
Our employees contribute to improving people’s lives and transform the practice of medicine: integrated-report.sanofi.com/communities/key-trends-trans…
#sanofi #weneversettle -
Sanofi
@sanofi
With @Regeneron, we’re presenting late-breaking, two-year data in children aged 6 to 11 years with uncontrolled asthma at #erscongress.
Learn more about these Phase 3 data results: www.sanofi.com/en/media-room/press-releases/2022/2022-09-… -
Sanofi
@sanofi
Ready to see philanthropic #healthcare initiatives go that much further? Follow @Collective_FS
The #foundations collective works to create healthier futures for generations to come!
#weneversettleThis media couldn't be displayed. See it on the original post.
Sanofi
@sanofi
Looking for more news from @Collective_FS on #linkedin? Follow www.linkedin.com/showcase/foundation-s/
#foundations -
Sanofi
@sanofi
Our CEO Paul Hudson reflects on our 2021 performance, the power of collaboration and our key achievements in R&D.
integrated-report.sanofi.com
#sanofi #weneversettle -
Sanofi
@sanofi
Today, the @US_FDA approved the first and only therapy for non-CNS manifestations of #asmd, a progressive and #raredisease. Read more: www.news.sanofi.us/2022-08-31-XenpozymeTM-olipudase-alfa-…
-
Sanofi
@sanofi
Learn more about today’s news as part of our ongoing commitment to break treatment barriers in #hemophilia A.
www.sanofi.com/en/media-room/press-releases/2022/2022-08-… -
Sanofi
@sanofi
Discover how we chase the miracles of science to improve people’s lives:
integrated-report.sanofi.com
#sanofi #weneversettle -
Sanofi reposted
Foundation_S
@Collective_FS
Today is a big day for Foundation S - The @Sanofi Collective! We're officially introducing ourselves to the @Twitter community. 🗣️
Learn more about us 👇This media couldn't be displayed. See it on the original post. -
Sanofi
@sanofi
With an innovative trial design streamlining the process for all involved, our #rsv HARMONIE study is an important step toward our goal to protect all infants from RSV.
With @AstraZeneca, we announce the first enrollment today: www.sanofi.com/en/your-health/vaccines/respiratory-syncyt… -
Sanofi
@sanofi
Today, we announced a collaboration with @Innovent_2011 to bring innovative medicines to China for people with difficult-to-treat cancers. We look forward to a successful partnership and to bringing much needed treatments to #cancer patients.
www.sanofi.com/en/media-room/press-releases/2022/2022-08-… -
Sanofi
@sanofi
We’re entering a new era in the modern workforce – today’s talent doesn’t dream of a ‘dream job’.
Our CEO Paul Hudson shares four things business leaders need to keep in focus when encouraging #genz employees: www.fastcompany.com/90772850/gen-z-isnt-looking-for-a-dre… -
Sanofi
@sanofi
Our CEO Paul Hudson reflects on our Q2 2022 performance, the progress we’ve made on our social impact strategy and our key achievements in R&D transformation. Learn more: www.sanofi.com/en/media-room/press-releases/2022/2022-07-…
#sanofiresults $SAN $SNY -
Sanofi
@sanofi
Our Q2 2022 Financial Results are now available. Read the press release: www.sanofi.com/en/media-room/press-releases/2022/2022-07-…
#sanofiresults $SAN $SNY -
Sanofi
@sanofi
Moving from a sick care to a #selfcare approach can have a major positive impact on people and the planet.
Julie Van Ongevalle, EVP of Consumer Healthcare shares the importance of having health in people’s hands. #betterselfcare -
Sanofi
@sanofi
"A red alert for child health…The consequences will be measured in lives" says @unicefchief. This is an urgent wake-up call for the public health community to restore routine immunization so no child must live with the consequences of a vaccine-preventable disease. #vaccineswork
World Health Organization (WHO)
@WHO
1⃣8⃣ million children did not receive a single vaccine in 2021 - the largest ↘️ in 29 years, due to:
🔸 #covid19-related disruptions
🔸 emergencies
🔸 misinformation undermining vaccine acceptance & demand
WHO & @UNICEF sound the alarm 🚨
🆕 data on global vaccine coverage ⬇️ -
Sanofi
@sanofi
With @regeneron, we’re announcing the first positive Phase 3 trial in children 1 to 11 years of age with eosinophilic esophagitis - a painful disease that can impact growth and development:
www.sanofi.com/en/media-room/press-releases/2022/2022-07-… -
Sanofi
@sanofi
A new wave of innovation is developing novel treatments that could help people with #hemophilia live the lives they choose.
Here are some big moments that changed the field of hemophilia research and a look ahead to what’s next:
www.sanofi.com/en/science-and-innovation/stories/a-timeli… -
Sanofi
@sanofi
We’re working tirelessly to address the unmet needs of the #hemophilia community.
Together with Sobi, we’re supporting the WFH Humanitarian Aid Program, helping to close the gap between those who have access to essential medicines and those who don’t. #actwithimpact -
Sanofi
@sanofi
What can be done to improve the survival rate of children with cancer? Read more in our article for the Financial Times. #actwithimpact
-
Sanofi
@sanofi
Bad for the planet, bad for human health: what can be done about climate change?
Find out how we #actwithimpact in our article for the Financial Times. -
Sanofi reposted
AESGP
@aesgp
@sanofi is committed to #actwithimpact for the environment. Their #planetmobilization environmental sustainability program covers the entire life cycle of the products, from the raw materials used to make them, to their use and disposal by patients.
⏩ #sustainableselfcare -
Sanofi
@sanofi
Non-communicable diseases are becoming ever more deadly in lower income countries.
Learn how we #actwithimpact to address this issue with our non-profit Global Health Unit. -
Sanofi
@sanofi
In Sierra Leone, we’re working with @MedtronicLabs to make a difference for people in the local community with noncommunicable diseases.
People like Ibrahim Kamara – hear about the challenges he’s faced managing his diabetes and hypertension.
#actwithimpact
#accesstohealthcareThis media couldn't be displayed. See it on the original post. -
Sanofi
@sanofi
We’re welcoming global health experts and stakeholders at our head office in Paris to discuss how we can #actwithimpact and build end to end health programs in local communities. So we can best reach, treat and manage patient’s health in an effective and sustainable way.
Post not available here, view on X
Sanofi
@sanofi
Our second panel explores how the use of data and digital technologies can help accelerate access to health. #actwithimpact
Sanofi
@sanofi
Thank you to our second panelists for this great discussion!
• Ruchika Singhal, @MedtronicLabs
• Dr. William Mapham, CEO @vulamobile
• @Rockson2, CEO @mPharmaHealth
• Edwina Ong, @reach52healt
• Prof. Maimouna, @ucad_senegal
Sanofi
@sanofi
Jon Fairest shares more about our Impact brand and fund, and what's next for our Global Health Unit: “We're building partnerships that will help to improve and establish health systems to reach our goal of a healthier, more resilient world.” #actwithimpact
Sanofi
@sanofi
Honored to have @FNimfura, Ambassador of Rwanda in France, close our event.
Thank you to all panelist and guests for attending, and for everyone who followed along live on Twitter! #actwithimpact -
Sanofi
@sanofi
With Sanofi Global Health, we’re committed to #actwithimpact so everyone can receive the care they need.
Discover our new nonprofit Impact brand and Impact Fund, which will help increase access to medicines and healthcare in the world’s most impoverished countries. -
Sanofi
@sanofi
Coming out is one of the most important moments in many people’s lives. We’re thankful for our colleague Jill, for sharing her personal story about coming out at work as a transgender woman. #pride
Sanofi
@sanofi
And while #pridemonth has come to an end, #pride has not! We’re 100% committed to delivering on our promise to build an inclusive and equitable workplace where everyone can live OUT loud. www.sanofi.com/en/our-responsibility/equality-and-inclusi…
-
Sanofi
@sanofi
#rabies is 100% #vaccine preventable! For over 45 years, we’ve been committed to the fight against this disease and we’re proud to support @rabiesalliance in the quest to end human deaths from dog-mediated rabies by 2030.
#vaccinatetoeliminate #zeroby30 -
Sanofi
@sanofi
#weneversettle in the pursuit to find answers for patients and are proud of the approval in Europe of the first new therapy in 15 years for the rare, degenerative muscle disorder, #pompe disease.
Read the news and learn about the condition: www.sanofi.com/en/media-room/press-releases/2022/2022-06-… -
Sanofi
@sanofi
We're excited to announce that our treatment for non-Central Nervous System (CNS) manifestations of Acid Sphingomyelinase Deficiency in pediatric and adult patients with #asmd type A/B or B has been approved in the EU: www.sanofi.com/en/media-room/press-releases/2022/2022-06-…
-
Sanofi
@sanofi
This week, at the #kigalisummit for Malaria & Neglected Tropical Diseases, we’re recommitting our long-established efforts — and our collaboration with countries and partners — to control and eliminate #sleepingsickeness among other neglected tropical diseases.
This media couldn't be displayed. See it on the original post. -
Sanofi
@sanofi
For 21 years, we’ve partnered with @WHO through financial support and drug donations to eliminate #sleepingsickness. We continue to work towards developing a novel, single-dose treatment, and we’ll never settle until the elimination of this disease. #weneversettle
-
Sanofi
@sanofi
We encourage everyone at Sanofi to be an authentic ally for our LGBTQ+ colleagues. To listen, learn and show up for the community beyond #pridemonth, so that everyone can live out loud.
#pride #pride2022 -
Sanofi
@sanofi
What's the role of industrial affairs in a healthcare company? Brendan O’Callaghan, our EVP for Industrial Affairs, talks to @POLITICOStudio about our global manufacturing operations and our digital-first approach to chasing the miracles of science: www.politico.eu/sponsored-content/turning-miracles-of-sci…
-
Sanofi
@sanofi
"Life can be transformative when you embrace who you are and live the life you were always meant to live. I'm proud to lead Sanofi's Pride+ Employee Resource Group and aspire to equip our LGBTQ+ community with the support and resources to truly live OUT loud." - Jake Prodoehl
-
Sanofi
@sanofi
We’ve partnered with @MSDEurope & @Pandemos_eu to host a simulation game at #ehma2022 on June 15.
Step in the shoes of a healthcare professional, policy maker and more to explore the #vaccine ecosystem!
Register here: ➡ ehmaconference.org/explore-this-session-hosted-by-msd-and… -
Sanofi
@sanofi
While we use our birth date to determine our age, for many of us, our health and wellness may vary by age. Head of Global Oncology Medical Affairs, Zsuzsanna Devecseri, discusses this concept with experts and the potential outcomes if we change how we think about aging.
-
Sanofi
@sanofi
We’re proud to join over 80 companies in signing @thrive and @shrm’s #mentalhealthpledge to continue prioritizing employee mental health and well-being.
Thrive Global
@thrive
Thrive and @SHRM have brought together over 80 companies to pledge to continue prioritizing their employees’ mental health and well-being through the challenging times that lie ahead.
-
Sanofi
@sanofi
“Coming out is about being authentic with the people who love you and who you love.” Meet John Amaechi, one of our external DE&I board advisors, who shares his coming out story. #pride #pride2022 #pridemonth #dei
This media couldn't be displayed. See it on the original post. -
Sanofi
@sanofi
Beth finds strength to continue enjoying her passions while living with metastatic breast cancer (MBC). Learn more about Beth and others living with MBC. #mbcunfiltered
-
Sanofi
@sanofi
Progress needs people with different backgrounds, skills and perspectives so we’re proud to sponsor European Women in Tech 2022, reinforcing our commitment to achieving gender balance across Sanofi. #ewit22 @WinTechSeries
-
Sanofi
@sanofi
Our new Digital Accelerator brings together an international team of digital experts to build products and solutions to support our mission to transform the practice of medicine with the use of digital, data & AI.
Learn more: www.sanofi.com/en/media-room/press-releases/2022/2022-06-… -
Sanofi
@sanofi
In 85-90% of patients with uncontrolled moderate-to-severe #atopicdermatitis, symptoms first appear before 5 years of age, and often persist into adulthood.
Read the news about our FDA approval for these patients: www.sanofi.com/en/media-room/press-releases/2022/2022-06-…
CC: @Regeneron -
Sanofi reposted
Sanofi US
@SanofiUS
It’s not just a new campus. It’s a new start. See what the opening of our new campus at Cambridge Crossing means for the future of science, our community and our people. www.news.sanofi.us/2022-06-07-Sanofi-unveils-new-900,000-…
-
Sanofi
@sanofi
Recognizing that healthcare contributes to 4-5% of greenhouse gas emissions per year, we’re joining our peers from @TheSMI Health Systems Taskforce to accelerate the delivery of #netzero health systems. www.devex.com/news/sponsored/opinion-taking-collective-ac…
#onlyoneearth #worldenviornmentday -
Sanofi
@sanofi
Worldwide, families are impacted by atopic dermatitis. With @Regeneron, we’re announcing the 2021 ‘Agents of Change’ AD grant recipients @eczemaresearch, @GA2P2, @AlerjiDernegi, COPAC, Israeli Assoc. for AD & their ideas to help these families. Learn more: www.changead.com/initiatives/agents-of-change/
-
Sanofi
@sanofi
With #planetmobilization we dedicate €3M every year to fund our employees’ environmental projects. For 2022, we’re helping 6 local initiatives expand globally to drive collective, transformative action for our planet. Swipe to learn more. #onlyoneearth. #worldenvironmentday
-
Sanofi
@sanofi
Encouraging better conversations between doctors and people diagnosed with cancer is at the heart of @UnidosTMO mission. Paulina shares the impact of their work in Mexico as a 2021 recipient of our When Cancer Grows Old contributions initiative support.
-
Sanofi
@sanofi
We’re PROUD to partner with @myGwork, the business community for LGBTQ+ professionals and allies, to promote diversity & inclusion and build a workplace where everyone can be their true selves to live out loud. www.sanofi.com/en/our-responsibility/equality-and-inclusi… #pride #pride2022 #pridemonth #dei
-
Sanofi
@sanofi
Learn more about this week’s announcement in #prurigonodularis, which has the potential to offer a new option to those living with the significant burden of this chronic type 2 inflammatory skin disease. @Regeneron
Read more here: www.sanofi.com/en/media-room/press-releases/2022/2022-05-… -
Sanofi
@sanofi
As a result of our ongoing research, our investigational #hemophilia A therapy was granted US FDA Breakthrough Therapy designation. Sanofi is committed to helping improve the lives of people living with hemophilia, a rare blood disorder: www.sanofi.com/en/media-room/press-releases/2022/2022-06-…
-
Sanofi
@sanofi
For patients with #prurigonodularis, a chronic type 2 inflammatory skin disease, today’s announcement with @Regeneron has the potential to offer a new option to many who have lived with the significant burden of the disease.
Read more: www.sanofi.com/en/media-room/press-releases/2022/2022-05-… -
Sanofi
@sanofi
This #worldmsday, we’re sharing our #msconnections to share support for the MS community and @MSIntFederation.
-
Sanofi
@sanofi
Jaime and Bruna are a married couple living with MS. Their diagnoses brought them together over a decade ago, and they continue to be tremendous advocates for the MS community. This #worldmsday, read their incredible story: www.upworthy.com/they-met-over-a-shared-diagnosis-their-l…
-
Sanofi
@sanofi
How can improving #vaccine manufacturing by developing evolutive vaccine facilities better prepare us for the future? Find out in Pierre-Damien’s story 👇
#vaccinesforlife #teamvaccines
IFPMA
@IFPMA
With #covid19 we scaled up vaccine manufacturing from zero to billions of doses in a year. We continue to work on new, even more agile, manufacturing technologies so we can increase supply when needed. teamvaccines.ifpma.org/pierre-damien-story #vaccinesforlife #teamvaccines
-
Sanofi
@sanofi
Until now, patients with #eoe, a chronic, progressive type 2 inflammatory disease that damages the esophagus, had no medicines specifically for their condition. Learn more about a new option: www.sanofi.com/en/media-room/press-releases/2022/2022-05-…
-
Sanofi
@sanofi
On International #clinicaltrialsday, we honor the dedication and resilience of those who contribute to science in the face of adversity and express our deepest hope for a return to peace in Ukraine.
#ctd2022 #clinicaltrials #clinicalresearch
Sanofi
@sanofi
We stand in opposition to the Russian war in Ukraine and in full support of the position of the international community. Read our full statement: www.sanofi.com/en/media-room/our-response-to-the-situatio…
-
Sanofi
@sanofi
Want to dig deeper into our science? Follow our new showcase page @SanofiScience to keep your finger on the pulse of R&D and meet the people behind the discoveries.
-
Sanofi
@sanofi
At #asco22, we look forward to sharing new investigational data across our expanding #oncology portfolio in #multiplemyeloma, #lungcancer and #breastcancer.
Learn more here: www.sanofi.com/en/media-room/press-releases/2022/2022-05-… -
Sanofi
@sanofi
We’re connecting the dots between disease treatment and prevention. Discover more on May 19 when we’ll launch a new Twitter page to share news and stories about science across all Sanofi.
-
Sanofi
@sanofi
Excited to share the latest findings from a Phase 3 study of our treatment for relapsed #multiplemyeloma at the @COMyCongress. Read about these remarkable results here: www.sanofi.com/en/media-room/press-releases/2022/2022-05-…
-
Sanofi
@sanofi
Today, we’re at #espid2022 sharing new data in respiratory syncytial virus.
These positive data represent a step toward the goal of protecting infants against severe #rsv disease. -
Sanofi
@sanofi
At Sanofi, we're combining real world data with #ai to discover a new generation of medicines and achieve better outcomes for our patients. Read more from our Chief Digital Officer, Arnaud Robert, in @POLITICOEurope: www.politico.eu/sponsored-content/the-digitization-of-dru…
-
Sanofi
@sanofi
We strive to create healthier futures for generations to come and are proud to present our new approach to philanthropy: Foundation S – The Sanofi Collective. Learn more: www.sanofi.com/en/media-room/press-releases/2022/2022-05-…
-
Sanofi
@sanofi
Our Annual General Meeting was held today under the chairmanship of Serge Weinberg. All resolutions submitted to the vote were adopted by the shareholders. Read more: www.sanofi.com/en/media-room/press-releases/2022/2022-05-… #sanofigm
-
Sanofi
@sanofi
Our 2021 Integrated Report 2021 is now available! Learn more about our people, our science, the contribution we make to society and our strategy in action: integrated-report.sanofi.com
#sanofi #weneversettle -
Sanofi
@sanofi
Our collaboration program with @McLaren will be rolled out in 7 countries, covering more than 100 production lines, across all technologies.
Learn more: www.sanofi.com/en/media-room/press-releases/2022/2022-04-…
#factoryofthefuture #digitalfactory -
Sanofi
@sanofi
Our CEO Paul Hudson reflects on our Q1 2022 performance, the progress we’ve made on our CSR strategy and our key achievements in R&D transformation.
Learn more: www.sanofi.com/en/media-room/press-releases/2022/2022-04-…
#sanofiresults $SAN $SNY -
Sanofi
@sanofi
Our Q1 2022 Financial Results are now available. Read the press release: www.sanofi.com/en/media-room/press-releases/2022/2022-04-…
#sanofiresults $SAN $SNY -
Sanofi
@sanofi
Tim, a body builder with severe hemophilia A, shares his heroic quest of overcoming challenges living with this rare blood disorder. Tune in: sanofihemophilia.com
-
Sanofi
@sanofi
Our partnership with @McLaren aims at accelerating manufacturing performance in our journey to build world-class industrial standards of excellence.
Learn more: www.sanofi.com/en/media-room/press-releases/2022/2022-04-…
#factoryofthefuture #digitalfactory -
Sanofi
@sanofi
We are happy to announce a partnership focused on manufacturing asset efficiency with @McLaren, in 7 countries, covering more than 100 production lines, across all technologies.
#factoryofthefuture #digitalfactory -
Sanofi
@sanofi
Industrial site director Helene Deweerdt knows that only when she stops learning will she be ready to move on. “Patients are waiting for us. That’s why we do what we do. I believe in the power of our people to solve issues.”
www.sanofi.com/en/about-us/our-purpose/
#weneversettle -
Sanofi
@sanofi
Exciting day in Singapore where we laid the first stone of our new Evolutive Vaccine Facility! This EVF will help improve people’s lives by giving them faster access to the most innovative #vaccines and treatments.
Learn more:
www.sanofi.com/en/your-health/vaccines/production -
Sanofi
@sanofi
Data analyst Bruno Gagliardo, is a martial arts enthusiast who finds ways to do his best work at Sanofi by building new connections, and welcoming new ideas. "It’s all about people, together we are stronger and we are actually smarter."
www.sanofi.com/en/about-us/our-purpose/
#weneversettle -
Sanofi
@sanofi
Excited to share the publication of our @NEJM Phase 1/2 data in #itp, a rare bleeding disorder where there are currently no approved treatments. www.sanofi.com/en/media-room/press-releases/2022/2022-04-…
-
Sanofi
@sanofi
Vaccines communicator Barbara spent her son’s first birthday with him in hospital. “There was no vaccine for what he had. Vaccines for everyone, especially children, are so important. Science changes lives. That's the miracle.”
www.sanofi.com/en/about-us/our-purpose/
#weneversettle -
Sanofi
@sanofi
The @WHO theme for #worldhealthday is ‘Our planet, our health’. Learn how @TheSMI Health Systems Taskforce is committed to accelerating the delivery of #netzero healthcare for a #healthiertomorrow: www.sustainable-markets.org/taskforces/health-systems-tas…
-
Sanofi
@sanofi
On #worldhealthday, we’re focused on global impact, something exemplified by our Rare Humanitarian Program. For 30+ years, we’ve been committed to delivering care to people with rare diseases in underserved areas around the world.
Learn more:www.sanofi.com/en/about-us/our-stories/sanofis-rare-human… -
Sanofi
@sanofi
Our medicine for severe #asthma has been approved by the European Commission for children aged 6-11 years with type 2 inflammation, an important step for these patients and their families. Read more:
www.sanofi.com/en/media-room/press-releases/2022/2022-04-… @Regeneron -
Sanofi
@sanofi
The U.S. FDA has accepted for priority review the sBLA for our potential eosinophilic esophagitis medicine for patients aged 12 years and older. This type 2 inflammatory disease has no approved indicated medicines in the U.S.: www.sanofi.com/en/media-room/press-releases/2022/2022-04-… @Regeneron
-
Sanofi
@sanofi
Today, we’ve launched our own #diversity, #equity & #inclusion Board with 3 outside advisors to keep us on track towards our 2025 DE&I goals.
Our first act together? Creating an Employee Resource Group framework, which will allow already existing local ERGs to scale and grow! 🌱 -
Sanofi
@sanofi
The sBLA for our potential medicine has been accepted by the U.S. FDA for priority review in patients aged 12 years and older with eosinophilic esophagitis. This chronic disease can make eating a difficult experience. Learn more: www.sanofi.com/en/media-room/press-releases/2022/2022-04-… @Regeneron
-
Sanofi
@sanofi
We’re further contributing to the development of the #sustainablefinance market through the successful pricing of our first sustainability-linked bond.
Learn more: www.sanofi.com/en/media-room/press-releases/2022/2022-03-… -
Sanofi
@sanofi
We're live from Cambridge! Our CEO Paul Hudson kicks off our #sanofiimmunology Investor Event and reflects on our ambition: "It would be difficult for anyone to emulate what we’ve put together in immunology - mechanistically or strategically."
Follow for more live tweets 👇Post not available here, view on X
Sanofi
@sanofi
Up next: Naimish Patel, Head of inflammation R&D, shares what makes our #immunology pipeline unique: "We have a number of additional molecules in the portfolio that could further accelerate our growth, both in type 2 and beyond." #sanofiimmunology
Sanofi
@sanofi
Frank Nestle, Chief Scientific Officer, concludes the event: "We're putting patients first with precision immunology. This drives our ambition to break efficacy ceilings, achieve durable responses, and expand into new indications."
Thanks for following! #sanofiimmunology -
Sanofi
@sanofi
We’re pleased to partner with IGM Biosciences to create and develop engineered IgM #antibodies - a new class of potential therapeutics - for the treatment of #cancer, #autoimmune and #inflammatory diseases. www.sanofi.com/en/media-room/press-releases/2022/2022-03-…
-
Sanofi
@sanofi
Today, we’re hosting our first dedicated Immunology Investor Event with key members of our leadership team to share updates on our strategy and exciting #immunology pipeline.
www.sanofi.com/en/media-room/press-releases/2022/2022-03-…
#sanofiimmunology #weneversettle -
Sanofi
@sanofi
The Japanese Ministry of Health, Labor and Welfare has granted market authorization for the first approved treatment indicated for use in adults and children with #asmd: www.sanofi.com/en/media-room/press-releases/2022/2022-03-…
-
Sanofi
@sanofi
At #aad2022, we’re sharing late-breaking Phase 3 data from a pivotal clinical trial of our investigational medicine in #prurigonodularis. @Regeneron
-
Sanofi
@sanofi
We’re sharing late-breaking Phase 3 results at #aad2022 from our pivotal trial in patients with #prurigonodularis, a chronic inflammatory skin disease. @Regeneron
-
Sanofi
@sanofi
Meet scientist Al Hassan. On top of his day job, he works with a charity to improve healthcare for patients in the developing world. "In developed countries, people benefit from high-quality treatment, that's not the case in the third world.”www.sanofi.com/en/about-us/our-purpose/ #weneversettle
-
Sanofi
@sanofi
We stand in opposition to the Russian war in Ukraine and in full support of the position of the international community. We’ve stopped new spending not related to the supply of our essential and life-changing medicines and vaccines in Russia, as well as in Belarus.
Sanofi
@sanofi
A complete cessation of our activities would deprive people of the essential & life-changing medicines & vaccines they need and add to suffering. This would contradict our purpose. We'll stay focused on patients, as we always have. Read our full statement: www.sanofi.com/en/media-room/our-response-to-the-situatio…
-
Sanofi
@sanofi
Progress needs people who chase change for patients. And that’s what we wake up to do every day. Meet Vicky DiBiaso - as the wife of someone with Parkinson’s disease, she knows all too well how important it is to keep improving what we do.
www.sanofi.com/en/about-us/our-purpose/
#weneversettle -
Sanofi
@sanofi
We’re pleased to announce the next chapter of growth for EUROAPI with a listing on Euronext Paris in H1 2022. #activepharmaceuticalingredients
-
Sanofi
@sanofi
In our recent survey, less than half of the people with #multiplemyeloma felt they were part of their treatment decisions. This #myelomaaction Month, we encourage people to have open dialogue with their physicians and play an active role in the management of their disease.
-
Sanofi
@sanofi
How are #vaccines made in the future?
Here’s a first look inside our Evolutive Vaccine Facility that is currently being built in France. It will run on the most advanced digital technologies to make our production faster, more flexible, and better for the planet. #weneversettle -
Sanofi
@sanofi
We’re teaming up with @SeagenGlobal to design, develop, and commercialize up to three antibody-drug conjugate molecules (ADCs) for the treatment of #cancer.
-
Sanofi
@sanofi
We’re building our #mrnacenterofexcellence in the US & France and we’re looking for new colleagues, who are ready to discover the full potential of mRNA and re-invent the way we work to improve peoples’ lives. Hear more from Régis Gervier, who leads our center on both continents.
Sanofi
@sanofi
Don’t miss our live jobinar today at 6 PM CET / 12 PM EST to learn what it’s like to work at our #mrnacenterofexcellence: sanofi12.jobinar.com
#mrna #sanoficareers -
Sanofi
@sanofi
With @Blackstone, we’re pleased to announce a strategic collaboration under which Blackstone Life Sciences will help accelerate the global pivotal trial and clinical development program of our medicine to help patients with #multiplemyeloma. www.sanofi.com/en/media-room/press-releases/2022/2022-03-…
-
Sanofi
@sanofi
We’re shocked by the war in Ukraine and deeply saddened by the magnitude of the challenges facing the Ukrainian people. We’re focused on the safety of our employees and their families and maintaining our commitment to the patients and people we serve.
Sanofi
@sanofi
Through our foundation, we’ve donated €5m to the Red Cross for Ukraine and neighboring countries and to UNHCR, the UN Refugee Agency. This will support emergency access to necessities and will help receive and assist refugees from Ukraine.
Sanofi
@sanofi
We’re also accelerating donations of our essential medicines and vaccines to support both patients in Ukraine and Ukrainian refugees in neighboring countries. Our company is united by a common purpose, to improve people’s lives, and we unequivocally condemn all acts of violence.
Post not available here, view on X
Sanofi
@sanofi
Due to the unique nature of our industry, and in line with international law, we remain committed to continue supplying life-saving or essential medicines and vaccines to the people of Russia who need them and to continue ongoing clinical trials that involve Russian patients.
Sanofi
@sanofi
Our approach will be regularly reviewed given the volatility of the situation. Read our full statement: www.sanofi.com/en/media-room/our-response-to-the-situatio…
-
Sanofi
@sanofi
We’re sharing an update on a Phase 2 trial evaluating our investigational treatment in #metastaticbreastcancer. Read more: www.sanofi.com/en/media-room/press-releases/2022/2022-03-…
-
Sanofi
@sanofi
Imagination helps us have the greatest impact for patients and customers. Just ask Nizar, a #sanofiscientist working in cancer discovery. “In order to do groundbreaking things, you need to have an imagination, you need to be able to dream.”
www.sanofi.com/en/about-us/our-purpose/
#weneversettle -
Sanofi
@sanofi
Our novel, investigational factor VIII therapy has the potential to transform therapy for people with #hemophilia A. See the positive topline results from our Phase 3 study: www.sanofi.com/en/media-room/press-releases/2022/2022-03-…
-
Sanofi
@sanofi
Proud! We scored 86 out of 100 in @SPGlobalRatings’ #esg evaluation - one of the highest scores across all sectors globally! This confirms that we’re on the right track with our social impact strategy to fulfill our commitment to society. www.sanofi.com/en/media-room/press-releases/2022/2022-03-…
-
Sanofi
@sanofi
We're excited to share positive topline data from a pivotal Phase 3 study of our novel, investigational factor VIII therapy for #hemophilia A, a rare blood disorder.
www.sanofi.com/en/media-room/press-releases/2022/2022-03-… -
Sanofi
@sanofi
This #internationalwomensday, we celebrate women’s economic empowerment. With @WEConnection, we’re committed to #breakthebias for women entrepreneurs and pledge to double our spend with #womenownedbusinesses, like @Rangam_inc and @GR_Comms, by 2025.
#weneversettle #iwd2022 -
Sanofi
@sanofi
Exciting day in France, where we’re joined by French Prime Minister @JeanCASTEX to lay the first stone for our new Evolutive Vaccine Facility - a fully digitalized production site that will transform the way we make #vaccines and treatments.
-
Sanofi
@sanofi
Meet Paul Rowe: Medical Director, musician, and former football player. He always knew he wanted to work in healthcare but realized he could help more people in pharma than by following a traditional physician’s path.
www.sanofi.com/en/about-us/our-purpose/
#weneversettle -
Sanofi
@sanofi
This pandemic has forced healthcare companies to come together and work differently. What our industry has achieved for patients shows that this new way of working can help us reinvent healthcare as we know it. fortune.com/2022/02/22/pharmas-sense-of-urgency-must-outl… @FortuneMagazine
-
Sanofi
@sanofi
Immunization programs help protect infants and halt the spread of diseases. We're developing #vaccines that could save lives, and investigating how #monoclonalantibodies could help protect infants during their most vulnerable time in life. www.sanofi.com/en/science-and-innovation/stories/vaccines… #sanofiscience
-
Sanofi
@sanofi
Together with @Regeneron, we’re presenting positive late-breaking data in eosinophilic esophagitis at #aaaai22. Learn more about our research in this type 2 inflammatory disease: www.sanofi.com/en/media-room/press-releases/2022/2022-02-…
-
Sanofi
@sanofi
At #aaaai22, we’re presenting late-breaking pivotal data for our investigational medicine in chronic spontaneous urticaria, a debilitating inflammatory skin condition that causes intense itch and hives. @Regeneron
www.sanofi.com/en/media-room/press-releases/2022/2022-02-… -
Sanofi
@sanofi
Positive late-breaking data for our investigational medicine in eosinophilic esophagitis underscore our work with @Regeneron to help people living with this chronic, debilitating disease.
Learn more about our research at #aaaai22: www.sanofi.com/en/media-room/press-releases/2022/2022-02-… -
Sanofi
@sanofi
With @Regeneron, we’re presenting late-breaking pivotal data for our investigational medicine in chronic spontaneous urticaria, a debilitating inflammatory skin condition that causes intense itch and hives.
Learn more about our research at #aaaai22: www.sanofi.com/en/media-room/press-releases/2022/2022-02-… -
Sanofi
@sanofi
China’s National Medical Products Administration has expanded the use of our #atopicdermatitis medicine for children aged 6 to 11 years with moderate-to-severe symptoms. @Regeneron
-
Sanofi
@sanofi
We’re presenting new CNS pharmacology data on our investigational BTK inhibitor for #multiplesclerosis: www.sanofi.com/en/media-room/press-releases/2022/2022-02-…. #actrims
-
Sanofi
@sanofi
Meet Hélène Bonnet. When she beat cancer, her approach to life changed dramatically and acting for patients became deeply personal: “Keep searching, because the story is not to be alive. It’s to be alive with a great quality of life.”
www.sanofi.com/en/about-us/our-purpose/
#weneversettle -
Sanofi
@sanofi
To help protect infants against infectious diseases, broad immunization programs may one day include both #vaccines and #monoclonalantibodies
Learn more: www.sanofi.com/en/science-and-innovation/stories/vaccines…
#sanofiscience -
Sanofi
@sanofi
We welcome Ziv Bar-Joseph as our new Head of R&D and Computational Sciences. Ziv will leverage his years in #ai and #machinelearning to advance our R&D programs in #mrna, #oncology and #immunology, and to build an industry-leading global R&D data hub.
-
Sanofi
@sanofi
We're sharing an update on our chronic spontaneous urticaria Phase 3 program. Learn more: www.sanofi.com/en/media-room/press-releases/2022/2022-02-…
-
Sanofi
@sanofi
Respiratory syncytial virus is a contagious, usually mild virus that can send infants to doctors & hospitals in the winter. As COVID-19 restrictions eased, infections increased. This year’s #rsv activity demands attention. Learn more: www.sanofi.com/en/about-us/our-stories/respiratory-syncyt…
-
Sanofi
@sanofi
What if we can make the impossible possible?
It won’t be easy, and we might stumble.
But we’ll never settle for anything less than a miracle.
#sanofi #weneversettle
Learn how we chase the miracles of science to improve people’s lives:
www.sanofi.com/en/about-us/our-purpose/
Sanofi
@sanofi
Stay tuned! This “living” film reflects the evolving nature of our company and will be updated over the course of the year to include more of our people and their stories.
-
Sanofi
@sanofi
Now is Europe’s moment to aim high, and to realize an ambitious vision for its’ strategic autonomy in health. Read more in our article on @PoliticoStudio.
-
Sanofi
@sanofi
On International Day of Women and Girls in Science, hear from two Sanofi scientists who defied gender bias to pursue their passion and forge new paths to improve people's lives.
#idwgs2022 #womeninscience #womeninstem -
Sanofi
@sanofi
We’re announcing FDA priority review of our supplemental Biologics License Application as an add-on maintenance treatment for children aged 6 months to 5 years with uncontrolled moderate-to-severe #atopicdermatitis. Read the news: www.sanofi.com/en/media-room/press-releases/2022/2022-02-… @Regeneron
-
Sanofi
@sanofi
We are delighted to be recognized by #worldsymposia for bringing an additional treatment option to those living with late-onset #pompe disease.
-
Sanofi
@sanofi
Proud to be recognized as a Supplier Engagement Leader by @CDP for engaging our suppliers around #climatechange.
This recognition follows our double A score on their Climate and Water lists and reinforces that we’re backing up our commitment to society with real action. -
Sanofi
@sanofi
The supplemental Biologics License Application for our medicine has been accepted by the FDA for priority review as an add-on maintenance treatment in children aged 6 months to 5 years with uncontrolled moderate-to-severe #atopicdermatitis. www.sanofi.com/en/media-room/press-releases/2022/2022-02-… @Regeneron
-
Sanofi
@sanofi
Applications for the 2022 Sanofi Golden Ticket Competition are DUE TOMORROW! Send your completed application and a non-confidential pitch deck to GoldenTicket@sanofi.com to remain eligible.
-
Sanofi
@sanofi
People living with #asmd currently have no approved treatment options. Today at #worldsymposia, we presented new clinical data in this #raredisease. www.sanofi.com/en/media-room/press-releases/2022/2022-02-…
-
Sanofi
@sanofi
As a global sponsor of @BioLabs, we're hosting a Golden Ticket Competition to give three startups one-year free lab space at @BioLabsBoston, @BioLabsFR or Heidelberg! Apply by February 11. Finalists will present at the showcase on March 31.
-
Sanofi
@sanofi
In the US, the FDA approved the first treatment for use in people living with #coldagglutinindisease, a debilitating and #rareblooddisorder that destroys healthy red blood cells. www.sanofi.com/en/media-room/press-releases/2022/2022-02-…
-
Sanofi
@sanofi
On the dawn of a new era for Sanofi, our CEO Paul Hudson reflects on our 2021 performance.
#sanofiresults $SAN $SNY -
Sanofi
@sanofi
Our Q4 and Full Year Financial Results are now available. Read the press release: www.sanofi.com/en/media-room/press-releases/2022/2022-02-…
#sanofiresults $SAN $SNY -
Sanofi
@sanofi
We’re proud of our legacy, but today we begin a new era.
We’re connecting the dots to unite as one company behind a bold, new visual identity. With new energy to chase the miracles of science to improve people’s lives.
www.sanofi.com/en/about-us/our-purpose/
#sanofi #weneversettle -
Sanofi
@sanofi
With @Regeneron, we’re presenting new data at #aaaai22 showcasing our research in diseases with underlying type 2 inflammation. Learn more: www.sanofi.com/en/media-room/press-releases/2022/2022-02-…
-
Sanofi
@sanofi
#aaaai22: New analyses of our medicine will be presented across diseases with underlying type 2 inflammation, including investigations in chronic spontaneous urticaria and eosinophilic esophagitis. Learn more: www.sanofi.com/en/media-room/press-releases/2022/2022-02-… @Regeneron
-
Sanofi
@sanofi
“We still have more work to do”, says Dietmar Berger, although advances in #cancer care has already helped many patients live longer and better.
Learn more about our R&D and #healthequity
efforts: www.youtube.com/watch?v=mPa69SZ-i68&ab_channel=Sanofi
#worldcancerday #closethecaregap -
Sanofi
@sanofi
How do we ensure every patient gets the right
medicine for their #cancer? We leverage real-
world data to understand how medicines work
in diverse populations.
Watch our full video: www.youtube.com/watch?v=mPa69SZ-i68
#closethecare #worldcancerday
#sanofiscience -
Sanofi
@sanofi
This year’s #worldcancerday theme, #closethecaregap, inspires us to identify solutions that could improve quality of life and address the many challenges that exist for those who are older and living with cancer. www.uicc.org/blog/everyone’s-health-matters-no-matter-the…
-
Sanofi
@sanofi
With @Regeneron, we’re announcing that the CHMP has recommended the approval of our medicine as an add-on treatment for children aged 6-11 years with uncontrolled severe #asthma with type 2 inflammation. Read more: www.sanofi.com/en/media-room/press-releases/2022/2022-01-…
-
Sanofi
@sanofi
We’re announcing with @Regeneron that the CHMP recommends extending the approval of our medicine as an add-on treatment for children aged 6-11 years with uncontrolled severe #asthma with type 2 inflammation. Read more: www.sanofi.com/en/media-room/press-releases/2022/2022-01-…
-
Sanofi
@sanofi
World NTD day is a time to celebrate the gains we made in our combat to eradicate sleeping sickness by 2030. Thanks to our #partnership with @DNDi, we developed the first all-oral treatment for this disease.
Learn more ⤵️
www.sanofi.com/en/about-us/our-stories/a-two-decades-long…
#worldntdday2022 #beatntds -
Sanofi
@sanofi
There is still time to apply for our Golden Ticket Competition for one year free bench space at BioLabs’s premier co-working labs in Boston, Paris or Heidelberg. Submit your application via www.sanofi.com/en/science-and-innovation/partnering/golde….
-
Sanofi
@sanofi
We're happy to be listed again this year in @CorporateKnight's 2022 #global100 as one of the 100 most sustainable companies in the world!
Corporate Knights
@corporateknight
Introducing the 2022 Global 100 most sustainable corporations. Find out who made the list, what makes #global100 firms outperform others, and how this year's #1 company earned the top spot: www.corporateknights.com/rankings/global-100-rankings/202…
-
Sanofi
@sanofi
We're pleased to be launching a partnership between @LabsMedtronic & Sanofi Global Health, seeking to expand access to #healthcare for underserved patients with diabetes & hypertension. We aim to develop a replicable & sustainable community-focused approach to disease management.
-
Sanofi
@sanofi
Our CEO Paul Hudson is among the #healthcare industry leaders sharing their views on 2022 trends for @wef.
"By embracing collaboration and digitalization, we found ways to continue advancing science and innovation while making healthcare more inclusive." www.weforum.org/agenda/2022/01/biggest-healthcare-shifts-… -
Sanofi
@sanofi
With @Regeneron, we’re reporting positive topline results from our second pivotal trial in adults with #prurigonodularis, a chronic inflammatory skin disease. Learn more: www.sanofi.com/en/media-room/press-releases/2022/2022-01-…
-
Sanofi
@sanofi
Apply now for the 2022 Sanofi Golden Ticket Competition! Startups, this is your chance to win one-year free lab bench space at @BioLabsBoston, @BioLabsFR or @BioLabs in Heidelberg.
-
Sanofi
@sanofi
Protect the planet, preserve life 🌱
Learn what we are doing to #act4nature across our sites and entire value chain: www.act4nature.com/en/committed-companies-since-2020/
#wecandomore #planetmobilization #biodiversity #naturalresources #togetherfortheplanet -
Sanofi
@sanofi
As a global sponsor of BioLabs, we're hosting a Golden Ticket Competition to give three startups one-year free lab space at @BioLabsBoston, @BioLabsFR or @BioLabsHQ! Apply by February 11. Finalists will present at the showcase on March 31.
-
Sanofi
@sanofi
We're excited to announce a new research collaboration and license agreement with @exscientiaAI to accelerate drug discovery with #ai and develop up to 15 new small molecule medicines for cancer and immune-mediated diseases. www.sanofi.com/en/media-room/press-releases/2022/2022-01-… #sanofiscience
-
Sanofi
@sanofi
A big #thankyou to our Twitter community for commenting, liking and retweeting the Sanofi love this year! These were some of your favorite posts in 2021. What type of content would you like to see more of next year? #yearinreview #2021 #2022
-
Sanofi
@sanofi
We’re pleased to have entered into an agreement to acquire Amunix Pharmaceuticals, an #immunooncology company using next generation conditionally activated biologics to develop transformative #cancer therapies. www.sanofi.com/en/media-room/press-releases/2021/2021-12-…
-
Sanofi
@sanofi
Patients are at the core of everything we do. They motivate and inspire us. Watch our full video, produced for us by @BBCStoryWorks Commercial Productions, to see how we're advancing care for people living with hemophilia: www.bbc.com/storyworks/natures-building-blocks/the-women-… #naturesbuildingblocks
-
Sanofi
@sanofi
Last year, we awarded @MIT researcher Dina Katabi with a Sanofi iDEA Award to explore how #ai can help provide new insights into disease severity in pediatric #atopicdermatitis. Now, Raolat Abdulai shares updates on that research: www.linkedin.com/pulse/how-i-believe-ai-improve-way-we-tr…
-
Sanofi
@sanofi
Raolat Abdulai explains how #remotemonitoring and #ai can give us new insights into how #atopicdermatitis affects the lives of children diagnosed with the condition: www.linkedin.com/pulse/how-i-believe-ai-improve-way-we-tr…
-
Sanofi
@sanofi
With @GSK we’re announcing that the #booster study of our #covid19 vaccine candidate demonstrates strong immune responses regardless of the primary vaccine received, with a good safety and tolerability profile.
Read more: www.sanofi.com/en/media-room/press-releases/2021/2021-12-…
Sanofi
@sanofi
The global Phase 3 efficacy study of our #covid19 vaccine continues into early 2022, to provide the necessary data to regulatory authorities for submission of our vaccine candidate as a #booster.
www.sanofi.com/en/our-covid-19-vaccine-candidates -
Sanofi
@sanofi
#ash21 We’re excited to have presented positive data from two Phase 3 studies for the treatment of people with #hemophilia A or B. These #rareblooddisorders are caused by a deficiency of factor VIII and IX, respectively. www.sanofi.com/en/media-room/press-releases/2021/2021-12-…
-
Sanofi
@sanofi
At #ash21, we presented positive data from two Phase 3 studies for the prophylactic treatment of people with #hemophilia A or B, with or without inhibitors. @ASH_hematology #rareblooddisorders www.sanofi.com/en/media-room/press-releases/2021/2021-12-…
-
Sanofi
@sanofi
Traditional #sleepstudies can be limited by wearables, which can irritate the skin. @DrRaolat and co-founder of Emerald Innovations, Dina Katabi, explain how they're using touchless sensors to study #atopicdermatitis and sleep at home: www.sanofi.com/en/science-and-innovation/stories/from-wea… #sanofiscience
-
Sanofi
@sanofi
We’re presenting pivotal data with @Regeneron from our Phase 3 trial in children aged 6 months to 5 years with uncontrolled moderate-to-severe #atopicdermatitis: www.sanofi.com/en/media-room/press-releases/2021/2021-12-… #rad2021
-
Sanofi
@sanofi
During R&D Week at Sanofi, we bring together our R&D community from around the world to celebrate their contribution to science. Meet six Sanofi innovators who we’ve awarded for their achievements this year.
-
Sanofi
@sanofi
.@NEJM has published results from our pivotal trial with @Regeneron in children 6 to 11 years of age with uncontrolled moderate-to-severe #asthma. Read more:www.sanofi.com/en/media-room/press-releases/2021/2021-12-…
-
Sanofi
@sanofi
We’re proud to have earned a double A score on @CDP’s Climate and Water lists, demonstrating our continued commitment to the environment with our sustainability program #planetmobilization. #cdpalist #wecandomore
-
Sanofi
@sanofi
We welcome Matt Truppo to Sanofi as our new Global Head of Research Platforms. Matt will lead our efforts in integrated #drugdiscovery, large molecules research and #drugmetabolism and #pharmacokinetics, among others.
-
Sanofi
@sanofi
Fueled by advances in DNA technology, research into #rareblooddisorders only started to intensify in the 1990s. Ahead of #ash2021, discover the key moments in #hemophilia R&D over the past decades.
-
Sanofi
@sanofi
We’re live at our #sanofivaccines Investor Event where CEO Paul Hudson shares his outlook on #vaccines: “We’re confident that vaccines will remain a resilient and sustainable contributor to our growth.”
Follow this thread for more live tweets 👇Post not available here, view on X
Sanofi
@sanofi
“Our chlamydia research is on track to support the initiation of a first clinical trial for the chlamydia-based multivalent candidate in 2023.” - Jean-François Toussaint #sanofivaccines
Sanofi
@sanofi
Thomas Triomphe concludes our Vaccines Investor Event: “We’re building our future on a highly innovative pipeline, addressing unmet needs and providing new solutions to patients suffering from severe diseases.”
Thanks for following #sanofivaccines! -
Sanofi
@sanofi
Today, at our Vaccines Investor Event, we’re sharing our #vaccines strategy for growth and kicking off a new chapter with the exciting advancement of our R&D pipeline. #sanofivaccines
-
Sanofi
@sanofi
We’re pleased to announce a new strategic collaboration and equity investment with @OWKINscience to expand insights in translational #oncology through #ai and #machinelearning: www.sanofi.com/en/media-room/press-releases/2021/2021-11-…
-
Sanofi
@sanofi
Our CEO Paul Hudson reflects on our Q3 2021 performance and shares our accelerated #climatetargets to become #carbonneutral by 2030 and reach #netzero emissions by 2050.
Learn more: www.sanofi.com/en/investors/financial-results-and-events/…
#sanofiresults #wecandomore -
Sanofi
@sanofi
Our Q3 Financial Results are now available. Read the press release: www.sanofi.com/en/media-room/press-releases/2021/2021-10-…
#sanofiresults $SAN $SNY -
Sanofi
@sanofi
Our acquisition of @TranslateBio is now complete. We welcome Translate Bio to the Sanofi Family.
$SAN $TBIO
www.sanofi.com/en/media-room/press-releases/2021/2021-09-… -
Sanofi
@sanofi
Today the @US_FDA approved our therapy for late-onset #pompe disease, a progressive and debilitating #raredisease that damages muscle cells:
-
Sanofi
@sanofi
Sanofi CEO Paul Hudson: "Today’s acquisition adds mRNA technology & capabilities, advancing our ability to explore the promise of this technology to develop best-in-class vaccines and therapeutics".
Read the press release: www.sanofi.com/en/media-room/press-releases/2021/2021-08-…
$SAN $SNY $TBIO -
Sanofi
@sanofi
[#sanofiresults] Our Q2 financial results are now available. Read the press release: www.sanofi.com/en/media-room/press-releases/2021/2021-07-… $SAN $SNY
-
Sanofi
@sanofi
We are pleased to announce the launch of our mRNA Center of Excellence, bringing together ~400 dedicated employees with integrated end-to-end mRNA vaccine capabilities to work at accelerating the development and delivery of next-generation vaccines. www.sanofi.com/en/media-room/press-releases/2021/2021-06-…
-
Sanofi
@sanofi
Recent analysis by Sanofi teams focuses on the #covid19 pandemic’s impact on transmission of endemic diseases & circulation of other #respiratory viruses. Read more in @ScienceMagazine
#sanofiscience #sanofiacts -
Sanofi
@sanofi
At #eha2021, we’re presenting new data from our pivotal Phase 3 CADENZA study in #coldagglutinindisease, a chronic rare blood disorder. Read more: www.sanofi.com/en/media-room/press-releases/2021/2021-06-…
-
Sanofi
@sanofi
#oncology is a cornerstone of transformational science at Sanofi. Ahead of #asco21, Paul Hudson shares how bringing together leading scientific minds is essential to a successful pipeline. www.linkedin.com/pulse/asco-2021-advancing-science-togeth…
-
Sanofi
@sanofi
#covid19vaccine candidate
Sanofi and @GSK today started a large-scale global Phase 3 clinical efficacy study, with a booster study program complementing the Phase 3 beginning in the coming weeks
www.sanofi.com/en/media-room/press-releases/2021/2021-05-…
#sanofiacts -
Sanofi
@sanofi
We celebrate teamwork for International Clinical Trials Day. Every advance in healthcare is thanks to collaboration between patients, caregivers, medical professionals, scientists, technicians & regulators, who all make #clinicalresearch possible www.sanofi.com/en/science-and-innovation/stories/clinical… #ictd2021
-
Sanofi
@sanofi
At #asco21 today, we’re announcing results from our Phase 1/2 trial in #metastaticbreastcancer: www.sanofi.com/en/media-room/press-releases/2021/2021-05-…
-
Sanofi
@sanofi
In Paul Hudson’s words, the world will never go back to the way it was before the #pandemic—and that’s a good thing. Read more about the positive impact that technology has had on #healthcare during the pandemic in @FastCompany: www.fastcompany.com/90637069/how-technology-is-making-hea…
-
Sanofi
@sanofi
Today we announced positive results of the Phase 2 trial of our #covid19 recombinant #vaccine candidate developed with @GSK. We can now progress to Phase 3, bringing us another step us closer to protecting people against this virus. www.sanofi.com/en/media-room/press-releases/2021/2021-05-…
#sanofiacts -
Sanofi
@sanofi
Live from #sanofiresults webcast
Today, Sanofi’s top management reviewed Q1 financial results and provided a strategy update during a live video webcast with investors.
$SAN $SNY -
Sanofi
@sanofi
[#sanofiresults] Our Q1 Financial Results are now available. Read the press release: www.sanofi.com/en/media-room/press-releases/2021/2021-04-… $SAN $SNY
-
Sanofi
@sanofi
#attheheartofsanofi
Paul Hudson shares his vision for the future: “All of us at Sanofi will keep moving forward with a strong sense of purpose, and with the objective of doing the right thing for our people, our patients, our communities, and the planet.”
integrated-report.sanofi.com/foreword-by-paul-hudson/ -
Sanofi
@sanofi
Announcing the acquisition of Tidal Therapeutics, a biotech company with a novel #mrna-based approach for #invivo reprogramming of immune cells. This new technology platform expands our research capabilities in both oncology and immunology. www.sanofi.com/en/media-room/press-releases/2021/2021-04-…
-
Sanofi
@sanofi
As we pass the one-year anniversary of the first global lockdowns due to the Covid-19 pandemic, Paul Hudson shares with @CNBC how we can manage for the foreseeable future: www.cnbc.com/2021/03/12/op-ed-sanofi-ceo-on-navigating-co…
#1yearofcovid #covid19 -
Sanofi
@sanofi
#sanofiacts
To #fightcovid19, Sanofi will donate 100 million doses of #hydroxychloroquine across 50 countries. Read the news: www.sanofi.com/en/media-room/press-releases/2020/2020-04-… -
Sanofi
@sanofi
#sanofi announces exclusive licensing agreement with
@VerastemOncolog, a collaboration that will enable us to deliver enhanced patient care and expand our presence in emerging markets. Learn more about our work in #oncology: www.sanofi.com/en/your-health/oncology
-
Sanofi US reposted
Sanofi
@sanofi
Our Q3 2026 results are now available.
Read the full press release for detailed insights: www.sanofi.com/en/media-room/press-releases/2026/2026-10-…
#sanofiresults $SAN $SNY -
Sanofi US
@SanofiUS
We’ve added a new teammate to help keep the conversation around COVID-19 awareness in play.🏀 Together, we’re encouraging individuals at increased risk of COVID-19 illness to stay informed and speak with their healthcare providers.
Learn more: www.news.sanofi.us/2026-10-02-Sanofi-and-2026-NBA-Champio… -
Sanofi US reposted
Sanofi
@sanofi
#news: We’ve announced an expansion of our global Alliance with @Regeneron to add multiple next-generation, long-acting antibodies to our joint immunology portfolio.
Read more here: www.sanofi.com/en/media-room/press-releases/2026/2026-10-… -
Sanofi US
@SanofiUS
Pickleball is the fastest-growing sport in the US, and older adults are the MVPs. 🏓 But aging can increase risk from COVID-19, potentially leaving them sidelined. So, we’re partnering with @USAPickleball to help bring education: www.news.sanofi.us/2026-09-09-Sanofi-partners-with-USA-Pi…
-
Sanofi US
@SanofiUS
Protection against serious respiratory syncytial virus lung infection is important for all babies entering their first RSV season.
Discover which celebrity mom is joining us in our mission to help families learn how they can help protect their babies: www.news.sanofi.us/2026-09-08-Sanofi-and-Keke-Palmer-team… -
Sanofi US
@SanofiUS
The @US_FDA has approved our #multiplemyeloma treatment, offering patients and providers a new subcutaneous treatment option.
Read more about the approval ⬇️
www.news.sanofi.us/2026-07-10-Sanofis-subcutaneous-Sarcli… -
Sanofi US
@SanofiUS
The @US_FDA granted accelerated approval for a treatment for #type1diabetes. Learn more ⬇️
www.news.sanofi.us/2026-06-12-Sanofis-Tzield-approved-in-… -
Sanofi US
@SanofiUS
Our new drug application for our first-in-class investigational oral molecule for type 3 Gaucher disease (GD3) has been accepted for priority review by the @US_FDA. Learn more: www.news.sanofi.us/2026-05-28-Sanofis-venglustat-accepted…
-
Sanofi US
@SanofiUS
Today at #ats we presented for the first time, data that our investigational treatment for #aatd met all primary and key secondary endpoints. These findings reinforce our commitment to innovation for people living with this rare disease ⬇️
www.news.sanofi.us/2026-05-18-ATS-phase-2-data-demonstrat… -
Sanofi US
@SanofiUS
At Digestive Disease Week, we’re sharing late-breaking results from our phase 4 study in adults with eosinophilic esophagitis (EoE), a progressive disease that can cause narrowing of the esophagus.
Learn more here: www.news.sanofi.us/2026-05-05-DDW-Sanofi-and-Regenerons-D…
@Regeneron -
Sanofi US reposted
Sanofi
@sanofi
Our Q1 2026 results are now available.
See the press release for more details: www.sanofi.com/en/media-room/press-releases/2026/2026-04-…
#sanofiresults $SAN $SNY -
Sanofi US
@SanofiUS
The @US_FDA has approved our medicine for certain children aged 2-11 years with uncontrolled chronic spontaneous urticaria (CSU), a chronic skin disease. Read more: www.news.sanofi.us/2026-04-22-Sanofi-and-Regenerons-Dupix…
-
Sanofi US
@SanofiUS
The @US_FDA has approved a treatment for eligible young children with #type1diabetes. With this approval, we hope to better support these young T1D patients and their families. Learn more ⬇️
www.news.sanofi.us/2026-04-22-Sanofis-Tzield-approved-in-… -
Sanofi US
@SanofiUS
#news: COMPARE study presented at #escmidglobal2026: head-to-head tolerability comparison of a protein-based and an mRNA COVID-19 vaccine.
Learn more ⬇️
www.news.sanofi.us/2026-04-18-ESCMID-Sanofis-NUVAXOVID-TM… -
Sanofi US
@SanofiUS
Proud to announce Sanofi is an Official Supporter of @FIFAWorldCup Boston 2026! With ~5K employees & our largest US site in MA, we're all in for Commonwealth. Science meets community on the world's biggest stage! 🌍 Learn more: www.news.sanofi.us/2026-02-25-Sanofi-Becomes-Official-Sup…
-
Sanofi US
@SanofiUS
The @US_FDA has approved our medicine as the first and only medicine for allergic fungal rhinosinusitis (AFRS) in certain adults and children aged 6 years and older. Learn more: www.news.sanofi.us/2026-02-24-Sanofi-and-Regenerons-Dupix…
CC: @Regeneron -
Sanofi US
@SanofiUS
Our investigational BTK inhibitor for the potential treatment of wAIHA was granted Breakthrough Therapy Designation by @US_FDA and Orphan Drug by @MHLWitter_en in Japan, highlighting our commitment to advancing therapies for #rarediseases with significant unmet need.
Sanofi US
@SanofiUS
Read more ⬇️
www.news.sanofi.us/2026-02-09-Sanofis-rilzabrutinib-desig… -
Sanofi US
@SanofiUS
Phase 3 study results of our investigational oral therapy for Fabry disease and type 3 Gaucher disease are now available.
Discover more about our ongoing #raredisease research. ⬇️
www.news.sanofi.us/2026-02-02-Sanofis-venglustat-met-all-… -
Sanofi US reposted
Sanofi
@sanofi
Our Q4 and full-year 2025 results are now available.
Learn more: www.sanofi.com/en/investors/financial-results-and-events/…
#sanofiresults $SAN $SNY -
Sanofi US
@SanofiUS
The @US_FDA accepted for Priority Review our sBLA for children between one and eight years of age with stage 2 #type1diabetes. Learn more about this milestone ⬇️
www.news.sanofi.us/2026-01-05-Sanofis-Tzield-accepted-for… -
Sanofi US
@SanofiUS
On #veteransday, we salute all who served — including Lois and Adam from our VETS Employee Business Resource Group (EBRG).
Their leadership continues to drive impact for patients and communities every day.
Thank you to all veterans for your courage and dedication. -
Sanofi US
@SanofiUS
New phase 3 results from our investigational medicine for allergic fungal rhinosinusitis (AFRS) in adults and children over age 6 will be presented at #acaai25 and have been accepted for priority review by the US FDA. Learn more.
CC: @Regeneron -
Sanofi US
@SanofiUS
Sanofi and our partner Regeneron were honored this week to accept the #prixgalien “Best Biotechnology Product” award from @GalienFdn. Thank you to the people and partners who make our work possible.
Learn more about this recognition ⬇️
#biotechnology -
Sanofi US
@SanofiUS
Every day, we chase the miracles of science so you can chase your dreams.
Learn more about how we’re chasing the miracles of science: www.sanofi.com/en/chasing-miraclesThis media couldn't be displayed. See it on the original post. -
Sanofi US reposted
Sanofi
@sanofi
Our Q3 2025 Results are now available. Read the press release. ⬇️
#sanofiresults $SAN $SNY -
Sanofi US
@SanofiUS
Results from a phase 2 study evaluating an investigational treatment for alpha-1 antitrypsin deficiency (#aatd), achieved all primary and key secondary endpoints.
Read our press release to learn more about our research on this #raredisease ⬇️ -
Sanofi US
@SanofiUS
We have presented phase 2 data at #esmo25 supporting the potential of our investigational therapy for gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
Learn more ⬇️
CC: @OranoMed @RadioMedix -
Sanofi US
@SanofiUS
#news: The @US_FDA accepted the filing of our sBLA for recently diagnosed stage 3 #type1diabetes for expedited review through the FDA Commissioner’s National Priority Voucher (CNPV) pilot program.
Learn more ⬇️ -
Sanofi US
@SanofiUS
We're expanding our Insulins Valyou Savings Program: any Sanofi insulin for $35 to all US patients, regardless of insurance status.
No one should struggle to afford their insulin.
Learn more: www.news.sanofi.us/2025-09-26-Sanofi-expands-patient-affo… -
Sanofi US
@SanofiUS
We’re proud to join the @IMFmyeloma’s efforts to help more people #knowmyeloma. Visit knowmyeloma.org to learn how to get involved this #bloodcancerawarenessmonth.
International Myeloma Foundation
@IMFmyeloma
September is Blood Cancer Awareness Month! Before diagnosis, many struggle with figuring out what symptoms like back pain mean. What's one thing you wish people knew about myeloma? Thank you, @sanofi for supporting the IMF's #bloodcancerawarenessmonth initiative #knowmyeloma
-
Sanofi US
@SanofiUS
We wish we could share which celebrity moms we’ve partnered with to raise awareness for serious respiratory syncytial virus (RSV) lung infection prevention for babies… but you’ll have to head over to protectagainstrsv.com for the big reveal. 👀
-
Sanofi US
@SanofiUS
We’re proud to be recognized by @Seramount as a Top Company for Executive Women—a reflection of our commitment to advancing women and inclusion for all in the workplace.
-
Sanofi US
@SanofiUS
#news: The @US_FDA has approved the first oral, reversible, Bruton’s tyrosine kinase (BTK) inhibitor for adults with persistent or chronic immune thrombocytopenia (#itp), underscoring our commitment to transforming care for people living with #rareblooddisorders.
Learn more ⬇️ -
Sanofi US reposted
Sanofi
@sanofi
Our CEO, Paul Hudson, on Q2 2025: continued pipeline progress, key approvals, and milestones.
Read more: www.sanofi.com/en/investors/financial-results-and-events/…
#sanofiresults $SAN $SNYThis media couldn't be displayed. See it on the original post. -
Sanofi US
@SanofiUS
📢 #news: The @US_FDA has granted Orphan Drug Designation to our investigational IgG1-based, GPRC5D-targeting antibody treatment for patients with relapsed or refractory #multiplemyeloma.
Learn more ⬇️ -
Sanofi US
@SanofiUS
A major US real-world study published in PEDIATRICS®, an official journal of @AmerAcadPeds, shows the impact respiratory syncytial virus (#rsv) prevention had in reducing hospitalizations due to serious RSV lung infection in babies.
Read our press release to learn more ⬇️ -
Sanofi US
@SanofiUS
Building the future of healthcare means building sustainably 🌎
Our new Morristown, NJ office will be LEED Gold certified with eco-friendly features to help shape a greener future for the planet, and our communities 🌿
Learn more ▶️ www.sanofi.us/en/sanofi-today/our-sanofians/sanofi-opens-…
#sanofiatmorristown -
Sanofi US
@SanofiUS
Congratulations to @BreakthroughT1D on the first-ever Barbie doll with type 1 diabetes! A huge step for inclusion—kids with T1D can now see themselves in Barbie and be reminded: You can be anything.
Breakthrough T1D
@BreakthroughT1D
Yesterday, we were thrilled to announce a major milestone - the release of the first-ever @barbie with type 1 diabetes (T1D)! Just like advocacy, visibility matters. We’re so excited to see a Barbie with T1D out in the world, helping to represent and empower even more kids living with diabetes.
This media couldn't be displayed. See it on the original post. -
Sanofi US
@SanofiUS
Through our newly launched Health Futures Solution Fund, we're awarding grants to 13 nonprofits across Massachusetts tackling food insecurity, housing, and more.
🌍 Learn more: www.news.sanofi.us/2025-06-26-Sanofi-awards-Healthy-Futur…
#healthyfutures #socialimpact #communitypartnerships -
Sanofi US
@SanofiUS
Wrapping up a great week at the @ADA_DiabetesPro Conference in Chicago, IL! Thanks for another great year full of connection & collaboration with the diabetes community. Check out a few pictures of our team on the ground at #ada2025 below.
-
Sanofi US
@SanofiUS
The @US_FDA has granted Orphan Drug Designation to our investigational treatment for antibody-mediated rejection (AMR) in solid organ transplantation, reinforcing our commitment to addressing critical unmet needs in #transplant medicine.
Learn more ⬇️ -
Sanofi US
@SanofiUS
#news: Two different AI/ML based models accepted as late-breakers were presented at #ada2025, showing potential to detect type 1 diabetes early. Learn more: diabetes.org/newsroom/press-releases/novel-artificial-int…
-
Sanofi US
@SanofiUS
Our treatment for #bullouspemphigoid (BP) is now approved by the @US_FDA. This approval helps close a long-standing gap in care for adults with this chronic, relapsing skin condition.
CC: @Regeneron -
Sanofi US
@SanofiUS
At #rad2025, we shared new phase 4 data in people with skin of color and #atopicdermatitis.
Explore the results we presented with @Regeneron ⬇️ -
Sanofi US
@SanofiUS
#news: At ISTH 2025, we’re presenting new data highlighting our commitment to evolving patient expectations and exploring therapeutic options for #rareblooddisorders.
Learn more about our ongoing work in immune thrombocytopenia (#itp) and #hemophilia ⬇️ -
Sanofi US
@SanofiUS
#news: New data at #asco25 published in @JCO_ASCO analyzed the potential of an investigational delivery method to administer our investigational subcutaneous #multiplemyeloma combination therapy.
Learn more ⬇️ -
Sanofi US
@SanofiUS
#news: The @US_FDA has granted Orphan Drug Designation to our novel, advanced, oral, reversible Bruton’s tyrosine kinase (BTK) inhibitor for the treatment of #sicklecelldisease.
Read more about the potential of this novel approach ⬇️ -
Sanofi US
@SanofiUS
#news: First real-world comparison of respiratory syncytial virus (#rsv) immunization programs for infants to be presented at #espid2025.
Read more ⬇️ -
Sanofi US
@SanofiUS
#news: The @US_FDA has expanded the indication for use of our vaccination for protection against meningococcal #meningitis to infants aged six weeks and older.
Read more ⬇️ -
Sanofi US
@SanofiUS
Unveiling #sanofiatmorristown—our new innovative workspace in NJ.
Our CEO Paul Hudson joins local leaders to open this state-of-the-art hub where scientific innovation and collaboration fuel tomorrow’s breakthroughs 🏢✨
Learn more ⬇️ -
Sanofi US
@SanofiUS
What’s one hidden contributor to severe asthma symptoms? Mucus plugs. By better understanding the connection between mucus plugs and asthma symptoms, we hope to pave the way for improved care for this respiratory disease. Learn more.
-
Sanofi US
@SanofiUS
Uncontrolled asthma shouldn’t be a barrier to enjoying life. This #worldasthmaday, understand the symptoms of uncontrolled asthma and talk to a healthcare provider.
-
Sanofi US reposted
Sanofi
@sanofi
Our first quarter 2025 results are now available. Read the press release. ⤵️
#sanofiresults $SAN $SNY -
Sanofi US
@SanofiUS
Today, the @US_FDA approved our medicine for #chronicspontaneousurticaria (CSU) for certain patients aged 12 years and older, marking the first new targeted therapy for people with this inflammatory skin disease in more than a decade. Read more about the news 👇
CC: @Regeneron -
Sanofi US
@SanofiUS
Before Chrissy Teigen’s son Miles was unexpectedly diagnosed with #type1diabetes, her family knew nothing about the disease. Now, she’s joining the Screen For Type 1 movement to build awareness for T1D screening.
Learn more ⬇️ -
Sanofi US
@SanofiUS
#news: Results from phase 3 studies of our investigational treatment for adults with #multiplesclerosis were published in @NEJM and presented during a plenary session at this year’s American Academy of Neurology’s Annual Meeting #aanam
Learn more ⬇️ -
Sanofi US
@SanofiUS
The @US_FDA has granted Orphan Drug Designation to our investigational Bruton’s tyrosine kinase (BTK) inhibitor for two treatment indications, validating our commitment to pursuing medicines for #rarediseases with significant unmet medical need.
Learn more ⬇️ -
Sanofi US
@SanofiUS
Living kidney donation can transform lives. This #nationaldonatelifemonth, learn how to make a difference by helping the nearly 100,000 people waiting for a transplant in the U.S.
Learn more about the urgent need for living donors ⬇️
#ndlmThis media couldn't be displayed. See it on the original post. -
Sanofi US
@SanofiUS
#news: The @US_FDA approved the first treatment for adult and pediatric patients (12+) with hemophilia A or B with or without inhibitors, underscoring our commitment to advancing treatment goals in #rareblooddisorders.
Learn more ⬇️ -
Sanofi US reposted
Sanofi
@sanofi
#news: The @US_FDA has granted fast track designation to our #chlamydia vaccine candidate for the prevention of chlamydia infection.
Learn More ⬇️ -
Sanofi US
@SanofiUS
#news: @US_FDA has accepted for priority review our submission of an investigational #multiplesclerosis (MS) treatment to treat non-relapsing secondary progressive MS (nrSPMS) and to slow disability accumulation in adults.
Learn more ⬇️ -
Sanofi US
@SanofiUS
We're proud to stand with @IMFmyeloma this Myeloma Action Month to raise awareness and amplify the voices of the myeloma community. Visit myelomaactionmonth.org to be a part of the #myelomamilestone movement.
International Myeloma Foundation
@IMFmyeloma
Make an impact for #myelomaactionmonth. ❤️ Be part of a global movement and show your support! Share your #myelomamilestone to raise awareness through the power of personal stories. Download graphics to share and support the community on social >>> myelomaactionmonth.org
-
Sanofi US
@SanofiUS
Late-breaking results from our pivotal trial in adults with #bullouspemphigoid were presented at #aad2025.
Dive into our data in partnership with @Regeneron ⬇️ -
Sanofi US
@SanofiUS
Could you ace our graft-versus-host-disease (#gvhd) trivia? At #tandem25, hosted by @ASTCT and @CIBMTR, we engaged attendees and tested their knowledge on the rare but serious disease with GVHD trivia.
Learn more: www.gvhdalliance.orgThis media couldn't be displayed. See it on the original post. -
Sanofi US
@SanofiUS
There is more work to be done to promote a healthcare system that delivers for patients. Our 2025 Pricing Principles Report reviews our pricing approach and policy solutions that prioritize #patientaccess and affordability.
Learn more ⬇️ -
Sanofi US
@SanofiUS
This #nationalkidneymonth, we're celebrating the life-changing impact of living kidney donation. Meet David, a kidney transplant recipient whose life was transformed by a selfless donor.
Learn more ⬇️ -
Sanofi US
@SanofiUS
🎙️ The latest episode of The Patient Advocacy Voices podcast is live now! Harold Wimmer, President and CEO of @LungAssociation joins this episode to discuss why he's proud to be a part of the organization’s growth over their 120-year history.
🎧 Tune in today ⬇️ -
Sanofi US
@SanofiUS
#news: The @US_FDA has granted priority review of our application for an investigational medicine for #bullouspemphigoid (BP). Read more about the recent news. ⬇️
CC: @Regeneron -
Sanofi US
@SanofiUS
This #gvhdday, we celebrate the resilience of the many patients and caregivers navigating life with Graft-versus-host-disease (#gvhd).
Join us in raising awareness about GVHD. Learn more about resources and community support from #gvhdalliance ⬇️ -
Sanofi US
@SanofiUS
Early detection is crucial in T1D. Proud to announce the launch of #screeningcentral, the first telehealth-enabled, user-initiated platform to request T1D autoantibody screening. Learn about how this digital tool builds upon existing screening options:
www.sanofi.us/en/sanofi-today/your-health/exploring-scree… -
Sanofi US reposted
Sanofi
@sanofi
Our CEO, Paul Hudson, reflects on the pivotal role innovation plays in driving our growth.
Learn more: www.sanofi.com/en/media-room/press-releases/2025/2025-01-…
#sanofiresults $SAN $SNY -
Sanofi US
@SanofiUS
This #mlkday, Sanofians across the US are participating in acts of service to honor Dr. Martin Luther King Jr.’s legacy. Giving back to our communities isn’t just a once-a-year calling, it’s a commitment we live every day.
Learn more ways #wevolunteer ⬇️ -
Sanofi US
@SanofiUS
🎙️ Season 2 of Patient Advocacy Voices is out now! Host Eric Racine sits down with a panel of co-hosts to recap the powerful lessons learned in season 1 and share how we can all take these learnings into the new year and beyond.
🎧 Tune in today: patientadvocacyvoices.buzzsprout.com/2303007/episodes/163… -
Sanofi US
@SanofiUS
The @US_FDA granted Breakthrough Therapy designation for our investigational treatment for adults with non-relapsing secondary progressive #multiplesclerosis (nrSPMS).
Read more ⬇️ -
Sanofi US
@SanofiUS
🎙️ New Patient Advocacy Voices episode out now! Randy Rutta, CEO of @NHCouncil, joins the podcast to talk about driving equitable patient access, influencing health tech assessments, and ensuring responsible AI use in healthcare.
Listen now: patientadvocacyvoices.buzzsprout.com/2303007/episodes/162… -
Sanofi US
@SanofiUS
We’re working to ensure marginalized communities are represented in clinical trials.
Our latest initiative, Reflections, featured an art installation capturing artists’ unique views on healthcare.
Learn more about how we’re shaping an inclusive future ⬇️ -
Sanofi US
@SanofiUS
#news: New data presented at #ash24 highlights the potential of our investigational treatment for #immunethrombocytopenia (ITP), and our combination regimens in newly diagnosed #multiplemyeloma.
Learn more about our phase 3 data ⬇️ -
Sanofi US
@SanofiUS
It might seem like flu season is winding down, but the flu typically peaks between December and February. Schedule your flu vaccine for #nationalinfluenzavaccinationawarenessweek and remember, not all flu vaccines are the same.
Learn more below ⬇️ -
Sanofi US
@SanofiUS
🎙️ New Patient Advocacy Voices episode out now! Dr. Jean Wright of @COPDFoundation joins the podcast for a discussion on innovative approaches to healthcare's biggest challenges and tackling care for #copd.
Listen today: patientadvocacyvoices.buzzsprout.com/2303007/episodes/161… -
Sanofi US
@SanofiUS
#dyk that 93% of 600 HCPs believe it's very/extremely important to vaccinate 11–12-year-olds against meningococcal disease. 87% of surveyed HCPs find the current vaccination schedule to be appropriate.
Learn more: www.ipsos.com/en-us/healthcare-professional-sentiments-me…
#meningitisawareness -
Sanofi US
@SanofiUS
#copd can have a devastating impact on lung function, but the COPD community is resilient. For #worldcopdday, we reaffirm our commitment to standing with and supporting this community as they face the road ahead, one step at a time.
-
Sanofi US
@SanofiUS
As friends and family gather, it is important to remember that some people are at higher risk for flu-related complications. Older adults and pregnant individuals should speak with a pharmacist or healthcare professional about what #fluvaccine is right for them.
Learn more ⬇️ -
Sanofi US
@SanofiUS
#news: The @US_FDA has accepted for review the resubmission of our application for an investigational chronic spontaneous urticaria (#csu) medicine. Learn more about our most recent news ⬇️
CC: @Regeneron -
Sanofi US
@SanofiUS
Chronic obstructive pulmonary disease (#copd) is a growing health crisis with a significant impact on patients. Together with @Regeneron, we have the potential to transform how COPD is treated by exploring novel therapies that address an underlying source of inflammation.
-
Sanofi US
@SanofiUS
What is the difference between inflammation and #immunology? (Hint: one is part of the other.)
-
Sanofi US
@SanofiUS
#dyk that not all flu shots are the same? On #worldfluday, ask your healthcare provider about which flu vaccine is right for you.
Learn more about the importance of getting protected against flu: www.sanofi.us/en/your-health/vaccines/influenza -
Sanofi US
@SanofiUS
When Jill Putegnat’s son was diagnosed with #type1diabetes at two years old, she was faced with the reality of what it meant to be a caregiver. Read Jill’s story and learn how she navigated this new normal.
www.sanofi.us/en/sanofi-today/our-sanofians/shining-a-spo… -
Sanofi US reposted
Sanofi
@sanofi
Our Q3 2024 results are now available. Learn more. ⤵️
#sanofiresults $SAN $SNY -
Sanofi US
@SanofiUS
The immune system uses many different mechanisms to modulate and protect the body.
The study of #immunoscience explores how alterations to these mechanisms can help us treat or defend against diseases. -
Sanofi US
@SanofiUS
#news: Positive late-breaking results from our phase 3 study in chronic spontaneous urticaria (CSU) are being presented at #acaai24. Learn more ⬇️
CC: @Regeneron -
Sanofi US
@SanofiUS
Three journeys, one extraordinary purpose 🌟
Go behind the scenes with Willy, Derya and Rene as they share how they found their extraordinary at Sanofi—and how you can too.
Explore our career opportunities⬇️
#pursueprogress #discoverextraordinary -
Sanofi US
@SanofiUS
Last week at the #tiesummit, we united Sanofians, advocates and community leaders to confront healthcare disparities head-on and forge a path to advance #healthequity. Together, we are committed to creating lasting change.
Read the highlights 👇 -
Sanofi US
@SanofiUS
Diversity and inclusion are essential to developing medicines and vaccines for everyone. We’re excited to announce our 10-year investment in @HowardU, @MeharryMedical, and @MSMEDU to help increase #diversity in clinical studies.
Learn more in our press release 👇 -
Sanofi US
@SanofiUS
Pharmacists play a crucial role in keeping our communities healthy. This #americanpharmacistsmonth, speak with a pharmacist to understand which flu vaccine is most appropriate for you.
-
Sanofi US
@SanofiUS
What is Juan most proud of this #hispanicheritagemonth? He says, “My Latino heritage, including my accent.” At Sanofi, diverse backgrounds represent our collective perspectives, which only strengthens our work for the patients & communities we serve.
Learn about Juan’s story ⬇️ -
Sanofi US
@SanofiUS
🎤Don't miss the latest episode of Patient Advocacy Voices out now!
Listen in as Sara Loud joins the pod to share how @AcceleratedCure is driving faster and more inclusive healthcare innovation through collaboration with biopharmaceutical companies and patient advocacy leaders⬇️ -
Sanofi US
@SanofiUS
Fall brings pumpkin spice lattes, cozy sweaters, and...the flu. But you can help protect yourself by getting your flu shot this #fluseason.
Learn more: www.sanofi.us/en/your-health/vaccines/influenza -
Sanofi US
@SanofiUS
Juan moved to the U.S. from Colombia seven years ago to pursue a higher education. Now, he supports biosurgery operations at Sanofi, helping patients around the world.
Learn why he takes great pride in his work and heritage 👇 #hispanicheritagemonth -
Sanofi US
@SanofiUS
We were honored to be a part of the 38th Carousel of Hope Ball this year. Thank you to @CDFDiabetes for all the work you do for the #t1d community.
Learn more about T1D resources ⬇️
#screenfortype1 #carouselofhope #childrensdiabetesfoundation -
Sanofi US
@SanofiUS
On #worldmeningitisday, we raise the Meningitis Flag to honor survivors and those continuing the fight for a brighter future. Together, we can help protect future generations and help #defeatmeningitis.
-
Sanofi US
@SanofiUS
#tldr: we're passionate about advancing #diversity in clinical trials.
We asked AI to summarize a few key points from our Inclusion & Social Impact Report. Here’s what it had to say.
Read the full report to learn more: www.sanofi.us/assets/dot-us/pages/images/home/inclusion-s…
#drivingimpacttogether -
Sanofi US
@SanofiUS
Among those who survive meningococcal #meningitis, as many as 1 in 5 live with permanent disabilities. To learn more or to make your voice heard, you may visit: www.cdc.gov/acip/meetings/?CDC_AAref_Val=https://www.cdc.….
This media couldn't be displayed. See it on the original post.
Sanofi US
@SanofiUS
We thank John for sharing his story as we prepare to honor #worldmeningitsday
-
Sanofi US
@SanofiUS
Today @US_FDA approved our medicine as an add-on maintenance treatment of adult patients with inadequately controlled chronic obstructive pulmonary disease (COPD) and an eosinophilic phenotype. This marks the first-ever biologic approved for COPD. Learn more ⬇️
CC: @Regeneron -
Sanofi US
@SanofiUS
#news: The @US_FDA has approved our combination therapy for people with newly diagnosed #multiplemyeloma.
Read more about the news ⬇️ -
Sanofi US
@SanofiUS
Sharing the ground-breaking phase 3 results for our investigational #multiplesclerosis treatment, a critical step towards reaching the unmet needs of people living with #ms. #ectrims2024
Learn more: www.news.sanofi.us/2024-09-20-Tolebrutinib-demonstrated-a… -
Sanofi US
@SanofiUS
This #hispanicheritagemonth, we’re proud to spotlight Sanofians like Willy, whose diverse background is helping to bridge gaps across nations.
Learn more about our #dei efforts at Sanofi: www.sanofi.us/en/our-company/social-impact/diversity-equi… -
Sanofi US
@SanofiUS
🎤New Patient Advocacy Voices episode!
Eric Racine and Andrew Vilcinskas sit down with David Panzirer from @HelmsleyTrust to talk about their personal connections to #t1d and creating and investing in measurable impacts for patients
Listen now ⬇️ -
Sanofi US
@SanofiUS
2 out of 3 babies will get respiratory syncytial virus (#rsv) by age 1. We are committed to helping ensure that protection against serious RSV lung infection is widely available for babies.
Learn more about our efforts: www.news.sanofi.us/2024-09-16-Sanofi-shipping-BEYFORTUS-R… -
Sanofi US
@SanofiUS
Today the @US_FDA approved an age expansion for our medicine to treat adolescents aged 12 to 17 years with inadequately controlled chronic rhinosinusitis with nasal polyps (#crswnp). Learn more about what this means for patients living with this disease.
CC: @Regeneron -
Sanofi US
@SanofiUS
During #bloodcancerawarenessmonth, we honor the strength of those living with #multiplemyeloma, like Thomas. Diagnosed at 34, Thomas embraced self-advocacy and sought support from his community, serving as an inspiration for others affected by this disease.
-
Sanofi US
@SanofiUS
Vaccination is the best defense against meningococcal disease. To learn more or to make your voice heard, you may visit: www.cdc.gov/vaccines/acip/meetings/index.html.
This media couldn't be displayed. See it on the original post. -
Sanofi US
@SanofiUS
With @Regeneron, we’re announcing pivotal data in adults with bullous pemphigoid, a chronic autoimmune inflammatory skin disease.
Learn More: www.news.sanofi.us/2024-09-11-Dupixent-is-the-first-and-o… -
Sanofi US
@SanofiUS
We’re announcing positive phase 3 data for our investigational medicine in patients aged 6 years and older with chronic spontaneous urticaria (CSU), a disease characterized by sudden and debilitating hives and persistent itch.
CC: @Regeneron
Learn more: www.news.sanofi.us/2024-09-11-Dupixent-phase-3-study-conf… -
Sanofi US
@SanofiUS
At Sanofi diversity fuels our innovation. That’s why we're proud to be named a Top Company for Executive Women by @Seramount, reflecting our commitment to empowering and celebrating women across our organization, like Deborah Glasser, who lead us forward. #seramountexecutivewomen
-
Sanofi US
@SanofiUS
It’s not every day that you attend university at the same time as your daughter. But for Sanofian, and single mom of three, Katie Hamm, that’s exactly what she did.
Learn about Katie’s #mba journey and how our tuition reimbursement benefits supported her: www.sanofi.us/en/sanofi-today/our-sanofians/empowerment-t… -
Sanofi US
@SanofiUS
For Rene, being extraordinary means bringing his best self to work every day. Inspired by the mentorship and leadership of those around him, Rene is now a leader in his own right.
Explore our career opportunities: jobs.sanofi.com/en
#pursueprogress #discoverextraordinary -
Sanofi US
@SanofiUS
#discoverextraordinary with us ✨
Take a behind-the-scenes look at how Willy, Sophia, Juhyun and Myles live their extraordinary every day.
Ready to learn about the endless possibilities that await you? Join us: jobs.sanofi.com/en #pursueprogress -
Sanofi US
@SanofiUS
We're proud to support Community Health Workers (#chws) and organizations like the @CHWNational that empower CHWs in their work to break down inequities and barriers to care in our communities.
Join us in celebrating CHWs and read more about #nchwaw2024 👇 -
Sanofi US
@SanofiUS
🎙️ Listen to the latest episode of Patient Advocacy Voices featuring Michael Osso, President and CEO of @CrohnsColitisFn, where he talks about his unique path to healthcare and the importance of data in fueling and personalizing patient care.
Listen now: ⬇️
#podcast #ibd -
Sanofi US
@SanofiUS
We’re proud to be recognized in @Seramount’s 2024 Inclusion Index for our commitment to advancing DE&I. And we’re even more proud to amplify voices like Samira’s from our Interfaith ERG, who help foster diversity and inclusivity at Sanofi. #seramountinclusionindex
-
Sanofi US
@SanofiUS
Living donors can be a lifeline for those awaiting a #kidneytransplant, especially for Black and Hispanic Americans who are disproportionately affected by kidney failure. Discover the power of living donation through real stories at www.kidneytransplantconnectors.com/patient-resources.
#nmdam -
Sanofi US
@SanofiUS
#news: Latest phase 3 data in #multiplemyeloma study shows investigational combination regimen meets key survival endpoint in newly diagnosed, transplant-eligible patients.
Learn more ⬇️ -
Sanofi US
@SanofiUS
Now published in @NEJM: pivotal phase 3 data highlighting treatment potential for children under 12 living with severe #hemophilia A.
Learn more: www.sanofi.com/en/media-room/press-releases/2024/2024-07-… -
Sanofi US
@SanofiUS
We're proud to announce the first shipment of our flu shots for the 2024/25 season. With 125+ years of heritage, we’re deeply committed to helping meet public health needs: www.news.sanofi.us/2024-07-10-Sanofi-ships-U-S-influenza-…
-
Sanofi US
@SanofiUS
🎤 The latest episode of Patient Advocacy Voices is out now! Tune in as Maria Santaella from @nbd_foundation discusses the importance of centering patients in research and advocacy with hosts Eric Racine and Jane Smith.
Listen now ⬇️ -
Sanofi US
@SanofiUS
Honored to be recognized, together with @Regeneron, by @LungAssociation as an Outstanding Corporate Partner.
We’re proud to contribute to the ongoing efforts to improve lung health and make a meaningful impact on patients, families and communities.
American Lung Association
@LungAssociation
We are thrilled to announce that the American Lung Association has recognized Sanofi and the Sanofi and Regeneron Alliance for their incredible work in preventing lung disease and improving lung health. @SanofiUS @Regeneron @HaroldWimmer
-
Sanofi US
@SanofiUS
A proud alum of the @RutgersU Fellowship program, Hamza turned his passion and experience into a career at Sanofi, where he helps shape the future of medicine as part of our Global Medical Affairs team.
Learn more about our early career opportunities: jobs.sanofi.com/en/early-talent -
Sanofi US
@SanofiUS
We’re proud to support the 2024 #transplantgames in Birmingham, AL – a celebration of the organ transplant community and a milestone for raising awareness about disparities in access to kidney transplantation. Learn more ⬇️
-
Sanofi US
@SanofiUS
Together with @GoHealio, three of the nation’s top pediatricians voiced their concerns about the potential change to the MenACWY vaccine schedule proposed by the CDC’s #acip.
Read the full Q&A: www.healio.com/advertorial/2024/adv-121_sanofi_biosector2 -
Sanofi US
@SanofiUS
Wednesday, the CDC’s Advisory Committee on Immunization Practices (#acip) voted to update their pediatric vaccination recommendations for American Indian and Alaska Native infants and children.
Learn more: www.news.sanofi.us/2024-06-27-CDCs-ACIP-unanimously-votes… -
Sanofi US
@SanofiUS
We caught up with Subarna and Diana, the leaders behind the Inclusion & Social Impact Report, to discuss what #dei and #socialimpact at Sanofi look like. Read the full report: www.sanofi.us/assets/dot-us/pages/images/home/inclusion-s…
This media couldn't be displayed. See it on the original post. -
Sanofi US
@SanofiUS
#news: Results from our Phase 3 trial with @Regeneron in pediatric patients aged 1 to 11 years with eosinophilic esophagitis (#eoe) have been published in @NEJM. ⬇️
-
Sanofi US
@SanofiUS
Amy, an advocate for the LGBTQ+ community, is passionate about building a positive and inclusive work environment for all.
Empowered to bring her best self to work, she is dedicated to helping others achieve the same.
Learn more ⬇️
#pridemonth -
Sanofi US
@SanofiUS
At Sanofi, our team is what makes us who we are, which is why we encourage all employees, like Teddy, to bring their whole, authentic selves to work and why we offer benefits with everyone in mind.
Learn more⬇️
#pridemonth #thisorthat -
Sanofi US
@SanofiUS
When Jodie, a @RutgersU Fellow alum, joined Sanofi full-time, she was excited to be part of a team with a strong commitment to mentorship and promoting an inclusive culture.
Learn more about early career opportunities at Sanofi: jobs.sanofi.com/en/early-talent -
Sanofi US
@SanofiUS
In recognition of #juneteenth, Sanofians are coming together throughout the week to learn, reflect, celebrate, and give back to the community.
-
Sanofi US
@SanofiUS
Far too many people with #t1d are diagnosed after serious complications. Our Summit brought together the T1D community and advocates for an open dialogue focused on the importance of early screening and risk detection. Learn more ⬇️
#screenfortype1 #the1pledge -
Sanofi US
@SanofiUS
How do we support women from diverse backgrounds? By creating an inclusive culture that empowers them to grow and thrive. We’re honored to be recognized once again as one of @Seramount’s Best Companies for Multicultural Women. Learn more 👇
#seramountmcw -
Sanofi US
@SanofiUS
#news: The @US_FDA has approved a new option for the treatment of certain patients with polyarticular juvenile idiopathic arthritis (pJIA).
@Regeneron.
Learn more⬇️ -
Sanofi US
@SanofiUS
Meet Christophe, a dad, cook and movie-lover who spends his days researching treatments for rare blood and liver diseases. #littlemomentsfromthelab
-
Sanofi US
@SanofiUS
Over 1 in 7 U.S. adults have chronic kidney disease. When #ckd progresses to end-stage renal disease, patients face a choice: start on dialysis or explore transplant options. Transplantation may offer benefits.
Learn more below and visit www.kidneytransplantconnectors.com/patient-resources.
#pledge2reflectThis media couldn't be displayed. See it on the original post. -
Sanofi US
@SanofiUS
🎤On this episode of Patient Advocacy Voices, Julie Block, CEO of @nationaleczema, discusses growing an organization from the early days to now and the emotional impact of being a leader. Listen and subscribe today ⬇️
#podcast #patientadvocacy -
Sanofi US
@SanofiUS
We’re presenting new data from an investigational phase 3 study in #multiplemyeloma at #asco24.
Learn more about the ASCO 2024 phase 3 data for investigational use in multiple myeloma ⬇️ -
Sanofi US
@SanofiUS
#news: The @US_FDA accepted for Priority Review our application for an investigational combination regimen for #multiplemyeloma. Learn what this could potentially mean for newly diagnosed patients.
Learn more ⬇️ -
Sanofi US
@SanofiUS
For Chien-Chia, a member of our #aapi ERG, APEX, #aapiheritagemonth is more than a celebration of her Taiwanese & Japanese heritage—It’s also a time to reflect on & address unmet needs in the community. Learn about our #amillionconversations initiative: www.sanofi.us/en/our-company/social-impact/diversity-equi…
-
Sanofi US
@SanofiUS
🎤 In the newest episode of Patient Advocacy Voices, Kim Thiboldeaux shares her powerful journey creating a first of its kind cancer center bringing necessary and culturally conscious cancer care to the Navajo Nation.
Listen and subscribe today ⬇️ -
Sanofi US
@SanofiUS
Positive late-breaking data from our replicate Phase 3 trial in COPD, a potentially debilitating respiratory disease, were presented at #ats2024 and published in @NEJM. ⬇️
CC: @Regeneron -
Sanofi US
@SanofiUS
At #ddw24, we’re presenting our latest data in eosinophilic esophagitis (#eoe), a chronic inflammatory disease driven in part by type 2 inflammation. Together with @Regeneron, we are committed to improving the lives of patients living with this disease.
ddw.org/education/abstracts/ -
Sanofi US
@SanofiUS
When Devrim joined APEX, our #aapi ERG, he embraced the opportunity to share his rich Turkish heritage and discover the diverse experiences and blend of cultures that makes APEX unique.
Learn more about our ERGs: www.sanofi.us/en/our-company/social-impact/diversity-equi…
#aapiheritagemonth -
Sanofi US
@SanofiUS
For the seventh year in a row, we’re honored to be recognized by @Fair360_ as one of the Top 50 Companies for Diversity.
Learn more: fair360.com/company/sanofi-us/
#fair360top50 -
Sanofi US
@SanofiUS
#news: The @US_FDA has approved an updated label for our first-in-class #hemophilia A treatment. This is a testament to our ongoing commitment to evolve treatment expectations for the #rareblooddisorder community:
www.news.sanofi.us/2024-05-10-FDA-approves-updated-ALTUVI… -
Sanofi US
@SanofiUS
Today the @US_FDA has accepted for Priority Review our sBLA for our medicine to treat adolescents aged 12 to 17 with chronic rhinosinusitis with nasal polyposis (CRSwNP). Learn more about our most recent news.
CC: @Regeneron
Learn more ⬇️
www.news.sanofi.us/2024-05-13-Dupixent-R-sBLA-accepted-fo… -
Sanofi US
@SanofiUS
Khalea, an @aamuedu student and a @tmcf_hbcu NextGen Scholar, is passionate about health equity and breaking down barriers to care for underserved communities.
Learn more about the Sanofi NextGen Scholarship program & apply today: tmcf.org/students-alumni/scholarship/tmcf-sanofi-scholars…
#amillionconversations -
Sanofi US
@SanofiUS
This #aapiheritagemonth, we’re celebrating the next generation of healthcare leaders like Eugina, one of our @RutgersU Fellows, who is passionate about engaging with the medical community to help ensure we can bring new and innovative treatments to patients.
-
Sanofi US
@SanofiUS
We’re committed to chasing the miracles of science for patients as we further our research and understanding of #copd and #asthma. At #ats2024 we’re presenting 25 abstracts across these chronic respiratory conditions. Learn more ⬇️
www.news.sanofi.us/2024-04-26-New-data-presented-at-ATS-d… -
Sanofi US
@SanofiUS
Episode 3 of Patient Advocacy Voices is here. Listen in as Meredith Cowden from @cowdenfdn discusses #gvhd and the power of forging alliances and collaboration between patients and organizations to meet common goals with hosts Eric Racine and Angie Bricco. patientadvocacyvoices.buzzsprout.com/2303007/episodes/149…
-
Sanofi US reposted
Sanofi
@sanofi
Our CEO Paul Hudson reflects on our strong start of the year, driven by launches and the transformation of our portfolio of medicines and vaccines.
Learn more about our first quarter 2024 results: www.sanofi.com/en/investors/financial-results-and-events/…
#sanofiresults $SAN $SNY -
Sanofi US
@SanofiUS
We're proud to have @HowardU student Pierce Medy join our @tmcf_hbcu NextGen Scholars program. Pierce is helping to amplify the often-unheard voices of his community and empower the next generation of healthcare leaders.
Learn more and apply today: tmcf.org/students-alumni/scholarship/tmcf-sanofi-scholars… -
Sanofi US
@SanofiUS
What are the top concerns for people living with #hemophilia?
Sanofi US
@SanofiUS
The answer? All three are major concerns for those living with hemophilia. Discover the full list and more insights from our survey with @HarrisPoll: www.sanofi.com/en/magazine/your-health/global-hemophilia-…
#worldhemophiliaday -
Sanofi US
@SanofiUS
If you loved episode 1 of the Patient Advocacy Voices podcast, tune in to ep 2 as Aicha Diallo from @power4patients discusses the key to empowering patients through health equity data with hosts Eric Racine and Elizabeth Franklin. Listen: patientadvocacyvoices.buzzsprout.com/2303007/episodes/148…
-
Sanofi US
@SanofiUS
Meet Sanofi scientist Jessie, a record-collector and dancer who thinks gene therapy is cool. Watch the video to learn more about Jessie’s interest in neurological diseases.
-
Sanofi US
@SanofiUS
We’re proud to be a part of @IMFmyeloma’s efforts to raise awareness about multiple myeloma during #myelomaactionmonth.
International Myeloma Foundation
@IMFmyeloma
We're counting on YOU to take action for the myeloma community. Help Us Raise Awareness! Download and share facts & messages of hope and resilience. Learn More myelomaactionmonth.org #myelomaactionmonth
-
Sanofi US
@SanofiUS
Our commitment to the multiple myeloma community is strong - driving us to innovate, support, and empower those living with this blood cancer. Join us in supporting @imfmyeloma efforts to amplify the stories of the multiple myeloma community. #myelomaactionmonth
-
Sanofi US
@SanofiUS
🤝 Health ally alert: Our patient assistance programs help to ensure that everyone can access the medicines and vaccines they need. Read more in our 2024 Pricing Principles Report. #patientaccess #corporateresponsibility
www.sanofi.us/en/our-company/social-impact/responsible-bu… -
Sanofi US
@SanofiUS
Chenda, Jamie and Debora are helping to shape a brighter future for women in healthcare. Congrats to these three women on their @HBAnet recognition!
Learn more: www.sanofi.us/en/sanofi-today/our-sanofians/recognizing-t…
#hbaimpact #hbawoty24 -
Sanofi US
@SanofiUS
This #womenshistorymonth, in partnership with @RutgersU, we’re spotlighting our Sanofi NextGen Scholar Anabell Castillo who is driven to help pave the way for underrepresented voices in healthcare.
Learn More: www.sanofi.com/en/our-company/sustainability/inclusion/a-…
#amillionconversations -
Sanofi US
@SanofiUS
During #womenshistorymonth, we’re proud to celebrate the next generation of healthcare leaders like Madison, a second-year postdoctoral fellow at @RutgersU who is helping to make the U.S. healthcare system work better for all patients.
-
Sanofi US
@SanofiUS
For patients who have atopic dermatitis, other aspects of their health and well-being can be impacted, like sleep, daily functioning, and relationships. Learn more from Dr. Ainara Marco. #aad2024 www.youtube.com/watch?v=NEFm4dgVr9w&list=PLJ3snXOLamPg9LU…
-
Sanofi US
@SanofiUS
We’re attending #aad2024 in San Diego, where we'll be sharing new data across several chronic inflammatory skin conditions.
Learn more here: www.news.sanofi.us/2024-03-08-New-data-presented-at-AAD-s…
#atopicdermatitis #prurigonodularis #chronicspontaneousurticaria -
Sanofi US
@SanofiUS
As a Sanofi NextGen scholar, Ifeoma is committed to creating a more inclusive healthcare system.
Learn how we're supporting our next generation of healthcare leaders, like Ifeoma: www.sanofi.com/en/our-company/sustainability/inclusion/a-…
#amillionconversations -
Sanofi US
@SanofiUS
Our promise to patients is simple: transparent and responsible pricing. The 2024 Pricing Principles Report outlines how we are actively working toward improving the health system to work better for patients. Read more. #pricetransparency #patientaccess #corporateresponsibility
-
Sanofi US
@SanofiUS
Introducing a new podcast, Patient Advocacy Voices. Join us for compelling discussions with unsung heroes from patient advocacy groups like Dr. Laura Lee Hall from @SHC_tweets. Listen and subscribe now! patientadvocacyvoices.buzzsprout.com #patientadvocacyvoices #patientadvocacy #podcast
-
Sanofi US
@SanofiUS
This #nationalkidneymonth, join us in helping empower those on the #kidneytransplant waiting list or considering donation. Discover inspiring stories and learn more: www.kidneytransplantconnectors.com/patient-resources
-
Sanofi US
@SanofiUS
For all, not just few: #clinicaltrials must reflect everyone. Hear perspectives on the importance of diverse clinical trials from an advocate and researcher.
Sanofi
@sanofi
Only 2-16% of clinical trial participants identify as racial and ethnic minorities. Watch more to learn about the importance of diversity in #clinicaltrials and our collaboration with @TriNetX: www.youtube.com/watch?v=LOqzTK1oVb8
-
Sanofi US
@SanofiUS
Our commitment to advancing care starts with research. Understanding type 2 inflammation and its impacts on immune-mediated diseases can affect practices across dermatology, respiratory and more. Learn more about our latest data at #aaaai24. CC: @Regeneron annualmeeting.aaaai.org
-
Sanofi US
@SanofiUS
#news: The @US_FDA accepted for priority review our application for an investigational COPD medicine. Learn how we’re one step closer to the first biologic treatment option in over a decade for certain patients with COPD.
CC: @Regeneron
www.news.sanofi.us/2024-02-23-Dupixent-R-sBLA-accepted-fo… -
Sanofi US
@SanofiUS
#dyk that about half of patients who receive a bone marrow/stem cell transplant from donor cells develop Graft-versus-host disease (GVHD)?
This #gvhdday, learn more about the support and resources offered by the #gvhdalliance at gvhdalliance.org. -
Sanofi US
@SanofiUS
We’re proud to support Sanofians like Dr. Jaunetta Hill who are breaking barriers in representation and medicine. Learn more about Jaunetta's work. #womeninscience
-
Sanofi US
@SanofiUS
Bridgett and Michael are champions for health equity. This #blackhistorymonth, they're taking time to reflect and support their communities. Let's continue to amplify Black voices and have #amillionconversations together. Learn more: www.sanofi.us/en/corporate-responsibility/diversity-equit…
-
Sanofi US reposted
Sanofi
@sanofi
#news: we're launching our 'Cancer & Work: Acting Together' Global Program, supporting Sanofians impacted by cancer and critical illness. Learn more: www.sanofi.com/en/media-room/press-releases/2024/2024-02-…
-
Sanofi US reposted
Sanofi
@sanofi
Our CEO, Paul Hudson, reflects on how we begin the year as a development-driven, science-led, tech-powered biopharma company: www.sanofi.com/en/investors/financial-results-and-events/…
#sanofiresults $SAN $SNY -
Sanofi US
@SanofiUS
The @US_FDA has approved an age expansion for eosinophilic esophagitis medicine to include people struggling with this debilitating disease. Learn more about our ongoing commitment to those impacted by diseases driven in part by type 2 inflammation. @Regeneron
-
Sanofi US
@SanofiUS
The @US_FDA has updated the label for our medicine to include Phase 3 data for patients with atopic dermatitis with moderate-to-severe hand and foot involvement. Learn more about our most recent news. @Regeneron Learn more: www.news.sanofi.us/2024-01-16-Dupixent-R-dupilumab-U-S-la…
-
Sanofi US
@SanofiUS
This #mlkday, we are honoring Dr. Martin Luther King Jr.'s legacy through acts of service. Learn more about the ways #wevolunteer: www.sanofi.us/en/corporate-responsibility
-
Sanofi US
@SanofiUS
As the new year begins, we welcome back employees like Jon Florio, who celebrated his daughter's first holiday season. Jon recently shared his story and how our U.S. benefits supported his new parenting journey. Read more: www.sanofi.us/en/about-us/our-stories/Preparing-to-Welcom…
-
Sanofi US
@SanofiUS
Dr. Sharon Humiston shares insights into the devastating impact of IMD in a recent Contemporary Pediatrics article and provides tips to help enhance patient vaccination adherence. Learn more: bit.ly/3vr7O6n
-
Sanofi US
@SanofiUS
Innovation = Hope
For Jeff Schaffnit, head of our US rare blood disorders team, it’s a simple equation that he’s reminded of at #ash23. Find out how being on the ground at ASH inspires Jeff’s work in #rareblooddisorders. -
Sanofi US
@SanofiUS
When he’s not jumping out of planes, Isaac channels his bold spirit to help ensure diversity in clinical trials. Learn more about our commitment to health equity: www.sanofi.us/en/corporate-responsibility/diversity-equit… #amillionconversations @HowardU
-
Sanofi US
@SanofiUS
We’re presenting new data at #ash23 from a Phase 3 trial of an investigational therapy in people with newly diagnosed transplant-eligible #multiplemyeloma in collaboration with @EMN_EUMMnet. Read more about the news. www.news.sanofi.us/2023-12-11-Sarclisa-R-isatuximab-irfc-…
-
Sanofi US
@SanofiUS
We remain dedicated to the advancement of care for those living with cardiovascular diseases and we’re encouraged by the new guideline update for the diagnosis and management of atrial fibrillation from the @AHAScience @ACCinTouch @ACCP & @HRSonline
AHA Science
@AHAScience
New joint guideline from @ACCinTouch and AHA describes AFib as a disease continuum, requiring different strategies at different stages: prevention, risk reduction, screening & therapy.
Published jointly with @ACCP & @HRSonline
🔗 professional.heart.org/en/science-news/2023-acc-aha-accp-…
✍🏽@JoseJoglar4 -
Sanofi US
@SanofiUS
Today’s breakthroughs in #hemophilia are due to the boundless curiosity and unfailing commitment of scientists, like Ekta Seth Chhabra. Learn what inspires our work to break barriers for children with hemophilia. www.sanofi.us/en/sanofi-today/our-science/from-aspiration…
-
Sanofi US
@SanofiUS
#news: Our Phase 3 trial for an investigational treatment combination in newly diagnosed #multiplemyeloma met its primary endpoint. Learn more: www.news.sanofi.us/2023-12-07-Sarclisa-R-isatuximab-irfc-…
-
Sanofi US
@SanofiUS
It’s the happiest (and busiest) time of the year! Don’t forget to add ‘flu shot’ to your to-do list. Learn more about the risks of the flu this #nationalinfluenzavaccinationawarenessweek www.sanofi.us/en/your-health/vaccines/influenza?sf2698805…
-
Sanofi US
@SanofiUS
Navigating a rare blood disorder diagnosis can be overwhelming. When Kyrie was diagnosed with #hemophilia, she turned to her community for support. Now she's giving back to that same community through her role at Sanofi. Learn more. www.sanofi.us/en/sanofi-today/our-sanofians/advocating-fo…
-
Sanofi US
@SanofiUS
People with #hemophilia may experience challenges and unseen impacts beyond just bleeds. Through #myhemophiliatruth, we’re sharing real stories and emotions of people with this #rareblooddisorder that highlight their whole experience.
-
Sanofi US
@SanofiUS
A diverse workforce reflects the diversity of our communities so we can better serve those in need. We're proud to have received an #equality100 score for @HRC’s Corporate Equality Index, reaffirming our commitment to LGBTQ+ equality. Learn more: www.hrc.org/CEI
-
Sanofi US
@SanofiUS
This month, we’re joining @COPDFoundation and @Regeneron to #laceupforlungs and encourage people living with COPD to include exercise as part of their overall management plan. Even light daily activity can make a positive difference. #copdawarenessmonth www.copdfoundation.org/Take-Action/Get-Involved/COPD-Awar…
-
Sanofi US
@SanofiUS
People living with #copd confront the obstacles of their disease every day. Their determination inspires us to increase our understanding about the disease. Learn how we’re rethinking COPD. www.thenextbreath.com/copd/?sf270269927=1
-
Sanofi US
@SanofiUS
During We Volunteer Month & throughout the year, our teams gave back to our communities - from a medical mission trip in Kenya to youth STEM programs, Sanofians are proud to support local people, so everyone has an equal opportunity to thrive. Learn more: www.sanofi.us/en/corporate-responsibility
-
Sanofi US
@SanofiUS
The holidays are around the corner. Get together without putting older family members at risk. Speak with a healthcare professional about a flu shot to help protect yourself and your loved ones from the flu and its complications www.sanofi.us/en/your-health/vaccines/influenza?sf2698802…
-
Sanofi US
@SanofiUS
Since joining Sanofi, Patrick has helped establish medical advisory boards to gather insights from primary care providers in underrepresented communities. Learn how we're empowering the next generation of healthcare leaders: www.sanofi.us/en/corporate-responsibility/diversity-equit… #amillionconversations @HowardU
-
Sanofi US
@SanofiUS
Last week we hosted the first-ever Trust, Inclusion & Equity (TIE) Summit. Guided by our global #amillionconversations initiative, we reaffirmed our commitment to discovering solutions to healthcare disparities. Learn more: www.sanofi.us/en/about-us/our-stories/Inclusion-Reimagine… #inclusionreimagined #tiesummit
-
Sanofi US
@SanofiUS
We kicked off American Diabetes Month in Times Square, launching #the1pledge Movement w/ paid spokespeople @Usher @RobinNYC @AdamSchefter, highlighting importance of early screening for type 1 diabetes. Talk to a doctor & take the pledge to get screened: the1pledge.com.
-
Sanofi US
@SanofiUS
We’ll be at #ash23 presenting our latest research in #bloodcancers and #rareblooddisorders in an effort to help address the unmet needs of these communities. Learn more about the data we’re presenting.
-
Sanofi US
@SanofiUS
Our 2023 Health Equity Accelerator Award winners share our belief that we need innovative solutions to bring equitable healthcare access to everyone. Learn how they're helping to transform health equity: www.news.sanofi.us/2023-11-02-Sanofi-honors-10-advocacy-o…
-
Sanofi US
@SanofiUS
As a postdoctoral fellow at @HowardU, Demi is driven to help support a patient-centered healthcare system that prioritizes access, equity, and quality of care. Learn how we’re helping to advance health equity with our #amillionconversations initiative: www.sanofi.us/en/corporate-responsibility/diversity-equit…
-
Sanofi US
@SanofiUS
#nativeamericanheritagemonth is about promoting cultural understanding. Meet our R&D colleague, Natalia. When Natalia is not developing methods to test drug efficacy in clinical trials, she's helping employees gain a better understanding of her Native American culture.
-
Sanofi US
@SanofiUS
Our “The 1 Pledge” movement with @Usher @AdamSchefter @RobinNYC highlights the importance of early screening for type 1 diabetes. Make your pledge today to get screened for type 1 diabetes: the1pledge.com #screenfortype1
Learn more: www.news.sanofi.us/2023-11-01-Sanofi-launches-The-1-Pledg… -
Sanofi US
@SanofiUS
Living with diabetes, even when well-managed, can put people at an increased risk for flu complications. Talk with a doctor about the flu, its complications, and vaccine options: www.sanofi.us/en/your-health/vaccines/influenza?sf2698799… #diabetesmonth
-
Sanofi US reposted
Sanofi
@sanofi
Our CEO Paul Hudson reflects on our Q3 Results and the next chapter of our strategy. Read more: www.sanofi.com/en/investors/financial-results-and-events/…
-
Sanofi US
@SanofiUS
Proud to be included in @TIME’s Best Inventions of 2023 list! #timebestinventions.
Learn more: time.com/best-inventions-2023 -
Sanofi US
@SanofiUS
We're breaking down healthcare barriers. By listening to and engaging with diverse populations, we’ll be better equipped to serve all communities. Learn more about our mission: www.sanofi.us/dam/jcr:6429ea09-856a-49d9-8e4a-05795ca8130… #progressisourpurpose
-
Sanofi US
@SanofiUS
Late-breaking Phase 3 trial data will be presented at #acg2023 with @Regeneron. Explore our latest results for children aged 1-11 with eosinophilic esophagitis (#eoe). Read our press release.
www.news.sanofi.us/2023-10-22-Dupixent-R-dupilumab-Phase-… -
Sanofi US
@SanofiUS
At #acg2023, we’re presenting new data from our #eosinophilicesophagitis (EoE) research. Together with @Regeneron, we’re committed to addressing the challenges this disease can present for patients.
-
Sanofi US
@SanofiUS
Today at #ispad2023 we presented findings from our Phase 3 clinical trial in autoimmune #type1diabetes. These findings were also published in @NEJM. Read more here: www.news.sanofi.us/2023-10-18-TZIELD-R-Phase-3-data-prese…
-
Sanofi US
@SanofiUS
Being named a 2023 @Seramount 100 Best Company for working parents means celebrating those who bring their best selves to everything they do—at work and at home. Congrats to our Working Parents of the Year, Ayanna and Lilya! Learn more: www.sanofi.us/en/about-us/our-stories/Meet-the-Sanofi-US-… #seramount100best
-
Sanofi US
@SanofiUS
Are you ready? Peak flu season is nearly here. This #idweek, schedule a flu shot and help protect yourself from the flu and its complications. Learn why a flu vaccine can be especially important for older adults and certain groups: www.sanofi.us/en/your-health/vaccines/influenza?sf2694466…
-
Sanofi US
@SanofiUS
An inclusive workplace means employees can bring their best selves to work. Our Employee Resource Groups (ERGs) help to unleash creativity and further tap into the richness of our diversity. Learn more about our mission: www.sanofi.us/dam/jcr:6429ea09-856a-49d9-8e4a-05795ca8130… #progressisourpurpose
-
Sanofi US
@SanofiUS
Congratulations to Doug Mildram on cycling 3,000+ miles in two months during @SaveOneLifeInc’s Wheels for the World cross-country ride! Let him inspire you to find a trail that calls to you and see how #sanofitrails are #ignitingpotential in the #hemophilia community.
-
Sanofi US
@SanofiUS
We take our commitment to prioritizing accessibility, diversity, and equity seriously. We’re proud to be named a 2023 #leadingdisabilityemployer by @NOD_ItsAbility, for promoting equal employment for those with disabilities.
Learn more: www.nod.org/national-organization-on-disability-announces…
#ndeam #allin -
Sanofi US
@SanofiUS
October is #healthylungmonth! This time of year, it’s important that eligible patients get a flu vaccine, especially for those living with chronic lung diseases such as asthma. Learn more about the potential risks associated with the flu: www.sanofi.us/en/your-health/vaccines/influenza?sf2694456…
-
Sanofi US
@SanofiUS
Like most parents, Stephanie was caught off guard when her newborn daughter, Millie, was diagnosed with respiratory syncytial virus (#rsv) and hospitalized for two weeks, fighting for every breath. Listen to Stephanie’s story below and learn more at knowingrsv.com.
-
Sanofi US
@SanofiUS
We’re pleased to share @NEJM published positive study results for our treatment for adult patients with polymyalgia rheumatica. Learn more at www.news.sanofi.us/2023-10-04-Phase-3-data-demonstrating-…
-
Sanofi US
@SanofiUS
Teams that reflect the diversity of our communities make the biggest impact. From new recruits to leadership pipelines, we’re making strides toward our 2025 workforce diversity ambitions. Learn more about our mission: www.sanofi.us/dam/jcr:6429ea09-856a-49d9-8e4a-05795ca8130… #progressisourpurpose
-
Sanofi US
@SanofiUS
As a leader for Sanofi's HOLA employee resource group, Nelson elevates Hispanic/Latinx perspectives to help improve equity and health. Learn more about Nelson and what #healthequity means to him. #hispanicheritagemonth #latinxleadership
-
Sanofi US
@SanofiUS
In August, Doug Mildram began his coast-to-coast bike ride in support of the #hemophilia community. Learn how Doug is inspiring people with hemophilia to embrace adventure and discover #sanofitrails as he takes on the Wheels for the World cross-country ride with @SaveOneLifeInc.
-
Sanofi US
@SanofiUS
It's back-to-school season, and vaccinations are crucial. During a recent discussion, Nurse Practitioner @wendywrightnp provided valuable tips to help enhance patient vaccination adherence. Learn more @Healio: bit.ly/3LB1iiO
-
Sanofi US
@SanofiUS
Today, the @US_FDA accepted for Priority Review our application for our medicine for children aged 1 – 11 with eosinophilic esophagitis (EoE). #eoe is a disease driven in part by type 2 inflammation that damages the esophagus. @Regeneron
-
Sanofi US
@SanofiUS
It’s flu season, are you prepared? #getreadyforfluday with the American @PublicHealth Association and find out important information about the flu – including the risks for older adults: www.sanofi.us/en/your-health/vaccines/influenza?sf2689576…
-
Sanofi US
@SanofiUS
Certain groups can be at an increased risk for the flu and its complications, including older adults. That’s why it’s important to talk to a healthcare provider about finding the right flu vaccine and the risks associated with the flu. Learn more at www.sanofi.us/en/your-health/vaccines/influenza?sf2689576…
-
Sanofi US
@SanofiUS
Nelson proudly embraces his Hispanic/Latinx cultural roots that have shaped who he is today. Hear more from Nelson about his rich heritage and his experiences within healthcare. #hispanicheritagemonth
-
Sanofi US
@SanofiUS
We’ve been #ignitingpotential within the #hemophilia community by supporting the @SaveOneLifeInc’s Wheels for the World 2023 season. Join the adventure by registering for an upcoming ride in Wisconsin, New York, or Maine or participating virtually! #sanofitrails
-
Sanofi US
@SanofiUS
This September, during #bloodcancerawarenessmonth, we are proud to partner with @IMFmyeloma to raise awareness around multiple myeloma – a blood cancer most commonly diagnosed among people aged 65-74. Click here to learn more: www.myeloma.org/ways-help/be-advocate/blood-cancer-awaren…
International Myeloma Foundation
@IMFmyeloma
Myeloma accounts for 19% of blood cancer diagnoses (around 35,000 cases) /year. Yet, many have still not heard of it and often mistake it for "melanoma" (skin cancer). Thank you @sanofi for helping us raise myeloma awareness during Blood Cancer Awareness Month! #knowmyeloma
-
Sanofi US
@SanofiUS
Have you gotten your flu shot yet? There are so many reasons for older adults to get their flu shot. Remember to schedule yours this #healthyagingmonth. Learn more about the risks at www.sanofi.us/en/your-health/vaccines/influenza?sf2688847…
-
Sanofi US
@SanofiUS
Today, the @US_FDA accepted a supplemental biologics license application for our first-in-class #hemophilia A treatment based on final results from a pivotal study in children under 12 with this rare blood disorder. Learn more about this important step towards progress.
-
Sanofi US
@SanofiUS
Flu season can be unpredictable and more dangerous than many think. Learn how researchers are using data from previous flu seasons, as well as relevant global and regional findings, to help protect our communities from the flu and its complications: www.sanofi.us/en/about-us/our-stories/trying-to-predict-t…
-
Sanofi US
@SanofiUS
For the second year in a row, the @CDCgov has adopted the ACIP recommendation for preferred flu guidance for adults 65+ so they can get the protection they need. Learn what it can mean for access, health equity and protection from flu and its complications www.cdc.gov/mmwr/volumes/72/rr/rr7202a1.htm?sf268632190=1
-
Sanofi US
@SanofiUS
Curious about the science behind #mrna?
Discover here how our #scientists at the mRNA Center of Excellence are pushing the boundaries to develop new #therapeutics and #vaccines.
#weneversettle -
Sanofi US
@SanofiUS
This week, the @CDCgov published its recommendations on use of our #rsv prevention for infants in the Morbidity and Mortality Weekly Report (MMWR). Learn how this milestone brings us one step closer to providing broad infant protection against RSV: www.cdc.gov/mmwr/volumes/72/wr/mm7234a4.htm?ACSTrackingID…
-
Sanofi US
@SanofiUS
The recent historic @CDCgov ACIP vote for routine use of our #rsv prevention and for inclusion in the Vaccines for Children program, will help advance equitable access and narrow the disparities in RSV prevention for infants: www.news.sanofi.us/2023-08-03-U-S-CDC-Advisory-Committee-…
@NAPNAP -
Sanofi US
@SanofiUS
At #nhf2023, we premiered an inspiring documentary sharing the stories of five elite athletes and their journey to redefine life with #hemophilia. Discover how we’re #ignitingpotential and working to break barriers so people with hemophilia can explore what matters most to them.
-
Sanofi US
@SanofiUS
Hem Sessions is out now on @SpotifyUSA! Inspired by true stories, this album puts the thoughts and feelings of people living with #hemophilia into song.
Listen to the real-life experiences of people with this #rareblooddisorder. -
Sanofi US
@SanofiUS
As an OB, Shreya Patel learned how critical it is to support maternal mental health during the transition to motherhood. One way to help? Creating a postpartum plan to help protect baby from highly contagious viruses like #rsv. Learn more: www.sanofi.us/en/sanofi-today/your-health/creating-a-plan…
-
Sanofi US
@SanofiUS
#sanofitrails are calling on the #hemophilia community to embrace activity and discover the path that calls to you. Tag along as we cheer on @SaveOneLifeInc’s Wheels for the World 2023 season or get moving to create a path of your own!
-
Sanofi US
@SanofiUS
Patient advocacy is purposeful work—just ask Preeya. Everything she does is rooted in her passion for empowering patients to receive the care they need.
-
Sanofi US
@SanofiUS
The @CDCgov’s ACIP recommended use of our monoclonal antibody for protection against #rsv disease for infants and children at increased risk, and for inclusion in the VFC program. Learn more: www.news.sanofi.us/2023-08-03-U-S-CDC-Advisory-Committee-…
-
Sanofi US
@SanofiUS
#dyk that any infant, even if they were born full term and healthy, can be hospitalized with #rsv in their first year? Our colleague Joe Sanchez is sharing a powerful account of what his family went through. Listen in and learn more at www.beyfortus.com/us/what-is-rsv
-
Sanofi US
@SanofiUS
Veronica leads a team dedicated to helping the Hispanic community take ownership of their health. Learn more about how we support transplant patients.
#nmdam #donatelife -
Sanofi US reposted
Sanofi
@sanofi
Our CEO, Paul Hudson, reflects on our solid second quarter driven by a flow of positive readouts and regulatory achievements that match our best-in-class ambitions.
Learn more about our Q2 2023 results: www.sanofi.com/en/investors/financial-results-and-events/…
#sanofiresults $SAN $SNY -
Sanofi US
@SanofiUS
Every year we partner with @INROADS to help empower students, like Kathleen, to take the next step in advancing their career. After interning with us for two summers, Kathleen feels prepared for what’s next. Discover your future at: jobs.sanofi.us/university-us?sf268085175=1 #nationalinternday
-
Sanofi US
@SanofiUS
We’re proud to support the @NMQF Health Equity Action Report and help shine a light on the RSV disparities impacting ALL babies. Together, we can help flip the script and reduce the burden of RSV as new preventives are made available. Learn more: rsvequityaction.org
-
Sanofi US
@SanofiUS
From healthier people to a healthier planet, we're always looking for new ways to help our communities. Earning our #bcorp certification means changes like reducing plastic packaging and greenhouse gas emissions are making a difference. Learn more: www.news.sanofi.us/2023-07-25-Sanofi-Consumer-Healthcare-…
-
Sanofi US
@SanofiUS
Flu season will be here before we know it. As leaders in the flu space, we know the public is counting on us. That’s why we’re innovating and starting to ship out our vaccines to meet demand. We’re committed to helping protect the public from the flu and its complications.
-
Sanofi US
@SanofiUS
How does Sharon measure the benefits of flexible work? In miles, of course. This #parentsday, learn more about her family's 12-year journey to hike the Appalachian Trail and the lessons they learned along the way at www.sanofi.us/en/sanofi-today/our-sanofians?sf268016619=1
-
Sanofi US
@SanofiUS
What’s Leighton’s favorite part of working in the #robotics lab? The hood—where he starts and ends each day taking care of cells. Check out how Leighton uses robots to help advance the discovery of life-changing treatments.
Sanofi US
@SanofiUS
ALT Text: Leighton Marcovici, Senior Associate Scientist, takes viewers on a tour of the robotics lab, talking about his role in creating potential new drugs.
-
Sanofi US
@SanofiUS
The @US_FDA has approved our monoclonal antibody for protection against #rsv disease in all infants through their first RSV season and children up to 24 months who remain vulnerable through their second season. Learn more: www.news.sanofi.us/2023-07-17-FDA-approves-Beyfortus-TM-n…
-
Sanofi US
@SanofiUS
#asco23 highlighted advances in cancer care and included updates on where the oncology field is headed. Emily Morris, U.S. Franchise Head of Oncology, shares a few key takeaways and thoughts on the future of oncology. www.sanofi.us/en/about-us/our-stories/Science-and-Sanofi-…
-
Sanofi US
@SanofiUS
Inclusivity matters. That's why we're proud to have earned a score of 100 on @DisabilityIN's Disability Equality Index, making us a Best Place to Work for Disability Inclusion. Learn more:
www.disabilityin.org/what-we-do/disability-equality-index… #progressisourpurpose -
Sanofi US
@SanofiUS
The @US_FDA has granted fast track designation for our investigational medicine in advanced non-small cell lung cancer (NSCLC). #adcs #lungcancer
-
Sanofi US
@SanofiUS
Grateful for our freedom today and every day. Happy Fourth of July!
-
Sanofi US
@SanofiUS
Yesterday we welcomed @RepCartwright to tour our vaccine manufacturing site in Swiftwater, PA. Thank you, Representative Cartwright, for your support and commitment to public health. #vaccinemanufacturing
-
Sanofi US
@SanofiUS
Today at #isth2023, results were presented from a Phase 3 study for children under 12 evaluating a new FDA-approved treatment for #hemophilia A.
The oral presentation shared detailed results from the study. Learn more: www.news.sanofi.us/2023-06-25-ALTUVIIIO-TM-late-breaking-… -
Sanofi US
@SanofiUS
For Lynden and Nina, #hemophilia is top of mind when considering their future.
Our team is dedicated to developing innovative treatment options with the potential to change care for generations to come. Learn how we're redefining what it means to live with hemophilia. -
Sanofi US
@SanofiUS
Despite progress that’s been made, more can be done to support the LGBTQ+ community. Learn how Keira Hobbs, Sanofi PrideConnect member, is using her voice to help employees live authentically during #pridemonth and beyond. www.sanofi.us/en/about-us/our-stories/transforming-my-jou… #progressisourpurpose
-
Sanofi US
@SanofiUS
Cassandra’s time with Special Olympics helped her find a purpose in giving back. As a member of our patient advocacy team, she’s able to live her passion every day—helping and empowering patient communities.
-
Sanofi US
@SanofiUS
#juneteenth is a day to learn and reflect. For Marcus, that means further understanding the history of inequities for Black Americans. Join us in committing to an inclusive future for all—today and every day. #progressisourpurpose
-
Sanofi US
@SanofiUS
The Health Equity Accelerator Awards were launched to help organizations amplify their solutions for equitable access to care. This year, we're expanding the awards to help even more patients. Want to be part of the change? Submit an application by June 30 www.sanofi.us/en/corporate-responsibility/Health-Equity-A…
-
Sanofi US
@SanofiUS
As a runner, Kate knows that going the distance means not quitting. Whether the goal is advocating for patients or crossing the finish line, Kate is driven by a purpose to help make a difference for people in need. Learn more: www.sanofi.us/en/sanofi-today/social-impact/focused-on-th…
Sanofi US
@SanofiUS
ALT Text: Kate Tighe, Head of Public Affairs & Patient Advocacy, takes a midday break to go for a run. She’s ran 5 marathons and uses today’s run to help shake the cobwebs loose and think through how her team can continue to support patient advocacy organizations.
-
Sanofi US
@SanofiUS
As a PhD student who loved science, Ekta discovered the more human side of it while recovering from a serious accident. Today, she looks back on a dream to help patients and a 13-year journey to provide hope for those living with #hemophilia: www.sanofi.us/en/about-us/our-stories/from-aspirations-to…
Sanofi US
@SanofiUS
ALT Text: Dr. Ekta Seth Chhabra, a Clinical Researcher in Rare Diseases at Sanofi, shares, “we’re helping to evolve expectations of hemophilia care and, most importantly, providing hope.”
-
Sanofi US
@SanofiUS
At Sanofi, we foster an inclusive culture so that all employees feel supported. That’s why we’re proud to once again be recognized as one of @Seramount’s Best Companies for Multicultural Women for the 3rd year in a row. Learn more: seramount.com/best-companies/2023-best-companies-for-mult… #progressisourpurpose
-
Sanofi US
@SanofiUS
Though #polymyalgiarheumatica (PMR) is the second most common rheumatic disease in the United States, it only has a diagnosis rate of about 50%.
Learn more about common symptoms of PMR:
www.pmrandil6.com -
Sanofi US
@SanofiUS
Can you identify the signs and symptoms of #coldagglutinindisease (CAD), a rare blood disorder? Learn about the significant impact #cad can have on patients' lives.
-
Sanofi US
@SanofiUS
The @US_FDA #amdac voted to recommend our investigational long-acting antibody to protect all infants against #rsv disease.
Learn more about this step toward ALL infant protection: www.news.sanofi.us/2023-06-08-FDA-Advisory-Committee-unan… -
Sanofi US
@SanofiUS
We are excited for what the future of #rsv holds for all babies and communities. As we approach a new era of RSV prevention, Dr. Greenberg shares how pediatricians can help advance ALL infant protection once a preventive option is approved: www.contemporarypediatrics.com/view/the-changing-landscap…
-
Sanofi US
@SanofiUS
#polymyalgiarheumatica (PMR) is an inflammatory rheumatic disease affecting roughly 800,000 people in the United States, characterized by symmetrical aching, tenderness and stiffness of the neck, shoulders and pelvis.
Learn about who is at risk: www.pmrandil6.com -
Sanofi US
@SanofiUS
As a young girl diagnosed with #hemophilia, Kyrie was curious about what her future would hold. Today at Sanofi, her connection and dedication to the bleeding disorders community is strong as ever, something young Kyrie would be proud of. Learn more www.sanofi.us/en/about-us/our-stories/Advocating-for-Wome…
-
Sanofi US
@SanofiUS
Looking forward to #bio2023 where we’ll meet with partners and industry peers to discuss the latest advancements in transformative medicines for patients, including AI in healthcare and the future of biotech in Massachusetts. #standupforscience
-
Sanofi US
@SanofiUS
We are proud to be accepting submissions for the 2023 Sanofi US Health Equity Accelerator Awards. These Awards crowdsource new ideas for 10 hard-to-solve health disparity challenges. Have an idea or solution to share? Submit an application today: www.sanofi.us/en/corporate-responsibility/Health-Equity-A…
-
Sanofi US
@SanofiUS
Meet Sini Ngobese, one of our champions for diversity, equity and inclusion. Passionate about promoting greater equity for all, Sini and her team are working to drive change across all areas of our organization. #progressisourpurpose
Sanofi US
@SanofiUS
Alt Text: Sini Ngobese, a Director of DE&I at Sanofi, shares the 3 things she’s looking forward to, which includes the Howard Fellows Program, pushing towards Sanofi’s hiring goals for women and people of color, and Sanofi’s “A Million Conversations” campaign.
-
Sanofi US
@SanofiUS
To Derek Green, #pridemonth is a time to spread love. At Sanofi, we support all of our employees to bring their true selves to work every day.
-
Sanofi US
@SanofiUS
We’re advancing research in multiple myeloma with the goal of discovering novel therapeutics. At #asco23, we’ll share new data from our clinical development program and highlight our commitment to those living with rare blood cancers and disorders. meetings.asco.org/abstracts-presentations/search?query=*&…
-
Sanofi US
@SanofiUS
Today we pay tribute to those who bravely served our country. Kiran Kodali, Head of R&D Data Governance & Strategy and Navy Reserve service member, reflects on what the day means to him. #memorialday
-
Sanofi US
@SanofiUS
Wonder what it’s like to work in our labs? Dr. Jaunetta Hill shows us a day in the life of a scientist. Jaunetta is a critical part of our research team, and her work is having a direct impact on new drugs for clinical trials.
Sanofi US
@SanofiUS
Alt Text: Dr. Jaunetta Hill takes us to work with her. She arrives at 8 AM and preps for her lab work. She is treating patient-derived cells using a gene therapy approach. She then has a lab meeting, talks with a friend, eats lunch, and wraps up some lab work before heading home.
-
Sanofi US
@SanofiUS
When factor levels drop below the normal range, people living with #hemophilia are at a greater risk for spontaneous bleeds.
Learn more about factor levels and bleed risk. -
Sanofi US
@SanofiUS
Positive results from our Phase 3 trial in COPD, a complex, potentially life-threatening respiratory disease, were presented for the first time at #ats2023 and published in @NEJM. @Regeneron Learn more: www.news.sanofi.us/2023-05-21-Dupixent-R-dupilumab-late-b…
-
Sanofi US
@SanofiUS
Belle, APEX ERG co-lead and first-generation Filipina-American, is honoring #aapiheritagemonth by sharing the rich culture and history of the AAPI community. Learn more about our commitment to inclusion in the workplace at www.sanofi.us/en/corporate-responsibility/diversity-equit… #progressisourpurpose
-
Sanofi US
@SanofiUS
This #aapiheritagemonth, we’re honored to hear from gymnast and #teamsanofi athlete, @Yul_Shin0122, on how he stays focused on his career while also breaking biases. Thanks to Yul for inspiring the next generation of inclusive leaders!
Sanofi US
@SanofiUS
Alt: Yul Moldauer, a gymnast and Team Sanofi athlete, celebrates AAPI Heritage month and acknowledges the racism his community has experienced. He says, “To stay focused throughout biases, I just think about who supports me, who is with me, who drives me and my support system.”
-
Sanofi US
@SanofiUS
We’re sharing new, late-breaking #respiratory data at #ats2023. Read more about our latest efforts in asthma and chronic obstructive pulmonary disease (COPD).
-
Sanofi US
@SanofiUS
Seeking out help can be hard, but it can make all the difference. This #mentalhealthawarenessmonth, Melissa Aguilar shares her mental health journey and how she found help through our U.S. Employee Assistance Program. Learn more: www.sanofi.us/en/sanofi-today/our-sanofians/a-lesson-lear…
Sanofi US
@SanofiUS
Alt Text: In honor of Mental Health Awareness Month, Melissa Aguilar, a people & culture transversal project lead at Sanofi, shares, “Asking for help doesn’t make me weak. In fact, it made me stronger.”
-
Sanofi US reposted
Sanofi
@sanofi
In a new article from @HarvardChanSPH, our CEO Paul Hudson and @HarvardChanDean share our poll results, which shows an urgent need to build back societal trust in the institutions delivering health information and medical care: www.hsph.harvard.edu/deans-office/2023/05/01/institutions…
#amillionconversations -
Sanofi US
@SanofiUS
Thank you to @DiversityInc for recognizing us on their 2023 Top 50 Companies for Diversity list. Read more #ditop50
-
Sanofi US
@SanofiUS
During #aapiheritagemonth, Amulya is helping to spark conversations around the trust gaps that exist in healthcare for the AAPI community. Learn more about our commitment to health equity: www.sanofi.us/en/corporate-responsibility/diversity-equit… #amillionconversations
-
Sanofi US reposted
Sanofi
@sanofi
Our CEO Paul Hudson reflects on our strong start of the year, driven by growth across our Specialty Care, Vaccines and Consumer Healthcare businesses.
Learn more about our first quarter 2023 results: www.sanofi.com/en/investors/financial-results-and-events/…
#sanofiresults $SAN $SNY #weneversettle -
Sanofi US
@SanofiUS
As respiratory syncytial virus (#rsv) prevention continues to evolve, we continue our mission to help advance ALL infant protection – during National Infant Immunization Week and year-round.
Learn more about RSV prevention: knowingrsv.com #niiw #knowingrsv -
Sanofi US
@SanofiUS
For Dr. Monique Adams, ensuring health equity for all isn’t just her job, it’s her passion. Thank you @blackdoctor_org for recognizing Monique as a 2023 Top Blacks in Healthcare Awards honoree. Learn more about our work in clinical trial diversity: www.sanofi.us/en/corporate-responsibility/diversity-equit…
-
Sanofi US
@SanofiUS
Yesterday, we had the honor of ringing the @Nasdaq closing bell in support of our mission to redefine standards of care for people with #rareblooddisorders.
-
Sanofi US
@SanofiUS
Coming from humble beginnings, Phillip St. James knows the power giving back can have. Today, he uses his passion of helping others to fuel his work at Sanofi as a community leader. Learn more about his story: www.sanofi.us/en/sanofi-today/social-impact/let-us-not-ge… #sanoficares #nationalvolunteermonth
Sanofi US
@SanofiUS
Alt Text: Phillip St. James is a man with a mission – to give back to his community. For his work feeding those in need, donating holiday gifts, and raising money for United Way, he’s been celebrated by his community and recognized for his selflessness.
-
Sanofi US
@SanofiUS
It is critical to help address health disparities in #rsv, during National Minority Health Month and year-round. RSV is a highly contagious virus that affects ALL babies. Education can help protect them. Learn more: www.youtube.com/watch?v=myrfL4whABY @patientaccess #nmhm2023 #knowingrsv
-
Sanofi US
@SanofiUS
Stories like those of Jane and her son drive our ambition to create a world where people with #hemophilia can live without limits. On #worldhemophiliaday, reflect on how life with this #rareblooddisorder has evolved.
-
Sanofi US
@SanofiUS
Why does Antwaun Cook volunteer? To help make the world a better place, starting by serving his own community. Read Antwaun's story and follow along for more this #nationalvolunteermonth: www.sanofi.us/en/about-us/our-stories/Driven-by-Giving-Ba…
Sanofi US
@SanofiUS
Alt Text: Antwaun Cook uses his free time to give back to his community. He feeds the homeless, volunteers for his church, and empowers voters. Through his efforts, he is helping show Sanofi’s values in action.
-
Sanofi US
@SanofiUS
This #aiaw23, it’s important to make sure all pre-teens and teens are up to date on immunizations against vaccine-preventable diseases like meningococcal #meningitis. Join us and @UnityConsortium to spread the word: www.unity4teenvax.org/aiaw23/?sf265661364=1
-
Sanofi US
@SanofiUS
Today, in partnership with @BARDA, we celebrated the groundbreaking of a new, state-of-the-art facility at our Swiftwater, Pennsylvania site. The facility will help increase production capabilities of pandemic flu vaccines. Read more: www.news.sanofi.us/2023-04-04-Sanofi-Breaks-Ground-on-Sta…
-
Sanofi US
@SanofiUS
This #donatelifemonth, Dr. @AmyWaterman of @MethodistHosp shares her goal of raising awareness of living donation to help the more than 100,000 people on the waitlist for a kidney through the Living Donation Storytelling Project.
-
Sanofi US
@SanofiUS
This winter, #rsv surged in communities across the nation, reinforcing the critical need for RSV education and prevention.
We can help empower ALL families to act against RSV. Check out and share this resource from our partner @AmerAcadPeds: www.healthychildren.org/English/health-issues/conditions/… #knowingrsv -
Sanofi US
@SanofiUS
Rebecca’s interests are wide-ranging – from competing on a national ice skating team to manufacturing products surgeons use everyday, she loves what she does. Join our team and learn how to #lovewhatyoudo jobs.sanofi.com/en/usa?sf265492422=1
Sanofi US
@SanofiUS
Alt Text: Rebecca Cunningham, a mom to 5 4-legged friends shows the love she has for ice skating, raising her pets, and making products people can count on as a member of the manufacturing team at Sanofi.
-
Sanofi US
@SanofiUS
The flu remains an unpredictable threat that’s more serious than many think. Read more from our North America Head of Vaccines, Dr. Greenberg, about lessons learned from this past flu season and how we can prepare for the future www.sanofi.us/en/sanofi-today/your-health/reflecting-on-l…
-
Sanofi US
@SanofiUS
We’re sharing positive results from a Phase 3 study of our medicine in adults with chronic obstructive pulmonary disease (COPD), a life-threatening disease in which no new treatment approaches have been approved in over a decade. www.news.sanofi.us/2023-03-23-Dupixent-R-demonstrates-pot… CC: @Regeneron
-
Sanofi US
@SanofiUS
#teamsanofi athlete @Yul_Shin0122, Olympic artistic gymnast, is a champion on and off the gym floor. We welcomed Yul to our Cambridge Crossing office to hear his journey of breaking barriers and helping the next generation reach their potential. #ignitingpotential
-
Sanofi US
@SanofiUS
We’re proud of our employees who are paving the way for women in the healthcare industry. Thank you to Raquel, Fernanda and Adama for their leadership and dedication to helping others. Learn more about their @HBAnet recognitions: hbanet.org/2023-rising-stars-and-luminaries?sf265147333=1 #hbawoty23 #hbaimpact
-
Sanofi US
@SanofiUS
What role does factor play in the clotting cascade?
To stop bleeds, various forms of factor are needed to form clots. People living with #hemophilia A, who lack factor VIII, should aim to maintain factor activity levels to form a stable clot. #levelsmatter -
Sanofi US
@SanofiUS
At #aad2023, we’re presenting late-breaking Phase 3 data from a clinical trial in patients with #atopicdermatitis of the hands and feet. Read more: www.news.sanofi.us/2023-3-18-Dupixent-dupilumab-late-brea… @Regeneron
-
Sanofi US
@SanofiUS
#womenshistorymonth recognizes those that pave a path for women. As the first woman in her family to enroll in higher education, Rakhi Agarwal is dedicated to helping the advancement of women through our supplier diversity efforts. Learn how: www.sanofi.us/en/about-us/our-stories/Remembering-the-Pas…
Sanofi US
@SanofiUS
ALT Text: Rakhi Agarwal’s passion for inclusion began after witnessing challenges to women throughout her career. In recognition of #womenshistorymonth, she shares, “While many companies talk about supplier diversity, I want to move the needle."
-
Sanofi US
@SanofiUS
Despite educational efforts, misconceptions that hemophilia only impacts men persist.
During #bleedingdisordersawarenessmonth, hear Kyrie’s journey as a woman with hemophilia and how she has advocated for care along the way. -
Sanofi US
@SanofiUS
When an injury occurs, a process called hemostasis begins to stop the bleed. For people with #hemophilia, a breakdown in the process prevents it from working properly.
Learn how increasing factor activity levels can help rebalance this process and improve bleed protection. -
Sanofi US
@SanofiUS
For #iwd2023, Sanofians are posing to #embraceequity. Our team is committed to driving greater gender equity through the recruitment and development of women. Join us and show your support.
-
Sanofi US
@SanofiUS
The U.S. FDA has accepted for review our application for our medicine for people living with chronic spontaneous urticaria, an inflammatory skin disease characterized by the sudden onset of hives on the skin and/or swelling deep under the skin. @Regeneron
-
Sanofi US
@SanofiUS
Together we can be faster. Our first-of-its-kind R&D Consortium brings together industry and patient advocacy groups to accelerate #medicinesdevelopment.
Read more: www.news.sanofi.us/2023-03-02-Sanofi-launches-R-D-Consort… -
Sanofi US
@SanofiUS
The @US_FDA has approved the first and only biologic indicated for patients with #polymyalgiarheumatica (PMR), an inflammatory rheumatic disease.
Learn more: www.news.sanofi.us/2023-03-01-Kevzara-R-sarilumab-approve… -
Sanofi US
@SanofiUS
This #myelomaactionmonth is about encouraging those living with multiple myeloma to live with, and not for, this blood cancer. Click here to learn more about how you can share your #myelomastory: mam.myeloma.org?sf264620285=1
-
Sanofi US
@SanofiUS
At #aaaai23, we’re presenting 18 abstracts with new results from our Phase 3 clinical program across five different chronic inflammatory diseases. Explore our latest research: annualmeeting.aaaai.org?sf264504551=1 @Regeneron
-
Sanofi US
@SanofiUS
#weneversettle in our efforts to address the unmet needs of people with #rareblooddisorders. Today’s @US_FDA approval marks an important step in transforming treatment for people living with #hemophilia A.
Read more about this new option: www.news.sanofi.us/2023-02-23-FDA-approves-once-weekly-AL…
Sanofi US
@SanofiUS
We’re proud to play a role in transforming the practice of medicine for #hemophilia A. Learn how we're raising the bar with the FDA approval of the first once-weekly high-sustained factor VIII replacement therapy for this #rareblooddisorder.
-
Sanofi US
@SanofiUS
For @dareiaaaa, life is about loving what you do. When she’s not crunching numbers at work, she’s crossing countries off her bucket list of places to see. Explore our career opportunities and learn how to #lovewhatyoudo at jobs.sanofi.com/en/usa?sf264468957=1
-
Sanofi US
@SanofiUS
To understand the total impact of respiratory syncytial virus (#rsv) and why all infants need protection, we must understand the stories behind the statistics. Read our latest Our Stories that shares our colleague’s RSV experience: www.sanofi.us/en/about-us/our-stories/stories-behind-the-… #knowingrsv
-
Sanofi US
@SanofiUS
GVHD patient, advocate and #gvhdalliance member @MeredithCowden shares her experience and thoughts on how #gvhd impacts others living with the condition.
#gvhdconnect4hope -
Sanofi US
@SanofiUS
This #blackhistorymonth, we were honored to hear from @MagicJohnson on the importance of health and his efforts to support diverse communities.
-
Sanofi US
@SanofiUS
We identified unmet needs among the #gvhd community and acted by helping bring together top transplant groups to form the #gvhdalliance, providing support and helpful resources.
#gvhdconnect4hope -
Sanofi US
@SanofiUS
Long-acting antibodies are a type of immunization that can rapidly help protect against disease. Learn more below and at this link: admin.allianceforpatientaccess.org/wp-content/uploads/202…
Alliance for Patient Access
@patientaccess
Do you know the difference between vaccines and preventive monoclonal antibodies?
Learn it here: instituteforpatientaccess.org/vaccines-and-preventive-mon… -
Sanofi US
@SanofiUS
#dyk factor activity plays a key role in helping determine what people with #hemophilia can safely do.
Learn more about the importance of keeping factor levels high. -
Sanofi US
@SanofiUS
#blackhistorymonth is a time to make change. For too many Black Americans, the trust in healthcare has been lost. Learn how we’re aiming to rebuild that trust and establish a more equitable healthcare system with #amillionconversations: www.sanofi.us/en/corporate-responsibility/diversity-equit…
-
Sanofi US
@SanofiUS
With 900+ miles between them, Sanofi colleagues Michael and Steve had never met. But that all changed after attending a long snapping competition for their sons.
As we get ready for the big game, learn how football brought two Sanofi families together at www.sanofi.us/en/about-us/our-stories/long-shot-sanofi-co… -
Sanofi US
@SanofiUS
Over 2/3 of parents say their child’s struggle with #rsv affected their #mentalhealth, based on a survey we and others supported from @patientaccess and @InfantCoalition. Learn about the impact of RSV and why all babies need protection: admin.allianceforpatientaccess.org/wp-content/uploads/202… #knowingrsv
Alliance for Patient Access
@patientaccess
Two national surveys with parents with children who had RSV and health care providers show that the disease's burden extends beyond immediate symptoms to reach people's financial, emotional and social lives.
Read the AfPA and @InfantCoalition report: healthpolicytoday.org/2023/01/11/amidst-tripledemic-the-b… -
Sanofi US
@SanofiUS
#gvhd can be an isolating disease that creates challenges beyond physical symptoms. By raising awareness of these challenges, our hope is more people can seek advice from their healthcare provider and be diagnosed earlier.
#bloodtransplant #marrowtransplant -
Sanofi US reposted
Sanofi
@sanofi
Our Q4 and full-year 2022 results are now available. Read the press release: www.sanofi.com/en/media-room/press-releases/2023/2023-02-….
#sanofiresults $SAN $SNY -
Sanofi US
@SanofiUS
#blackhistorymonth is more than a celebration of history. It's about building a better future. And it starts with access to quality healthcare for all. Learn how we're supporting diversity in healthcare with #amillionconversations: www.sanofi.us/en/corporate-responsibility/diversity-equit…
-
Sanofi US
@SanofiUS
Melanie’s role as an Occupational Health Nurse may look different from her former days in the ER, but her commitment to public health remains unchanged. Learn about her journey and how she found work-life balance at www.sanofi.us/en/sanofi-today/our-sanofians/from-hospital… #iamsanofi
-
Sanofi US
@SanofiUS
Trust in healthcare decreases where diversity increases. Our global poll discovered that people from more than one marginalized group are most likely to have had a negative healthcare experience. Let's change that: www.sanofi.us/en/corporate-responsibility/diversity-equit… #amillionconversations
-
Sanofi US
@SanofiUS
Timely and actionable information is integral to helping patients experiencing health challenges while living with conditions like #gvhd, a disease that can impact patients after allogeneic blood or marrow transplants.
#bloodtransplant #marrowtransplant -
Sanofi US
@SanofiUS
Our commitment to DE&I extends to all areas within the company, including the suppliers we work with. We’re honored to be recognized as one of @NaVOBA's Best Corporations for Veteran’s Business Enterprises. Learn more about our supplier diversity efforts: suppliers.sanofi.com/en/sustainable-procurement/supplier-…
-
Sanofi US
@SanofiUS
We’re working to transform the treatment landscape for #hemophilia A. Learn about the strides we’re making for people with this #rareblooddisorder in @NEJM: www.news.sanofi.us/2023-01-25-NEJM-publishes-once-weekly-…
-
Sanofi US
@SanofiUS
Our expanded label in cold agglutinin disease (#cad) by the @US_FDA underscores our commitment to deliver important treatment options for people living with #rareblooddisorders. Read more: www.news.sanofi.us/2023-01-15-FDA-approves-expanded-label…
-
Sanofi US
@SanofiUS
69% of people from ethnic minorities have had their trust damaged by past negative healthcare experiences. That’s why we’re launching #amillionconversations – a global initiative to listen, take action and help rebuild trust in healthcare. Find out how at: www.sanofi.us/en/corporate-responsibility/diversity-equit…
-
Sanofi US
@SanofiUS
We chase the miracles of science to help those who matter most – patients. Learn how we're helping to make a difference for patients by identifying better solutions to core challenges they face at www.sanofi.us/en/sanofi-today/social-impact/powerful-acti…
-
Sanofi US
@SanofiUS
How factor fluent are you? Test your #hemophilia knowledge!
Hemophilia is a rare blood disorder in which the body doesn’t produce enough:
Sanofi US
@SanofiUS
The severity level of hemophilia is determined by the amount of factor in the blood.
Sanofi US
@SanofiUS
Complications of hemophilia include:
Sanofi US
@SanofiUS
Thanks for playing! The correct answers are B, true, and C. www.levelsmatter.com
-
Sanofi US
@SanofiUS
Healthcare that works for everyone starts with healthcare that listens to everyone equally. That’s why we’re launching #amillionconversations. A global initiative to spark frank discussions between healthcare and marginalized communities. www.sanofi.com/en/our-company/sustainability/inclusion/a-…
-
Sanofi US
@SanofiUS
We strive to ensure our #clinicaltrials are inclusive by design and reflect the diversity of patients in need. Thank you @BioethicsIntl for recognizing us with the highest rating in the #goodpharmascorecard. Learn more: www.sanofi.us/en/corporate-responsibility/diversity-equit…
-
Sanofi US
@SanofiUS
#gvhd commonly impacts patients after a #bloodtransplant or #marrowtransplant. We are driven to create a community for these often-overlooked patients throughout their journey. Learn the signs and symptoms of GVHD.
-
Sanofi US
@SanofiUS
By supporting people impacted by graft-versus-host disease or #gvhd our mission is to empower those living with this condition.
#bloodtransplant #marrowtransplant -
Sanofi US
@SanofiUS
What factors into how blood clots? It’s factor: an essential protein that causes blood to clot. For people living with #hemophilia, this protein can be missing.
The severity of hemophilia is determined by the level of factor in a person's blood. Learn more 👇. -
Sanofi US
@SanofiUS
Brian had a mission – to help local kids discover how fun the lake can be. That’s why he teamed up with Wake The World to share his love of water sports with the community. #iamsanofi
-
Sanofi US
@SanofiUS
This holiday season, our teams helped spread a little holiday cheer by donating over 10,500 gifts to local families in need. From our community to yours, have a happy and healthy holiday.
-
Sanofi US
@SanofiUS
Eosinophilic esophagitis (EoE) is a chronic, progressive disease that damages the esophagus and can make it difficult to swallow food. Learn more about our #eoe data in @NEJM: www.news.sanofi.us/2022-12-21-Positive-Dupixent-R-dupilum… @Regeneron
-
Sanofi US
@SanofiUS
We may come from different generations, but our shared experiences unite us. See how we’re building a collaborative environment with our newest ERG, EveryGen, where employees of all age groups can grow, feel supported and connect. www.sanofi.us/en/corporate-responsibility/diversity-equit…
-
Sanofi US
@SanofiUS
2022 was a year of progress for science, for innovation and for patients. Thank you to all of our team members who made this year what it was.
-
Sanofi US
@SanofiUS
For too long, health inequities have not been addressed, but we’re on a mission with our Health Equity Accelerator Award winners to change that. Learn more about this year’s winners and their work to improve outcomes for all at www.sanofi.us/en/sanofi-today/social-impact/2022-hea-awar…
Sanofi US
@SanofiUS
We’re excited to partner with @StopAfib, @BeTheMatch, @AST_Info and Summit Health Cares to address a variety of health inequities.
-
Sanofi US
@SanofiUS
Join us at #ash22 Booth 643 to learn more about our commitment to scientific progress and mission to help improve the lives of people with #hemophilia A and B.
-
Sanofi US
@SanofiUS
Even after diagnosis – which can take years – people living with #coldagglutinindisease (CAD) often have a high degree of unmet needs. Learn about our latest work to support people with #cad at #ash22: www.sanofi.com/en/media-room/press-releases/2022/2022-11-…
-
Sanofi US
@SanofiUS
At Sanofi, our #clinicaltrials are inclusive by design. We’re honored to be recognized as an industry-leading organization with the ‘Delivering Inclusive Trials Award’ from @Reuters Events Pharma. #repawards @RE_Pharma
events.reutersevents.com/pharma/awards-usa/winners -
Sanofi US
@SanofiUS
We’re committed to advancing scientific innovation and to pushing the frontiers of research from all angles to improve the standard of care for people living with #rareblooddisorders.
Learn more about our work at #ash22. -
Sanofi US reposted
-
Sanofi US
@SanofiUS
It’s those who are most invested in the health of their neighbors that make the most impact. That’s why we’ve partnered with @CHWNational to find solutions that support community health workers and the well-being of their communities. Learn more: www.sanofi.us/en/sanofi-today/social-impact/sanofi-health…
-
Sanofi US
@SanofiUS
Mark your calendars. We’re attending #ash22 to share the latest findings from our research aimed at informing care for people living with multiple myeloma and other blood cancers. Learn more about the data: www.news.sanofi.us/2022-12-02-Sanofi-to-showcase-new-data…
-
Sanofi US
@SanofiUS
We'll be sharing clinical research updates from our #rareblooddisorder portfolio at #ash22. Learn more about the work we’re doing to ensure that no one living with a #raredisease is left behind: www.news.sanofi.us/2022-11-30-Sanofi-to-present-new-clini…
-
Sanofi US
@SanofiUS
For Pamela, leading our newest employee group, North American Indigenous Awareness (NAIA), means sharing the rich heritage of Indigenous peoples. Learn more this #nativeamericanheritagemonth www.sanofi.us/en/sanofi-today/our-sanofians/recognizing-a… #iamsanofi
-
Sanofi US reposted
Sanofi
@sanofi
Sports and science aren’t all that different: in the end, it's about the results. Sanofian and former Olympic rower Chris Liwski shares how athletes and scientists walk similar paths, fueled by failure to get better and fiercely focused on achieving the end goal. #weneversettle
-
Sanofi US reposted
NFID
@NFIDVaccines
Thanks for #leadingbyexample to help #fightflu. Read latest #nfid blog post to learn more: www.nfid.org/2022/11/14/early-start-to-flu-season-undersc…
@CDCgov @AAFANational @schoolnurses @LungAssociation @Vaxyourfam @MedStarWHC @IDSE_Online @CDCFlu @greenbergepi @DonnaMazyck @InfectiousPS @VaxCare @Drwandafiler -
Sanofi US
@SanofiUS
Today, we thank all veterans who have risked everything to protect our nation. We’re grateful for their service, including our own decorated veterans from our VETS Employee Resource Group. #veteransday
-
Sanofi US
@SanofiUS
Important reminder: #rsv cases typically spike from November to March. This means that now is the time to learn about RSV and its symptoms before your baby does. Visit www.beyfortus.com/us/what-is-rsv for RSV facts, preventive tips and family stories. #knowingrsv
-
Sanofi US
@SanofiUS
Inclusive work policies aren't a nice-to-have - they're a must-have. That's why we prioritize empowering our people, like Patrick, to bring their best selves every day and celebrate our differences. www.sanofi.us/en/corporate-responsibility/diversity-equit… #iamsanofi
-
Sanofi US
@SanofiUS
In partnership with @DirectRelief, Sanofi Cares North America donated 40,000 flu vaccines to Americans in need – a group often disproportionately affected by the flu. These vaccines are helping to provide protection from the flu and its complications for those at risk.
-
Sanofi US
@SanofiUS
Help our healthcare heroes fight the flu. It can help protect you from the flu and its complications. Find a flu shot near you at nottodayflu.com @NotTodayFlu
American Nurses Association
@ANANursingWorld
Flu season is here. Did you get your flu shot? It’s our best tool at helping fight the flu and helping protect ourselves, our community, and our loved ones. Find a flu shot near you at nottodayflu.com
#nottodayflu -
Sanofi US
@SanofiUS
The flu can be a serious public health threat – and many racial and ethnic groups are at an increased risk for flu-related complications. Get your flu shot today nottodayflu.com #nottodayflu
-
Sanofi US
@SanofiUS
November is #lungcancerawarenessmonth, and this type of cancer is the second most common type for both men and women in the U.S. We’re dedicated to raising awareness in hopes of improving the lives of those diagnosed and living with lung cancer.
-
Sanofi US
@SanofiUS
For our community, for the planet, for our patients, and for so many others, we volunteer.
Swipe through to see some of the latest volunteer projects our Sanofi US team members have taken on. #wevolunteermonth -
Sanofi US
@SanofiUS
The flu can be serious. Help prepare for the flu and its related complications. Get your flu shot! nottodayflu.com #nottodayflu
-
Sanofi US
@SanofiUS
No detail is too small, especially when it comes to manufacturing tens of thousands of self-care solutions every day. Hear the sounds of precision soundcloud.com/sanofius/sets/the-sounds-of-sanofi-manufac… #soundsofsanofi #nationalmanufacturingmonth
-
Sanofi US
@SanofiUS
As a Command Pilot, Will takes his volunteering to the sky – offering his time and aircraft to transport patients in rural areas to and from medical appointments. Will is a reminder that our commitment to community knows no bounds #iamsanofi www.sanofi.us/en/about-us/our-stories/taking-volunteering…
-
Sanofi US
@SanofiUS
Inclusivity starts with building trust, allowing everyone the ability to share their story and be vulnerable. And we’re proud to help share those stories, like Nancy’s. www.sanofi.us/en/about-us/our-stories/making-a-difference… #inclusionmonth
-
Sanofi US
@SanofiUS
You’ve heard the #soundsofsanofi in the lab, now hear the sounds of our manufacturing line helping to deliver tens of thousands of self-care solutions to people every day: soundcloud.com/sanofius/sets/the-sounds-of-sanofi-manufac… #nationalmanufacturingmonth
-
Sanofi US
@SanofiUS
A lifetime of dedication. A legacy of impact. Elizabeth’s goal has always been to help get patients care that’s not only innovative but meets them where they need it most. Join Elizabeth on her mission: jobs.sanofi.com/en/usa?sf261003813=1 #iamsanofi
-
Sanofi US
@SanofiUS
Respiratory syncytial virus (#rsv) sounds scary because it can be when it impacts your loved ones. Learn more about RSV, a highly contagious virus that can lead to respiratory illness for babies, at www.beyfortus.com/us/what-is-rsv. #rsvawarenessmonth #knowingrsv
-
Sanofi US
@SanofiUS
#hemophilia A affects approximately 1 in 5,000 US male births, and more rarely in females. Do you know how this #rareblooddisorder is treated?
Test your knowledge and learn more about the importance of high factor activity levels with our Factor Fluent quiz. -
Sanofi US
@SanofiUS
A chance encounter at a Sanofi college mentoring program meet-up led to Bob Shustack discovering his passion for mentorship and Drew Beach landing his first job. It’s stories like these that inspire us during our “We Volunteer” month of service. www.sanofi.us/en/corporate-responsibility
#iamsanofi -
Sanofi US
@SanofiUS
How do we ensure our culture is reflective of the patients we serve? We start with inclusion as our foundation. Each October, we celebrate our employees who bring their true selves to work. Learn more about our DE&I commitment: www.sanofi.us/en/corporate-responsibility/diversity-and-i…. #inclusionmonth
-
Sanofi US
@SanofiUS
Today is #worldmeningitisday. Learn how to help protect against this rare but potentially devastating disease with @CDCgov -recommended MenACWY vaccination, and other adolescent vaccines like MenB, at helpstoptheclock.org?sf260652272=1. #defeatmeningitis #time2talkmeningitis
-
Sanofi US reposted
Sanofi
@sanofi
Scientific discoveries don’t happen overnight or without hard work. But we’re determined to find the answers that will lead us to breakthrough medicines and vaccines for patients.
Meet a new cast of Sanofians who tell the story behind our purpose.
#weneversettle -
Sanofi US
@SanofiUS
Our cultures help shape and connect us with one another. For Alicia, her heritage has helped define who she is today. #hispanicheritagemonth #iamsanofi
-
Sanofi US
@SanofiUS
The impact of #prurigonodularis on quality of life is one of the highest among inflammatory skin diseases. Symptoms can negatively affect mental health, daily activities and social interactions. Learn more about a new treatment option: www.news.sanofi.us/2022-09-28-Dupixent-R-dupilumab-approv…. @Regeneron
-
Sanofi US
@SanofiUS
#prurigonodularis is chronic condition with underlying type 2 inflammation & is characterized by chronic itch. People with the condition can have hundreds of nodules covering their bodies. Learn more about the first & only FDA-approved medicine: www.news.sanofi.us/2022-09-28-Dupixent-R-dupilumab-approv… @Regeneron
-
Sanofi US
@SanofiUS
We brought 10 Sanofi sites across Massachusetts together at our new innovation hub. Learn more about Sanofi at Cambridge Crossing. jobs.sanofi.us/cambridgecrossing?sf260549028=1
-
Sanofi US
@SanofiUS
The rate of hospitalization for #rsv is 2.5x higher for American Indians & up to 5x higher for Native Alaskans compared to other U.S. populations. We are proud to support @NIHB1 to help advance equitable access to healthcare. Learn more about their impact: www.nihb.org/public_health/public_health.php?sf260459719=1
-
Sanofi US
@SanofiUS
What’s in a name? When it comes to the #rareblooddisorder, acquired thrombotic thrombocytopenic purpura (#attp), a name means a lot and it can help explain some of the serious signs and symptoms associated with this disease.
-
Sanofi US
@SanofiUS
Growing up in a big city taught Steve that opportunity is critical for success. #hispanicheritagemonth is about paving the way for future generations. That's why we’ve partnered with @HSFNews to create more opportunities for Hispanic youth. www.hsf.net/corporate-partners/sanofi?sf260261970=1 #iamsanofi
-
Sanofi US
@SanofiUS
A recent Sanofi study found that 67% of those living with multiple myeloma feel they need emotional support due to their disease. This #bloodcancerawarenessmonth, we join efforts to raise awareness of the unmet needs of those living with blood cancers and their caregivers.
-
Sanofi US
@SanofiUS
Some doctors are especially skilled at connecting with their patients. For Dr. Katherine Galarza, it is because she knows what it is like to hear a life-changing diagnosis herself. Learn more about what inspired her to become a pediatrician: www.sanofi.us/en/about-us/our-stories/making-a-difference…
-
Sanofi US
@SanofiUS
Atrial fibrillation (AFib), a type of irregular heartbeat, impacts millions of people in the U.S. For Wilson Ngai, supporting people with AFib is personal. Read more about what drives his work: www.sanofi.us/en/about-us/our-stories/making-a-difference… #afibawarenessmonth
-
Sanofi US
@SanofiUS
At #eadv2022, we’re presenting late-breaking Phase 3 data from a second clinical trial of our investigational medicine in adults with uncontrolled #prurigonodularis. Read more: www.news.sanofi.us/2022-09-08-Dupixent-R-dupilumab-late-b… @Regeneron
-
Sanofi US
@SanofiUS
Leslie Maier, President of @NMAtweets, lost her son to meningococcal #meningitis within 24 hours. Hear Leslie's story and join a conversation around the importance of MenACWY vaccination with @IAmCattSadler at helpstoptheclock.org?sf260047994=1. #time2talkmeningitis
-
Sanofi US reposted
Sanofi
@sanofi
breakthroughs
-
Sanofi US
@SanofiUS
The @US_FDA has approved the first and only treatment for non-CNS manifestations of #asmd in adult and pediatric patients. Learn more: www.news.sanofi.us/2022-08-31-XenpozymeTM-olipudase-alfa-…
-
Sanofi US
@SanofiUS
The @US_FDA has accepted our investigational #hemophilia A therapy for priority review.
Read how this novel factor VIII treatment can help address an unmet medical need in this community: www.news.sanofi.us/press-releases?item=137377&sf259943847=1 -
Sanofi US
@SanofiUS
One small step for flu recommendations. One giant leap for health equity. @CDCgov has officially adopted the June 22 Flu ACIP recommendation for preferred flu shot guidance for adults 65+. Learn more about this important decision: www.news.sanofi.us/2022-08-26-Sanofi-higher-dose-flu-vacc…
-
Sanofi US
@SanofiUS
Vaccines save five lives per minute worldwide. In the third episode of our “The Doc is In” series, Dr. Galarza answers questions about the importance of back-to-school vaccination, like the MenACWY and other adolescent vaccines. #vaccineswork #niam2022 www.sanofi.us/en/about-us/our-stories/making-a-difference…
-
Sanofi US
@SanofiUS
More than half of patients awaiting #kidneytransplant are minorities. As Kidney Transplant Connectors (KTCs), Reggie & Alana know the importance of speaking up, so they’re spreading the word during #nmdam. For more advocacy resources, visit: www.kidneytransplantconnectors.com?sf258941068=1
-
Sanofi US
@SanofiUS
We are committed to fighting for ALL infant protection from respiratory syncytial virus (#rsv). A recent supplement championed by Sanofi in the Journal of Infectious Diseases illuminates why this fight is so critical.
Journal of Infectious Diseases
@JIDJournal
Respiratory Syncytial Virus is the leading cause of infant hospitalization in the US. This supplement issue features articles discussing its impact on patients, families & healthcare systems, and the need to protect all infants from #rsv.
➡️ academic.oup.com/jid/issue/226/Supplement_2 -
Sanofi US
@SanofiUS
A new supplement in @JIDJournal shows that the burden of #rsv for ALL infants is more significant than previously known. We are proud to champion this body of work to advance our understanding of this pervasive virus. Learn more: www.sanofi.us/en/about-us/our-stories/making-a-difference…
-
Sanofi US
@SanofiUS
During National Minority Donor Awareness Month #nmdam, Kidney Transplant Connector (KTC) David tells us why he’s grateful to share his personal transplant journey. If you or someone you know needs resources for a #kidneytransplant, visit: www.kidneytransplantconnectors.com?sf258941016=1
-
Sanofi US
@SanofiUS
An annual flu shot is always important, especially in high-risk populations. Hear from our roundtable of health experts on how we can help address health inequities this flu season at: www.news.sanofi.us/2022-08-12-Public-health-experts-under…
-
Sanofi US
@SanofiUS
The recent meningococcal #meningitis outbreak in FL reminds us that the value of immunization goes beyond helping to avoid disease. Read the latest piece by Dr. Corey Robertson, Senior Director of Scientific and Medical Affairs @NMAtweets www.linkedin.com/posts/corey-robertson-1bb191b1_sharing-m…
-
Sanofi US
@SanofiUS
Parents, #dyk you can help protect your child against meningococcal meningitis, a potentially deadly disease with MenACWY vaccination? This #niam, talk to your child’s HCP and visit helpstoptheclock.org?sf259561455=1. #time2talkmeningitis
-
Sanofi US
@SanofiUS
Hear from Jonathan, a survivor of meningococcal #meningitis and a @NMAtweets advocate, as he shares his story with this rare but potentially devastating disease.
Visit helpstoptheclock.org?sf259430316=1 to learn more. #time2talkmeningitis -
Sanofi US
@SanofiUS
As a #livingdonor, Amanda proudly honors her father’s legacy as we celebrate National Minority Donor Awareness Month #nmdam. Learn more about our commitment to addressing health equity for all. www.linkedin.com/pulse/addressing-disparities-transplant-…
-
Sanofi US
@SanofiUS
#rsv is the leading cause of hospitalization in babies. Sara Rosenbaum discusses how introducing new technologies to the CDC’s Vaccines for Children program may prevent serious diseases in infants. Learn more @Health_Affairs: www.healthaffairs.org/do/10.1377/forefront.20220708.81880…
-
Sanofi US
@SanofiUS
We're excited to announce our first annual U.S. Health Equity Accelerator Awards to support organizations that tackle health disparities for the transplant community, for people living with atrial fibrillation, and people living with diabetes. Learn more: www.sanofi.us/en/corporate-responsibility/Health-Equity-A…
-
Sanofi US reposted
Sanofi
@sanofi
Our CEO Paul Hudson reflects on our Q2 2022 performance, the progress we’ve made on our social impact strategy and our key achievements in R&D transformation. Learn more: www.sanofi.com/en/media-room/press-releases/2022/2022-07-…
#sanofiresults $SAN $SNY -
Sanofi US
@SanofiUS
A start for the future.
We're partnering with @INROADS to create more than 40 summer intern positions, building pathways to careers for diverse talent in our communities. We’re proud to help empower our next generation of leaders. jobs.sanofi.us/university-us?sf258943611=1 #nationalinternday -
Sanofi US reposted
Sanofi
@sanofi
Our Q2 2022 Financial Results are now available. Read the press release: www.sanofi.com/en/media-room/press-releases/2022/2022-07-…
#sanofiresults $SAN $SNY -
Sanofi US
@SanofiUS
Parents, it’s about time to chat with your teens about the importance of MenACWY vaccination. Hear from @TiffaniThiessen and @IAmCattSadler about how you can help protect your teen at helpstoptheclock.org?sf258995714=1 #time2talkmeningitis
-
Sanofi US
@SanofiUS
This week marks the start of the 2022 @TransplantGames which bring together members of the transplant community, like Aimee, for some fun and friendly competition! Learn more about the Games and what they mean to Aimee. @Transplant_LF #tga2022sd www.sanofi.us/en/about-us/our-stories/making-a-difference…
-
Sanofi US
@SanofiUS
Building the next generation of scientists, together with @HowardU. Upon completion of their Post-Doctoral Pharmacy fellowship, ten graduate students will be considered for permanent full-time positions. Learn more about our partnership: www.news.sanofi.us/2022-07-26-Sanofi-partners-with-Howard…
-
Sanofi US
@SanofiUS
How do innovative solutions help reduce health inequities? Find out on August 2 when Adam Gluck, Head of U.S. Corporate Affairs, joins @SVInitiative , @Merck and @CDCFound to address challenges in access to healthcare. fsg.zoom.us/webinar/register/WN_laKoKcA9QOmHGB5F8xJk6Q?sf…
-
Sanofi US
@SanofiUS
Family comes first. At Sanofi, we provide inclusive benefits and resources, like 14 weeks of paid parental leave and access to employee resource groups such as Parents Connect, so parents can focus on their growing family. Learn more: jobs.sanofi.com/en?sf258748050=1. #parentsday
-
Sanofi US
@SanofiUS
Stories like Melanie’s are what fuel our commitment to help protect ALL babies from respiratory syncytial virus (#rsv).
Learn more about RSV and how you can help raise awareness of it at: rallyagainstrsv.com. #rallyagainstrsv
National Coalition for Infant Health
@InfantCoalition
#rsv places a real burden on families like Melanie's. 3 of her children were hospitalized because of RSV.
Watch her family's story here: www.youtube.com/watch?v=tw7bQbkCeAc
#rallyagainstrsv #rsvawarenessThis media couldn't be displayed. See it on the original post. -
Sanofi US
@SanofiUS
Representation matters at all levels of medicine. That’s why we’re working with @NovartisUS to address racial disparities and increase opportunities for historically marginalized groups, especially in clinical trial participation. Learn more at www.news.sanofi.us/2022-07-21-Sanofi-joins-Beacon-of-Hope…
-
Sanofi US
@SanofiUS
All women deserve to feel supported at work. That's why we’re proud to be one of @Seramount's Best Companies for Multicultural Women in 2022, helping employees like Sade reach their leadership goals. Learn more: seramount.com/best-companies/2022-best-companies-for-mult… #seramountmcw
-
Sanofi US
@SanofiUS
When we say we support our employees, we mean ALL of them. A 100% on the Disability Equality Index makes us a Best Place to Work for Disability Inclusion—and proud to share stories of those living with disabilities, like Nancy’s: www.sanofi.us/en/about-us/our-stories/making-a-difference… #dei22 @DisabilityIN
-
Sanofi US
@SanofiUS
Flu season is around the corner—and we're starting to ship our flu vaccines to help everyone eligible stay protected from flu. At Sanofi, we remain committed to helping meet public health needs through our innovative flu vaccines. Learn more: www.fluzone.com?sf258590536=1.
-
Sanofi US
@SanofiUS
The @InfantCoalition explores the burden that #rsv poses for ALL babies, their families and our healthcare system in a recent white paper. Learn more about RSV, how it spreads and how to help prevent it: static1.squarespace.com/static/5523fcf7e4b0fef011e668e6/t… #rallyagainstrsv
National Coalition for Infant Health
@InfantCoalition
Nearly 58,000 infants and young children are hospitalized because of RSV each year.
Learn more about the burden of #rsv: static1.squarespace.com/static/5523fcf7e4b0fef011e668e6/t…
#rallyagainstrsv #rsvawareness -
Sanofi US
@SanofiUS
Eosinophilic esophagitis is a chronic inflammatory disease driven by type 2 inflammation. It can cause eating difficulties and other symptoms that can impact growth and development. Learn more about today’s news: bit.ly/3cdmMD @Regeneron
-
Sanofi US
@SanofiUS
We continue to push forward with our work to address the unmet needs of the #rareblooddisorders community. Our latest Phase 3 data has the potential to transform care through innovative science for people living with #hemophiliaa.
www.news.sanofi.us/Pivotal-data-demonstrate-once-weekly-e… -
Sanofi US
@SanofiUS
Today’s news: positive Phase 3 data for our #hemophilia A and B with or without inhibitors investigational therapy was presented just now at a medical meeting. More here:
www.news.sanofi.us/Fitusiran-prophylaxis-reduced-bleeds-b… -
Sanofi US
@SanofiUS
Older adults need protection this flu season. While the ACIP’s recommendation is a step in the right direction, more can be done. Learn about how our vaccines, which are more effective than the standard dose, can help protect older adults this flu season www.news.sanofi.us/2022-07-01-Sanofi-flu-vaccines-license…
Sanofi US
@SanofiUS
The flu is dangerous, especially for older adults and underrepresented communities. While the ACIP’s recent designation for preferred vaccines is helpful, more can be done so all adults, regardless of race or ethnicity, have clear guidance on the most effective flu vaccines.
-
Sanofi US
@SanofiUS
We wish you a safe and relaxing Independence Day. #fourthofjuly
-
Sanofi US
@SanofiUS
Pride Month is a time to celebrate and show acceptance – but for many, coming out can be a challenging road, especially at work. Learn more about Amelia’s story and how her team supported her at www.sanofi.us/en/about-us/our-stories/making-a-difference…
-
Sanofi US
@SanofiUS
We applaud the ACIP preferential recommendation for 65+ and are pleased to have two of our vaccines included that help better protect older adults from flu and its complications. Learn more about our two recommended vaccines at www.fluzone.com?sf257744351=1
-
Sanofi US
@SanofiUS
The ACIP has announced preferred flu shot guidance for adults 65+. Learn more about the importance of this decision and what this means to help protect our most vulnerable population from flu and its complications at www.news.sanofi.us/2022-06-22-Sanofi-Statement-on-ACIP-20…
-
Sanofi US
@SanofiUS
We’re recognizing the important work advocates are doing to address the burden of non-melanoma skin cancers including advanced basal cell carcinoma and advanced cutaneous squamous cell carcinoma. Read this thread to learn more. CC: @Regeneron. 1/4
Sanofi US
@SanofiUS
A #nonmelanoma #skincancer (NMSC) diagnosis may seem like just “skin cancer” but there can be more to it than meets the eye.
Visit @CancerSupportHQ for easy-to-follow resources on #nmsc, including advanced forms of the disease: www.cancersupportcommunity.org/skin-cancer CC: @Regeneron. 2/4
Sanofi US
@SanofiUS
Proactive skin checks can help with identifying #nonmelanoma #skincancer (NMSC) before it advances.
Check out Skin Cancer Education Research Fund’s website for tips on self-examinations and scheduling check-ins with a professional: skincancerinfo.org CC: @Regeneron. 3/4
Sanofi US
@SanofiUS
For more helpful resources on #nonmelanoma #skincancer, visit @Regeneron. 4/4
-
Sanofi US
@SanofiUS
2 out of 3 infants will have contracted respiratory syncytial virus (#rsv) by their first birthday. That’s why parents like Dr. Anna Zimmermann are speaking up to #rallyagainstrsv.
Watch Dr. Zimmermann’s story and join the Rally movement today. Visit www.beyfortus.com/us/what-is-rsv. -
Sanofi US
@SanofiUS
The flu is serious. In years past, it has caused health complications for tens of thousands of Americans. But we’re working towards a future to better protect the public from the flu. Learn more about a recent HCP survey on flu vaccines at www.news.sanofi.us/2022-06-21-Survey-Physicians-and-pharm…
-
Sanofi US
@SanofiUS
We’re proud to join the efforts to raise awareness during Cancer Immunotherapy Month™ hosted by @CancerResearch. By harnessing the power of a person’s immune system to attack cancer cells, we’re pursuing advances in immuno-oncology to help shape a new era in cancer treatment.
-
Sanofi US
@SanofiUS
Today is #juneteenth, a day recognizing the emancipation of enslaved Black Americans. We’re honoring the day by giving employees a day off to reflect, have conversations and engage with causes to promote greater equity.
-
Sanofi US
@SanofiUS
We want our employees to succeed and grow. That’s why we offer inclusive benefits and have employee resource groups, like PRIDE connect, to support LGBTQ+ employees in the U.S. all year round. 🏳️🌈
-
Sanofi US
@SanofiUS
Severe respiratory syncytial virus (#rsv) is unpredictable. We recently partnered with pediatric infectious disease expert Dr. Jaime Fergie to discuss why ALL infants need protection from RSV. Learn more @GoHealio: www.healio.com/resources/pediatrics/sanofi-for-rsv?sf2572… #rethinkrsv
-
Sanofi US
@SanofiUS
This June marks the tenth annual Cancer Immunotherapy Month™, hosted by @CancerResearch. We’re committed to leveraging our deep expertise in immuno-oncology to develop new potential medicines for people living with cancer. #cim22 #immune2cancer
-
Sanofi US
@SanofiUS
More than 75,000 children less than 6 years of age in the US have uncontrolled moderate-to-severe #atopicdermatitis, a chronic, debilitating skin condition. Learn about the FDA approval of our first-of-its-kind medicine for these young children. @Regeneron
-
Sanofi US
@SanofiUS
Changing someone’s start can change their entire future. We want to empower a future of possibilities for our communities. Learn more about our partnership with @JustAStartCorp www.news.sanofi.us/2022-06-07-Sanofi-unveils-new-900,000-…
-
Sanofi US
@SanofiUS
It’s not just a new campus. It’s a new start. See what the opening of our new campus at Cambridge Crossing means for the future of science, our community and our people. www.news.sanofi.us/2022-06-07-Sanofi-unveils-new-900,000-…
-
Sanofi US
@SanofiUS
A new address. A new campus. A new promise of what the future will bring. Learn about our new center of innovation and what it could mean in our pursuit to chase the miracles of science to improve people’s lives: jobs.sanofi.us/CambridgeCrossing?sf257050836=1
-
Sanofi US
@SanofiUS
Years of planning and 30M pounds of concrete later, a dream has come to life. As we move into a new collaboration center, we also enter a new phase of discovery for patients, thanks to our hardworking team who brought the #onesanofi project to life. #iamsanofi
-
Sanofi US
@SanofiUS
We’re excited to announce @TiffaniThiessen as the spokesperson for our new campaign, It’s About Time, to help educate parents on #meningitis vaccination in collaboration with @NMAtweets. Visit helpstoptheclock.org?sf256923189=1 to learn more. #time2talkmeningitis
-
Sanofi US
@SanofiUS
Sustainability first, sustainability always. Our new campus at Cambridge Crossing is LEED Gold Certified and a demonstration of what’s possible for sustainable architecture.
-
Sanofi US
@SanofiUS
Our investigational #hemophilia A treatment received @US_FDA Breakthrough Therapy designation. It is the first factor VIII therapy to receive this recognition, and it aims to transform treatment expectations for people with hemophilia A: www.news.sanofi.us/2022-06-01-FDA-grants-efanesoctocog-al…
-
Sanofi US
@SanofiUS
We’re celebrating, and we’re listening – to challenges, experiences, dreams and inequities. #pridemonth is time for all to learn, share and feel accepted. #iamsanofi
-
Sanofi US
@SanofiUS
#prurigonodularis is a chronic type 2 inflammatory skin disease that causes extreme itch and skin lesions. @Regeneron. Read more about today’s news here: www.news.sanofi.us/2022-05-31-FDA-accepts-Dupixent-R-dupi…
-
Sanofi US
@SanofiUS
On Memorial Day, we pay tribute to those who bravely fought to protect our nation. Every day, we honor their memories. #memorialday.
-
Sanofi US
@SanofiUS
We support the mental health and well-being of our employees and their families. That is why we offer benefits in the U.S. that are designed to help them. #mentalhealthawarenessmonth
-
Sanofi US
@SanofiUS
Asthma and pertussis don’t mix—and contrary to what some believe, pertussis isn’t just a childhood disease. Adults with asthma are up to four times more likely to catch this highly contagious disease. #asthmaandallergyawarenessmonth
-
Sanofi US
@SanofiUS
For people living with eosinophilic esophagitis (EoE), excessive type 2 inflammation can lead to scarring and narrowing of the esophagus. Read more about how this underlying biological process affects disease progression: www.adventprogram.com/us
-
Sanofi US
@SanofiUS
At #ddw2022, we’re presenting data that highlights our efforts to address the impact of underlying type 2 inflammation on signs and symptoms of eosinophilic esophagitis. @Regeneron ddw.org?sf256469288=1
-
Sanofi US
@SanofiUS
Eosinophilic esophagitis (#eoe) is a painful, chronic, progressive type 2 inflammatory disease that damages the esophagus, creating substantial burden for patients in their everyday lives. Read the news about a new option for EoE: www.news.sanofi.us/2022-05-20-FDA-approves-Dupixent-R-dup… @Regeneron
-
Sanofi US
@SanofiUS
Eosinophilic esophagitis is a chronic, progressive disease that damages the esophagus and can make it difficult to swallow food. Learn more about a new option for patients aged 12 years and older with this challenging disease. www.news.sanofi.us/2022-05-20-FDA-approves-Dupixent-R-dup… @Regeneron
-
Sanofi US
@SanofiUS
Help protect yourself against #pertussis by talking to your doctor about the Tdap vaccine. Vaccination has been shown to be more than 80% efficacious at preventing severe pertussis disease.
American Lung Association
@LungAssociation
“If adults with underlying lung diseases, such as #asthma, get pertussis, their underlying #lungdiseases may become so severe they may be hospitalized & even fighting for their lives.”- Dr. Galiatsatos. How do you protect yourself? By getting vaccinated.
This media couldn't be displayed. See it on the original post. -
Sanofi US
@SanofiUS
We look forward to sharing new investigational data from our expanding #oncology portfolio at #asco22. Learn more about our innovative research here: www.news.sanofi.us/2022-05-17-New-data-from-fast-growing-…
-
Sanofi US
@SanofiUS
We're announcing the latest positive results from a Phase 3 study of our therapy for relapsed #multiplemyeloma. Read more here: www.news.sanofi.us/2022-05-15-Sarclisa-R-isatuximab-irfc-… #mmsm
-
Sanofi US
@SanofiUS
Asthmatics are at 4x greater risk of contracting pertussis. Our new series, “The Doc is In,” explains how to help protect against this contagious disease. #asthmaandallergyawarenessmonth. #vaccineswork #asthma www.sanofi.us/en/about-us/our-stories/making-a-difference…
-
Sanofi US
@SanofiUS
We believe in creating a culture where diversity, equity and inclusion is always top of mind. And @DiversityInc recognized our efforts by naming us #25 in their list of “Top 50 Companies for Diversity.” Learn more at: www.diversityinc.com/diversityinc-top-50-2022/ #ditop50
-
Sanofi US
@SanofiUS
During National Asthma & Allergy Awareness Month, we are encouraging families with asthma to visit www.thenextbreath.com?sf256032388=1 to learn more about #asthma and its underlying causes. Together, let’s share our #asthmastrong stories so that better asthma control is the new #asthma norm.
-
Sanofi US
@SanofiUS
As summer approaches, stories like James’ are a reminder that advanced #nonmelanoma #skincancers like Cutaneous Squamous Cell Carcinoma (CSCC) can become serious. #skincancerawarenessmonth
-
Sanofi US
@SanofiUS
In our first episode of “The Doc Is In,” Dr. Corey Robertson talks about how you can help protect your kids from meningococcal disease. Watch here: www.sanofi.us/en/about-us/our-stories/making-a-difference… #vaccineswork
-
Sanofi US
@SanofiUS
One of our newest employee resource groups (ERG), APEX, is giving AAPI employees a seat at the table to bring attention to, and find solutions for, challenges facing the community. Stay tuned throughout the month as we highlight AAPI groups and voices #apahm #iamsanofi
-
Sanofi US reposted
Sanofi
@sanofi
Our CEO Paul Hudson reflects on our Q1 2022 performance, the progress we’ve made on our CSR strategy and our key achievements in R&D transformation.
Learn more: www.sanofi.com/en/media-room/press-releases/2022/2022-04-…
#sanofiresults $SAN $SNY -
Sanofi US reposted
Sanofi
@sanofi
Our Q1 2022 Financial Results are now available. Read the press release: www.sanofi.com/en/media-room/press-releases/2022/2022-04-…
#sanofiresults $SAN $SNY -
Sanofi US
@SanofiUS
We slow down the spread of infectious diseases the best way we know how: by developing vaccines. Hear the #soundsofsanofi as our scientists work to develop crucial vaccines and find breakthrough treatments soundcloud.com/sanofius/sets/the-sounds-of-sanofi?sf25520…
-
Sanofi US
@SanofiUS
In recognition of #worldimmunizationweek, Dr. Michael Greenberg discusses the importance of routine vaccination and the launch of our new video series, "The Doc Is In:” www.sanofi.us/en/about-us/our-stories/making-a-difference… #vaccineswork
-
Sanofi US
@SanofiUS
As we kick off National Infant Immunization Week, make it a priority to ensure that infants and young children are up to date on all routinely recommended #vaccines. #niiw #cdc www.cdc.gov/vaccines/events/niiw/overview.html?sf255840897=1
-
Sanofi US
@SanofiUS
Treating rare diseases means finding rare solutions. Hear how we’re developing transformative medicines to fight these diseases at soundcloud.com/sanofius/sets/the-sounds-of-sanofi?sf25520… #soundsofsanofi
-
Sanofi US
@SanofiUS
Thank you @InfantCoalition for joining us in the fight to help protect ALL infants from RSV. Read their paper to learn why emerging preventive options for RSV should be included in the CDC’s Vaccines for Children program: static1.squarespace.com/static/5523fcf7e4b0fef011e668e6/t… #rallyagainstrsv
National Coalition for Infant Health
@InfantCoalition
For infants and young children, monoclonal antibodies can provide protection from #rsv. To make sure all infants have access, they should be included in @CDCgov's Vaccines for Children program.
Read the paper to learn more: static1.squarespace.com/static/5523fcf7e4b0fef011e668e6/t…
#rsvawareness #rallyagainstrsv -
Sanofi US
@SanofiUS
Our favorite sounds are the sounds of discovery. Read through @Endpts’s latest article to learn more about the #soundsofsanofi and how we’re showcasing our latest research with ASMR.
Endpoints News
@endpts
Spinning pills, liquid pouring and machines whirring resonate across 6 audio tracks on the “Sounds of Sanofi” SoundCloud playlist — in what may be pharma’s first foray into the ASMR trend.
endpts.com/sounds-of-sanofi-pills-spinning-machines-whirr… -
Sanofi US
@SanofiUS
At Sanofi, we’re discovering the future of medicine today. Our technology, like the microcentrifuge heard here, is helping to usher in a new age in treatment. Listen to more of our sounds of innovation: soundcloud.com/sanofius/sets/the-sounds-of-sanofi?sf25520… #soundsofsanofi
-
Sanofi US
@SanofiUS
Increasing supplier diversity means working with more companies owned by groups that have historically been underrepresented. Learn about our commitment to diversity and inclusion and how we’re taking on @WEConnection's “Rising To The Challenge” at rb.gy/d6lgmo
-
Sanofi US reposted
Sanofi
@sanofi
Excited to share the publication of our @NEJM Phase 1/2 data in #itp, a rare bleeding disorder where there are currently no approved treatments. www.sanofi.com/en/media-room/press-releases/2022/2022-04-…
-
Sanofi US
@SanofiUS
We make solutions to find solutions. Here, our scientists are preparing a solution for our NANOBODY® technology platform, a revolutionary tool in drug discovery. Hear more of our #soundsofsanofi at soundcloud.com/sanofius/sets/the-sounds-of-sanofi?sf25520…
-
Sanofi US
@SanofiUS
This #internationalpompeday, we recognize the estimated 1 in 40,000 Americans who may face challenges receiving a #pompe disease diagnosis.
-
Sanofi US
@SanofiUS
Hear that? That’s the sound of ultra-purified water being prepared to create small molecule therapeutics for neurological diseases. This #internationalasmrday, listen to more of the #soundsofsanofi playlist at soundcloud.com/sanofius/sets/the-sounds-of-sanofi?sf25521…
-
Sanofi US
@SanofiUS
Destress and unwind with the #soundsofsanofi for Stress Awareness Month. Our sounds are not only soothing, but also feature groundbreaking discoveries. Hear us uncover the miracles of science at soundcloud.com/sanofius/sets/the-sounds-of-sanofi?sf25520…
-
Sanofi US
@SanofiUS
Respiratory syncytial virus (#rsv) is a very contagious virus that can lead to serious respiratory illness for infants; that’s why it’s so important to be able to recognize the signs and symptoms.
Visit lung.org/RSV to learn more. #rallyagainstrsv
American Lung Association
@LungAssociation
Know the signs and symptoms for #rsv that may indicate a worsening illness and when to contact your #healthcare provider. lung.org/RSV #rallyagainstrsv
-
Sanofi US reposted
Sanofi
@sanofi
Today, we’ve launched our own #diversity, #equity & #inclusion Board with 3 outside advisors to keep us on track towards our 2025 DE&I goals.
Our first act together? Creating an Employee Resource Group framework, which will allow already existing local ERGs to scale and grow! 🌱 -
Sanofi US
@SanofiUS
The U.S. FDA has accepted for priority review our sBLA to evaluate our medicine for use in patients aged 12 years and older with eosinophilic esophagitis, a type 2 inflammatory disease that can make eating a difficult experience. www.news.sanofi.us/press-releases?item=137353&sf255188154=1 @Regeneron
-
Sanofi US
@SanofiUS
At #aad2022, we are presenting late-breaking Phase 3 data from a pivotal trial of our investigational medicine in patients with uncontrolled #prurigonodularis. Learn more: www.news.sanofi.us/2022-03-26-Late-breaking-Phase-3-data-… @Regeneron
-
Sanofi US
@SanofiUS
Women are paving a new future in healthcare. They're leading change, performing for patients and inspiring their teams. We're thankful to have Cristina, Sarah and Amber's leadership at Sanofi. Learn more about their @HBAnet recognition. #hbaimpact
-
Sanofi US
@SanofiUS
For six consecutive years, we’ve lowered the average net price of our U.S. medicines portfolio. Why do patient out-of-pocket costs continue to rise? Read our 2022 Pricing Principles Report to learn about steps we are taking as a health care system to help lower patient costs.
-
Sanofi US
@SanofiUS
Tune in at #aad2022 where we will be sharing more than 20 abstracts with new or emerging research in three dermatological diseases where type 2 inflammation may play a role. @Regeneron
-
Sanofi US
@SanofiUS
Though peak respiratory syncytial virus (#rsv) season is ending soon, it always helps to be prepared by knowing the signs & symptoms of RSV and how to potentially prevent it. Knowledge is power: join our #rallyagainstrsv by learning more about this virus: lung.org/RSV
American Lung Association
@LungAssociation
The peak season for #rsv infection in the United States is Fall through Spring. It is spread from person to person through close contact with someone who is infected via secretions from coughing, sneezing or touching objects. lung.org/RSV #rallyagainstrsv
-
Sanofi US
@SanofiUS
When her daughter became sick with respiratory syncytial virus (#rsv), Dr. Anna Zimmermann was glad that she knew how to recognize the signs and symptoms.
Read her full story on @AP and learn why raising awareness of RSV is so important: apnews.com/direct/?prx_t=xWEHAAAAAAniAPA&prx_ro=s&sf25448… #rallyagainstrsv -
Sanofi US
@SanofiUS
Every year, Sanofi provides free medicines to thousands of patients to help alleviate cost burdens so they can get the treatments they need. Policymakers can help patients, too. Learn more about the patient-centered care we provide in our latest report.
-
Sanofi US
@SanofiUS
Amy’s love of science started young, and today she uses it to honor her father’s memory. Learn more about her story at www.sanofi.us/en/about-us/our-stories/science-and-solutio… #womeninstem #iamsanofi #womenshistorymonth
-
Sanofi US
@SanofiUS
There is a nationwide issue with patients facing challenges in getting medicines they need. Learn more about what we’re doing to help address this issue in our 2022 Pricing Principles report.
-
Sanofi US
@SanofiUS
For better outcomes. For better care. For a world where all those living with chronic conditions are supported. We work continuously to help patients and improve immunization rates, and we’re thankful @theAMGA has acknowledged us as a leader in the space. amga.org/about-amga/amga-newsroom/press-releases/031122/?…
-
Sanofi US
@SanofiUS
It is so important to educate families about respiratory syncytial virus (#rsv) signs, symptoms and when to escalate care.
Help protect ALL infants from RSV. Visit lung.org/RSV to learn more. #rallyagainstrsv
American Lung Association
@LungAssociation
#rsv (Respiratory Syncytial Virus) is the leading cause of hospitalizations in all infants. #knowthesigns. lung.org/RSV #rallyagainstrsv
-
Sanofi US
@SanofiUS
We’re announcing positive topline data from a pivotal Phase 3 study for our novel, investigational factor VIII therapy for people living with #hemophilia A, a rare #bleedingdisorder caused by a deficiency of factor VIII. Read more: www.news.sanofi.us/2022-03-09-Efanesoctocog-alfa-met-prim…
-
Sanofi US
@SanofiUS
Globally, women only make up 29% of people working in STEM. That’s not enough. And our employees agree. That’s why they’ve gathered together to #breakthebias #sanofiallin #iwd2022
-
Sanofi US reposted
Sanofi
@sanofi
We’re shocked by the war in Ukraine and deeply saddened by the magnitude of the challenges facing the Ukrainian people. We’re focused on the safety of our employees and their families and maintaining our commitment to the patients and people we serve.
-
Sanofi US
@SanofiUS
We’re pleased to share @NEJM published results from a Phase 3 trial on an investigational option that may help protect ALL infants against #respiratorysyncytialvirus (RSV).
Read more: www.news.sanofi.us/2022-03-03-Nirsevimab-significantly-pr… #rsvawareness -
Sanofi US
@SanofiUS
We’re doing our part to help ensure patients receive the medications they rely on. Read our 2022 Pricing Principles Report to learn more.
-
Sanofi US reposted
Sanofi
@sanofi
This pandemic has forced healthcare companies to come together and work differently. What our industry has achieved for patients shows that this new way of working can help us reinvent healthcare as we know it. fortune.com/2022/02/22/pharmas-sense-of-urgency-must-outl… @FortuneMagazine
-
Sanofi US
@SanofiUS
More than 34,000 Americans are diagnosed with #multiplemyeloma each year. For #myelomaaction Month, we’re joining @IMFmyeloma to spotlight actions that the community impacted by this blood cancer can take to build resilience – learn how to get involved. mam.myeloma.org?sf253967985=1
-
Sanofi US
@SanofiUS
As part of our mission to reverse the course of chronic diseases, we’re excited to announce our collaboration with @DarioHealth, a leader in global #digitaltherapeutics.
DarioHealth™
@DarioHealth
Under the strategic partnership, $DRIO & @SanofiUS will collaborate on promoting the Dario multi-condition #digitaltherapeutics solution, significantly increasing Dario’s sales reach in the health plan market & selectively in the employer channel. dariohealth.investorroom.com/2022-03-01-DarioHealth-Enter… $SNY
-
Sanofi US
@SanofiUS
More women should be in STEM because they deserve to be there. It’s really that simple. Follow along throughout #womenshistorymonth to see how we’re highlighting and supporting our #womeninstem #iamsanofi
-
Sanofi US
@SanofiUS
In recognition of #rarediseaseday we’re shining a light on the unique voices of the rare disease community. Meet Sandra, a non-profit professional living with a rare muscle disorder, Pompe disease, and hear her outlook for the future. #meettheunmet
-
Sanofi US
@SanofiUS
#bhm is about reflecting on cornerstones of the Black experience in America, but it’s also about uniting to continue to fight for change. Follow our thread for updates on how we’re recognizing the month and reaffirming our ongoing commitment to the Black community.
Sanofi US
@SanofiUS
Kat is leading BOLD on a mission: to better the Black experience. At Sanofi, that means continuing our work to improve HBCU representation, support Black employees, and increase diversity for clinical trials and suppliers.
Post not available here, view on X
Sanofi US
@SanofiUS
Living legend Dr. Marilyn Hughes Gaston changed sickle cell disease care and helped change the lives of countless people. We’re thankful for the paths she’s blazed and fortitude she’s shown. #blackhistorymonth
Sanofi US
@SanofiUS
Black excellence should be celebrated – this month and every month. Dr. David Kombo is an instrumental leader who has advanced science for decades. We’re grateful for his guidance and his advancements. #blackhistorymonth
-
Sanofi US
@SanofiUS
With @Regeneron, we’re presenting positive late-breaking data for our investigational medicine in eosinophilic esophagitis, a chronic and progressive disease that damages the esophagus. Learn more about our research at #aaaai22: www.news.sanofi.us/2022-02-26-Late-breaking-data-at-2022-…
-
Sanofi US
@SanofiUS
With @Regeneron, we’re sharing late-breaking pivotal data at #aaaai22 for our investigational medicine in chronic spontaneous urticaria. Learn more: www.news.sanofi.us/2022-02-26-Late-breaking-phase-3-data-…
-
Sanofi US
@SanofiUS
Through our continued partnership with @BARDA, we can help ensure preparedness measures are in place to help reduce the impact of the flu and its complications.
BARDA
@BARDA
We’re continuing our industry partnerships to help maintain readiness of #medicalcountermeasures for pandemic #flu. Together, we’re bolstering & modernizing U.S. pandemic preparedness capabilities to rapidly respond to novel #influenza outbreaks. www.medicalcountermeasures.gov/newsroom/2022/panfluprepar…
-
Sanofi US
@SanofiUS
We are proud to work with the @NFIDvaccines to help raise awareness about RSV, the leading cause of hospitalization in infants under 12 months. Check out the NFID’s full report on RSV to learn more: www.nfid.org/wp-content/uploads/2022/01/NFID-RSV-Call-to-… #rallyagainstrsv
NFID
@NFIDVaccines
#nfid Urges Action to Reduce Burden of Respiratory Syncytial Virus #rsv in the US www.prnewswire.com/news-releases/national-foundation-for-…
-
Sanofi US
@SanofiUS
We’re committed to advancing the standard of care for people living with #multiplesclerosis and are excited to share the latest research on our investigational BTK inhibitor for MS at #actrims: www.sanofi.com/en/media-room/press-releases/2022/2022-02-…
-
Sanofi US
@SanofiUS
All flu vaccines aren’t created equal. Without clear guidance, health disparities will continue to grow, especially for older adults. Learn how clear flu vaccine recommendations could help save lives.
-
Sanofi US
@SanofiUS
We are committed to help protect ALL infants from respiratory syncytial virus (RSV). 23 years after her son was hospitalized with RSV, Sanofi’s Robin Johnson is still dedicated to raising awareness.
Read Robin’s story and learn why we #rallyagainstrsv www.sanofi.us/en/about-us/our-stories/making-a-difference… -
Sanofi US
@SanofiUS
When type 2 inflammatory diseases are present throughout your family, daily life can be uniquely challenging. Joana copes with atopic dermatitis in her family, while Kara manages the impact of eosinophilic esophagitis.
Learn how type 2 inflammation can impact families. -
Sanofi US
@SanofiUS
Older adults are at a higher risk of flu-related complications, and they need proven protection. See how the Advisory Committee on Immunization Practices could be crucial in addressing the issue: www.sanofi.us/en/about-us/our-stories/science-and-solutio…
-
Sanofi US
@SanofiUS
Our commitment to the #asmd community is strong. We’re encouraged by this latest milestone, and we will never stop trying to deliver potential treatment options for #rarediseases.
-
Sanofi US
@SanofiUS
We’re announcing that the U.S. FDA has accepted for priority review the sBLA for our medicine as an add-on maintenance treatment for children aged 6 months to 5 years with uncontrolled moderate-to-severe #atopicdermatitis. Learn more: www.news.sanofi.us/2022-02-10-FDA-accepts-Dupixent-R-dupi… @Regeneron
-
Sanofi US
@SanofiUS
While we may have a new logo, one thing remains unchanged – our commitment to patients. See how we’ve evolved this year to come together as one Sanofi: www.sanofi.com/en/our-company/our-strategy?sf253440171=1
-
Sanofi US
@SanofiUS
The FDA approved the first treatment for use in people living with #coldagglutinindisease, a rare #blooddisorder that destroys healthy red blood cells: www.news.sanofi.us/2022-02-04-FDA-approves-Enjaymo-TM-sut…
-
Sanofi US
@SanofiUS
More than 235,000 people are diagnosed with lung cancer in the U.S. each year, and behind each case is a story of resilience and hope. Don’s story reminds us of the progress that has been made and the work that is still needed to improve the lives of patients. #worldcancerday
-
Sanofi US
@SanofiUS
Hear more from Chris Sarchi, U.S. Head of Oncology, about how we can work together to unite efforts, elevate voices and facilitate dialogue to help #closethecaregap for people living with cancer this #worldcancerday
-
Sanofi US reposted
Sanofi
@sanofi
Our Q4 and Full Year Financial Results are now available. Read the press release: www.sanofi.com/en/media-room/press-releases/2022/2022-02-…
#sanofiresults $SAN $SNY -
Sanofi US
@SanofiUS
Why has our logo changed?
Because we have changed.
Despite having different pasts, and traveling different paths, we've arrived at a new shared purpose:
We chase the miracles of science to improve people’s lives. #weneversettle
Learn more: www.sanofi.com/en/our-company/our-strategy?sf253287986=1 -
Sanofi US
@SanofiUS
We’re sharing new analyses of our medicine with @Regeneron being investigated in diseases with type 2 inflammation. Learn more about our research at #aaaai22: www.news.sanofi.us/2022-02-01-Positive-Dupixent-R-dupilum…
-
Sanofi US
@SanofiUS
With @Regeneron, we provided a regulatory update in advanced cervical cancer. www.news.sanofi.us/2022-01-28-Sanofi-and-Regeneron-provid…
-
Sanofi US
@SanofiUS
We believe everyone should always be able to be themselves. That’s why we build a culture to support all of our employees, and we appreciate the @HRC for recognizing us as a “Best Place to Work for LGBTQ Equality.” Learn more at www.hrc.org/resources/corporate-equality-index?sf253111034=1 #cei2022
-
Sanofi US
@SanofiUS
Asthma. Atopic dermatitis. Eosinophilic esophagitis. Chronic rhinosinusitis with nasal polyps. These different diseases have something in common. Learn about type 2 inflammation—and how better understanding can lead to important connections: www.understandtype2inflammation.com?sf252767656=1 @Regeneron
-
Sanofi US
@SanofiUS
Together with @Regeneron, we’re announcing positive topline data from our second pivotal trial in adults with #prurigonodularis, a chronic inflammatory skin disease that causes extreme itch. Learn more.
-
Sanofi US
@SanofiUS
Underlying type 2 inflammation may be present, even when symptoms are not. By learning more about type 2 inflammation, people can better understand their disease(s) and find different paths forward. @Regeneron
-
Sanofi US
@SanofiUS
Berkeley Research Group: More than half of brand medicine spending goes to the supply chain and others. Read more from @PhRMA.
PhRMA
@PhRMA
The amount hospitals, pharmacies and other health care providers receive from the sale of brand medicines reached $81 billion last year, up from $24.7 billion in 2013. Learn more on how the supply chain affects the cost of medicines: onphr.ma/3FbNBAQ
-
Sanofi US
@SanofiUS
When life doesn’t go as planned, Daniel Buckelew stays patient. 11 years after his MS diagnosis, Daniel reached his goal of running the Boston Marathon. He inspires us to enter 2022 with patience, positivity and determination. Read more at www.sanofi.us/en/about-us/our-stories/making-a-difference… #iamsanofi
-
Sanofi US
@SanofiUS
The new year is a great time to prioritize routine #vaccinations and #immunizations. Learn more. #returntoroutine #healthcare
-
Sanofi US
@SanofiUS
The holidays are a time to celebrate and reflect. We’re grateful to our Sanofi family for all they do to help patients each day. #iamsanofi
-
Sanofi US
@SanofiUS
Our peer-nominated 2021 Social Impact Award winners go above & beyond in supporting our #csr pillars: health equity, STEM education equity and local people & priorities. Check out our superstar winners! #sanofiacts www.sanofi.us/en/about-us/our-stories/making-a-difference…
Sanofi US
@SanofiUS
Rabiya Kader is the recipient of our 2021 Tony Whalen Mentorship Award. Her work in transforming our legal internship program to include people with more diverse backgrounds exemplifies our dedication to inclusion. #sanofiacts www.sanofi.us/en/about-us/our-stories/making-a-difference…
Post not available here, view on X
Sanofi US
@SanofiUS
Michael Phipps has been working for years to expand Sanofi’s efforts to mentor and empower youth in STEM, and it’s taught him a thing or two in the process. Take a look: www.sanofi.us/en/about-us/our-stories/making-a-difference… #sanofiacts
Sanofi US
@SanofiUS
We’re lucky to have countless employees who go above and beyond for their local communities. Watch here to learn what drives George, Marcus, Kristen, and Katie to go above and beyond for those around them. #sanofiacts www.sanofi.us/en/about-us/our-stories/making-a-difference…
-
Sanofi US
@SanofiUS
2021 was unlike any other year. So we had to be unlike any other company. See how we spent our time.
This media couldn't be displayed. See it on the original post. -
Sanofi US
@SanofiUS
We’re excited to partner with @LungAssociation
to educate expectant mothers and parents of infants and toddlers about how to help protect ALL infants from respiratory syncytial virus (#rsv). Learn more: lung.org/RSV -
Sanofi US
@SanofiUS
Everyone deserves a festive holiday season. Sanofi employees from across the country came together this year to make a difference. And we matched their efforts. Together, we helped donate over 12,000 gifts to families in need. #sanofiacts.
-
Sanofi US reposted
Sanofi
@sanofi
With @GSK we’re announcing that the #booster study of our #covid19 vaccine candidate demonstrates strong immune responses regardless of the primary vaccine received, with a good safety and tolerability profile.
Read more: www.sanofi.com/en/media-room/press-releases/2021/2021-12-… -
Sanofi US
@SanofiUS
At #rad2021, we’re presenting data with @Regeneron from our pivotal Phase 3 trial in children aged 6 months to 5 years with uncontrolled moderate-to-severe #atopicdermatitis. Learn more: www.news.sanofi.us/2021-12-13-Positive-Phase-3-Dupixent-R…
-
Sanofi US
@SanofiUS
Learn more about our latest investigational data in #rareblooddisorders that aims to transform the treatment landscape through innovative scientific advancements at The American Society of Hematology Annual Meeting and Exposition: www.hematology.org/meetings/annual-meeting
-
Sanofi US
@SanofiUS
Pivotal data for our medicine in children aged 6 to 11 years with uncontrolled moderate-to-severe #asthma have been published in @NEJM. As one of the most common chronic diseases among children, its symptoms can impact a child’s life. Read more www.news.sanofi.us/2021-12-08-New-England-Journal-of-Medi… @Regeneron
-
Sanofi US
@SanofiUS
It’s not too late to do your part to help #fightflu. During #nivw2021, Sanofi’s Dr. Michael Greenberg explains why there’s never been a more important time to ensure you’re up to date on your flu shot. #nivw #fluvaccine
-
Sanofi US
@SanofiUS
Help inspire children with eczema by using "My ECZ-ellent Day at Camp," an eBook by Tracee Blackburn in collaboration with Understand AD that follows Taylor, a child with eczema who wants to enjoy summer camp. Made in partnership with @Regeneron and @NationalEczema
-
Sanofi US
@SanofiUS
We’re excited to join the scientific community at #sabcs21 to share how we’re working to advance research and raise awareness about #metastaticbreastcancer. Follow along to hear about the economic, emotional and social toll this disease has on patients: www.mbcunfiltered.com?sf251909058=1
-
Sanofi US
@SanofiUS
Join us today at 12pm ET for a #fluchat with @greenbergepi, the @flucoalition and others to discuss how we can all help #fightflu this holiday season. #nivw
-
Sanofi US
@SanofiUS
We're proud of our continued commitment to improving STEM education for all students! We look forward to another year of the #stemcareerscoalition and working with @DiscoveryEd to connect diverse learners to the #futureofwork.
Discovery Education
@DiscoveryEd
We're thrilled to celebrate two years of STEM pipeline impact through the #stemcareerscoalition! Our dynamic, no-cost resources have reached over 4.5M students as we aim to build the next generation of diverse STEM solution-seekers. www.discoveryeducation.com/details/the-stem-careers-coali…
-
Sanofi US
@SanofiUS
There are millions of reasons to be grateful for the discovery of insulin. For the 100-year anniversary, we’re highlighting “100 Reasons Why” in a new storybook featuring stories from people impacted by #diabetes. Read them here: www.sanofi.us/en/about-us/our-stories/making-a-difference…
Sanofi US
@SanofiUS
A #diabetes diagnosis can be life-altering – and lifesaving. The first chapter of our “100 Reasons Why” storybook features 10 first-hand accounts from people living with diabetes on the day they were diagnosed. Read them here: www.sanofi.us/en/about-us/our-stories/making-a-difference…
Sanofi US
@SanofiUS
While there are major milestones in life that many of us look forward to, some face moments they never expected, like a diabetes diagnosis. The second chapter of our "100 Reasons Why" storybook focuses on more stories about that important day: www.sanofi.us/en/about-us/our-stories/making-a-difference…
Sanofi US
@SanofiUS
The third chapter of our “100 Reasons Why” storybook is here and features new stories from people who have found a silver lining living with #diabetes: www.sanofi.us/en/about-us/our-stories/making-a-difference…
Sanofi US
@SanofiUS
Before insulin, the future for people living with diabetes was unclear. A century later, people living with diabetes reflect on the importance of this life-saving medicine and their experiences with it. Read more in the fourth chapter of “100 Reasons Why”: www.sanofi.us/en/about-us/our-stories/making-a-difference…
Sanofi US
@SanofiUS
Before insulin, the future for people living with diabetes was unclear. A century later, people living with diabetes reflect on the importance of this life-saving medicine and their experiences with it. Read more in the fourth chapter of “100 Reasons Why”: www.sanofi.us/en/about-us/our-stories/making-a-difference…
Sanofi US
@SanofiUS
In the sixth chapter of the “100 Reasons Why” storybook, we share a creative look through poetry at what insulin means to people living with diabetes. Read the collection of poems here: www.sanofi.us/en/about-us/our-stories/making-a-difference…
Sanofi US
@SanofiUS
There’s no doubt that a positive attitude is powerful. In the seventh chapter of the “100 Reasons Why” storybook, 12 people prove just how crucial optimism in the face of a difficult diagnosis can be. Read more about the power of positive thinking here: www.sanofi.us/en/about-us/our-stories/making-a-difference…
Sanofi US
@SanofiUS
In the eighth chapter of the “100 Reasons Why” storybook, we hear what 14 individuals would say to the scientists who made the game changing discovery of insulin. Read these personalized – and often emotional – messages here: www.sanofi.us/en/about-us/our-stories/making-a-difference…
Sanofi US
@SanofiUS
Looking back at the previous chapters of the “100 Reasons Why” storybook, we’ve seen just how deeply the discovery of insulin has impacted people's lives. In the ninth and final chapter, we at Sanofi reflect on what it means to us: www.sanofi.us/en/about-us/our-stories/making-a-difference…
-
Sanofi US reposted
Sanofi
@sanofi
We’re live at our #sanofivaccines Investor Event where CEO Paul Hudson shares his outlook on #vaccines: “We’re confident that vaccines will remain a resilient and sustainable contributor to our growth.”
Follow this thread for more live tweets 👇 -
Sanofi US reposted
Sanofi
@sanofi
Today, at our Vaccines Investor Event, we’re sharing our #vaccines strategy for growth and kicking off a new chapter with the exciting advancement of our R&D pipeline. #sanofivaccines
-
Sanofi US
@SanofiUS
We know how priceless time with loved ones can be. Our new 14-week paid parental leave policy supports Sanofi’s commitment to equity and gives all employees, regardless of gender or sexual orientation, more time off to bond. Learn more: www.news.sanofi.us/2021-11-30-Sanofi-offers-all-employees…
-
Sanofi US
@SanofiUS
Infectious diseases don’t scare us. They motivate us. For R&D Week, see how our tireless vaccine research efforts have helped us face these diseases head on and make a difference: www.sanofi.com/en/our-science/therapeutic-areas/vaccines-…
-
Sanofi US
@SanofiUS
From our Sanofi family to you and yours, we wish you a happy and hearty #thanksgiving.
-
Sanofi US
@SanofiUS
We’re proud to stand alongside @LUNGevity and the lung cancer community to recognize #lungcancerawarenessmonth – including amplifying the importance of continuing research to help better understand the complex needs of these patients. #lcsm #changelungcancer
LUNGevity Foundation
@LUNGevity
It’s officially #lungcancerawarenessmonth! This #lcam, we are increasing general awareness about lung cancer and highlighting the hope that comes from progress in research.
Join us along with the entire community to take action and #changelungcancer this November. #lcsm -
Sanofi US
@SanofiUS
Their commitment has been tireless and their impact has been felt by many. Public health workers, including immunization workers, have made all the difference in helping to keep us safe. Join us in celebrating them this Public Health Thank You Day. #phtyd
AIM
@AIMimmunization
Happy #publichealth Thank You Day! Please join us in celebrating our #immunization program managers and staff by checking out our Thank You Video! Take the time today to thank a #publichealth worker for all they do! vimeo.com/648565481
-
Sanofi US
@SanofiUS
Insulin changed the course of #diabetes treatment 100 years ago. Our expert, Dr. Luigi Meneghini, envisions what technology and innovation can soon offer patients: www.sanofi.us/en/about-us/our-stories/making-a-difference…
-
Sanofi US reposted
Sanofi
@sanofi
We’re pleased to announce a new strategic collaboration and equity investment with @OWKINscience to expand insights in translational #oncology through #ai and #machinelearning: www.sanofi.com/en/media-room/press-releases/2021/2021-11-…
-
Sanofi US
@SanofiUS
How do you continue to foster inclusivity? By learning, listening, and growing. We launched #inclusionmonth on Oct. 12 to create spaces for conversations about complex topics. See how we promote inclusivity throughout the year at www.sanofi.us/en/corporate-responsibility/diversity-and-i… #onesanofi #allin
-
Sanofi US
@SanofiUS
Our goal? To empower employees every day and close gender gaps in the workplace. We're thankful to @Seramount for recognizing our work, and we will continue to create an environment where people at all levels can feel supported. Learn more at: www.sanofi.com/en/our-company/sustainability/inclusion/pe…
-
Sanofi US
@SanofiUS
The causes of the skin disease prurigo nodularis (PN) are not fully understood but are thought to involve interactions between the skin, the immune system (which may include type 2 inflammation) and the nervous system.
-
Sanofi US
@SanofiUS
It’s fitting that our fierce leader Carole Huntsman, Head of Sanofi Genzyme North America and US Country Lead, has been recognized as 2021’s Fiercest Women in Life Sciences by @FiercePharma. Learn more about why we are proud to call Carole our leader.
FiercePharma
@FiercePharma
Our 2021 Fiercest Women in Life Sciences special report is here. #wils2021 www.fiercepharma.com/special-report/women-life-sciences-2021
-
Sanofi US
@SanofiUS
The veterans of our country have given so much to protect us. We’re thankful for their service and thankful to have many of them as dedicated members of our team today. #veteransday #iamsanofi
-
Sanofi US
@SanofiUS
#dyk adults with asthma are at 4x greater risk of contracting #pertussis? We’re partnering with @LungAssociation to generate awareness about the important role vaccination plays in helping protect against pertussis www.lung.org/lung-health-diseases/lung-disease-lookup/per…
American Lung Association
@LungAssociation
Now, more than ever, maintaining routine vaccinations during the pandemic is important to help protect against infectious respiratory diseases, including #pertussis. Speak with your healthcare provider about getting a #tdap vaccination. lung.org/Pertussis
-
Sanofi US
@SanofiUS
This month and all year long, we are committed to supporting those living with lung cancer.
-
Sanofi US reposted
-
Sanofi US
@SanofiUS
One day. A world of impact. Take time this Friday to get your flu shot. You can also help protect yourself and others from COVID-19 by getting your COVID-19 vaccine. Learn more at flushotfridays.com?sf250857392=1 #flushotfridays
-
Sanofi US
@SanofiUS
As a volunteer firefighter, Jim sees the people he saves. As a procurement buyer, Jim doesn’t get to see the patients he helps, but he knows his work with vendors to source materials contributes to the greater goal of helping patients we serve. #iamsanofi www.sanofi.us/en/about-us/our-stories/making-a-difference…
-
Sanofi US reposted
Sanofi
@sanofi
Our CEO Paul Hudson reflects on our Q3 2021 performance and shares our accelerated #climatetargets to become #carbonneutral by 2030 and reach #netzero emissions by 2050.
Learn more: www.sanofi.com/en/investors/financial-results-and-events/…
#sanofiresults #wecandomore -
Sanofi US reposted
Sanofi
@sanofi
Our Q3 Financial Results are now available. Read the press release: www.sanofi.com/en/media-room/press-releases/2021/2021-10-…
#sanofiresults $SAN $SNY -
Sanofi US
@SanofiUS
The flu can lead to more than just aches and pains. It can lead to health complications for many, including those with diabetes. Help protect yourself, your loved ones and your community this flu season.
-
Sanofi US
@SanofiUS
DYK: Respiratory syncytial virus (RSV) is the leading cause of hospitalization in infants under 12 months.
Learn more about how we must #rallyagainstrsv via Sanofi’s Dr. Chris Rizzo: www.sanofi.us/en/about-us/our-stories/making-a-difference… #rsvawarenessmonth -
Sanofi US
@SanofiUS
Our #stem careers partnership with @DiscoveryEd is showing students the real world applications of science and helping them see manufacturing in a new light. Check out the @access2equityed podcast with Sanofi’s Tony Primerano. ace-ed.org/building-manufacturing-into-stem-education/?sf… #mfgday21
-
Sanofi US
@SanofiUS
We’re honored to support @American_Heart and @DCRINews on CHANGE #afib, a clinical trial that will help determine if early antiarrhythmic treatment can improve outcomes in patients with first-detected AFib. Visit changeafib.org?sf250589399=1. #ourheartisinit
-
Sanofi US
@SanofiUS
Almost 170,000 women in the U.S. are living with #metastaticbreastcancer. This #breastcancerawarenessmonth, we’re spotlighting the courage of Beth and all people living with this disease. Hear Beth’s story and more unfiltered moments from the MBC community. #mbcunfiltered
-
Sanofi US
@SanofiUS
#dyk that any infant can be hospitalized in their first season due to respiratory syncytial virus (RSV)? This #rsvawarenessmonth, let’s #rallyagainstrsv and help protect all infants against this highly contagious virus.
-
Sanofi US
@SanofiUS
We’re announcing topline results from a pivotal trial in people with #eosinophilicesophagitis, a chronic type 2 inflammatory disease that damages the esophagus. cc @Regeneron
Read more: www.news.sanofi.us/press-releases?item=137335&sf250625345=1 -
Sanofi US
@SanofiUS
Certain racial and ethnic minority groups are less likely to get the flu shot and more likely to face complications associated with the flu. Help spread the word to your friends and family to encourage them to get the flu shot this year. Learn more at: flushotfridays.com?sf249786619=1
-
Sanofi US
@SanofiUS
As a manufacturing associate, Scott has been working with his team to create rare disease medications. Due to his persistence and the persistence of many, we know we can help countless people around the world. #nationalmanufacturingmonth #mfgday21
-
Sanofi US
@SanofiUS
With @Regeneron, we’re announcing positive Phase 3 results from our pivotal trial in adults with the chronic inflammatory skin disease #prurigonodularis. Read more: www.news.sanofi.us/2021-10-22-Dupixent-R-dupilumab-is-the…
-
Sanofi US
@SanofiUS
Need a resource to help explain the impact of eczema on kids? We partnered with @Regeneron, Tracee Blackburn and @NationalEczema as a part of Understand AD to tell the story of a child with eczema at summer camp. Read now to help understand kids like Taylor.
-
Sanofi US
@SanofiUS
We received FDA approval for our medicine in certain children aged 6-11 years with uncontrolled moderate-to-severe #asthma with @Regeneron. Read more: www.news.sanofi.us/2021-10-20-FDA-expands-approval-of-Dup…
-
Sanofi US
@SanofiUS
Be prepared for the flu this season. Know the flu facts, including how the flu shot can help protect those with chronic conditions like lung disease, heart disease, diabetes and asthma from flu-related complications.
-
Sanofi US
@SanofiUS
We’re LIVE! Let’s rally together to help keep all infants protected against respiratory syncytial virus #rsv #rallyagainstrsv
-
Sanofi US
@SanofiUS
October is #niemannpick Disease Awareness Month. A diagnosis of this #raredisease, also known as #asmd, is often missed. An accurate diagnosis is important because it can help unlock answers and provide guidance for those impacted. Learn more. #askaboutasmd
-
Sanofi US
@SanofiUS
Meet Ria, a manufacturing supervisor whose reliability over the past six years at Sanofi has helped countless patients. Her work helps power our team, and we’re grateful for her guidance. #nationalmanufacturingmonth #mfgday21
-
Sanofi US
@SanofiUS
Help slow the spread of the flu. The flu shot can help protect you, your loved ones and your community from the flu and flu-related complications. Find a flu shot near you: flushotfridays.com?sf249786526=1 #flushotfridays
-
Sanofi US
@SanofiUS
After a #metastaticbreastcancer diagnosis,
Shonte learned the importance of speaking openly about MBC to break the silence that can surround this life-altering disease. Hear more about her life with MBC. #breastcancerawarenessmonth #mbcunfiltered -
Sanofi US
@SanofiUS
October 13 is Metastatic Breast Cancer Awareness Day (#mbcday), and we’re raising awareness of the disproportionately poor prognoses Hispanic and Black women with MBC face. Learn more about by why barriers to treatment exist & how we plan to help address them. #mbcunfiltered
-
Sanofi US
@SanofiUS
Cutting-edge science needs cutting-edge facilities. Our manufacturing site in Framingham was built with sustainability in mind and is giving us flexibility to support personalized medicines. See how it’s helping us lead the way in innovation. www.sanofi.com/en/our-science/manufacturing-and-supply?sf…
-
Sanofi US
@SanofiUS
#dyk a person infected with #pertussis can transmit it to as many as 17 other people? In fact, adults with asthma are at an increased risk of complications from #pertussis. Learn more about how to help protect against this vaccine-preventable disease. pertussisawareness.com?sf250263135=1
-
Sanofi US
@SanofiUS
For Cristina, diversity and scientific innovation go hand in hand. After all, it powers our teams to think more critically and helps us deliver better solutions to our patients. #hispanicheritagemonth
-
Sanofi US
@SanofiUS
Positive results from the first co-administration study using our high-dose #influenza vaccine and @Moderna COVID-19 #vaccine booster dose.
-
Sanofi US
@SanofiUS
What are you waiting for? Get your flu shot! It can help prevent the flu and its complications, which is important for people 50+ and those with chronic conditions like asthma, diabetes and heart disease. Find a flu shot near you at: flushotfridays.com?sf249786480=1 #flushotfridays
-
Sanofi US
@SanofiUS
October is #breastcancerawarenessmonth, and we recognize the need to provide greater support for people living with advanced stages of the disease. Learn more about #metastaticbreastcancer and hear from individuals living with this advanced cancer. #mbcunfiltered
-
Sanofi US
@SanofiUS
In the U.S., 1.5 million people aged 12 years and older live with a chronic inflammatory skin disease called chronic spontaneous #urticaria (CSU). We are working to better understand this disease.
-
Sanofi US
@SanofiUS
It's not just celebrating a culture – it's celebrating community, traditions and family. How do you celebrate #hispanicheritagemonth?
-
Sanofi US
@SanofiUS
People living with #multiplemyeloma often feel scared or anxious at the time of diagnosis. At Sanofi, we are committed to empowering patients to face the challenges presented by their condition through education and support. #bloodcancerawarenessmonth
-
Sanofi US
@SanofiUS
In 2021, it is estimated that there will be more than 240,000 new cases of prostate cancer diagnosed. Early screening can play a critical role in treating the disease. Ask your doctor if screening is right for you. #prostatecancerawarenessmonth www.pcf.org/patient-support/screening/
-
Sanofi US
@SanofiUS
Make the most of your Friday. Get your flu shot and help protect yourself, your loved ones and your community from the flu and its potential complications. Find a flu shot near you today: flushotfridays.com?sf249784099=1 #flushotfridays
-
Sanofi US
@SanofiUS
Being a working parent shouldn't mean missing time with family. Ever. See how we support parents and learn about our recent awards from @Seramount for supporting Sanofi moms and dads. www.sanofi.us/en/about-us/our-stories/inside-sanofi/worki…
-
Sanofi US reposted
American Lung Association
@LungAssociation
From our newest Lungcast™ episode with @MDMagazine: Dr. Michael Greenberg of @SanofiUS and Dr. Rick Nettles of @JNJNews join our Chief Medical Officer to discuss respiratory virus immunization. Download and listen: lung.org/lungcast
-
Sanofi US
@SanofiUS
Helping protect people’s health around the world is at the core of what we do. Join us virtually @IDWeek2021 to learn more about our latest research contributing to advancing public health protection. #idweek2021 www.news.sanofi.us/2021-09-28-New-research-presented-at-I…
-
Sanofi US
@SanofiUS
Diverse backgrounds power diverse thinking. As a leader for our Hispanic Employee Resource Group, Leticia helps our team to think inclusively and empower more opportunities for Hispanic and Latinx communities. #hispanicheritagemonth
-
Sanofi US
@SanofiUS
#dyk adults living with asthma are at four times greater risk of contracting #pertussis? @sanofi’s Dr. Vitali Pool discusses the importance of doing our part for public health and helping prevent the spread of serious illness. www.sanofi.us/en/about-us/our-stories/making-a-difference…
-
Sanofi US
@SanofiUS
We have seen the importance of biopharma innovation throughout the #covid19 pandemic. As we continue to rebuild, we need to protect the policies that allowed us to develop treatments and vaccines. Read more: onphr.ma/3zv8C6w
-
Sanofi US
@SanofiUS
Jennifer Grey knows a thing or two about taking time for her health. Join her and get your flu shot. It’s the best way to help protect yourself and others from the flu and its complications. Find a flu shot near you: flushotfridays.com #flushotfridays
-
Sanofi US
@SanofiUS
As we continue to recognize #bloodcancerawarenessmonth, people like John empower us with their strength as they take on their disease. Hear more of John’s story and the resources we have for patients like him: www.mmjourneypartners.com/changing-treatments-video?sf249…
-
Sanofi US
@SanofiUS
#icymi: Our late-breaking #esmo21 presentation with @Regeneron featured new data on our investigational #immunotherapy with chemotherapy in first-line advanced #nonsmallcelllungcancer (#nsclc). Read our press release here: www.news.sanofi.us/press-releases?item=137330
-
Sanofi US
@SanofiUS
#prostatecancer is the second most common cancer in American men. Learn more about actions that can be taken that may lower the risk of prostate cancer: www.cancer.org/cancer/prostate-cancer/causes-risks-preven…
-
Sanofi US
@SanofiUS
Use this Friday as a day for yourself and your flu shot. It can help protect you, your loved ones and your community from the flu. Find a flu shot near you: flushotfridays.com?sf249450696=1 #flushotfridays
-
Sanofi US
@SanofiUS
This month and every month, we create a workplace where everyone can bring their true selves – their culture, identity and beliefs – to work. #hispanicheritagemonth
-
Sanofi US reposted
Sanofi
@sanofi
Our acquisition of @TranslateBio is now complete. We welcome Translate Bio to the Sanofi Family.
$SAN $TBIO
www.sanofi.com/en/media-room/press-releases/2021/2021-09-… -
Sanofi US
@SanofiUS
For people living with multiple myeloma, a stem cell transplant using your own cells may be necessary. Hear Jim’s story on our Multiple Myeloma Journey Partner site which includes resources for patients in similar situations: www.mmjourneypartners.com/stage-three-diagnosis-video #bloodcancerawarenessmonth
-
Sanofi US
@SanofiUS
As we continue to #rallyagainstrsv we are partnering with @ScaryMommy for an episode of “Live. Work. Thrive.” to help raise #rsvawareness & empower parents with important info to help them recognize respiratory syncytial virus.
Join us: www.scarymommy.com/live-events?sf249467779=1 -
Sanofi US
@SanofiUS
As Sydney shares in an article Sanofi sponsored in @HealthyWomen, she didn’t want to bother doctors about her symptoms. Her mother’s insistence may have saved her life. Now, she hopes to educate others about #attp: www.healthywomen.org/created-with-support/rare-blood-diso…
-
Sanofi US
@SanofiUS
20 years ago everything changed. Today, on 9/11, we remember all the lives we lost on that tragic day. #neverforget
-
Sanofi US
@SanofiUS
#dyk more than 32,000 Americans are diagnosed with #multiplemyeloma each year? This #bloodcancerawarenessmonth and all year long, we are focused on advancing treatment options for people living with this difficult-to-treat disease.
-
Sanofi US
@SanofiUS
On Wednesday 9/22 at 6 PM CT, @dallasmoms is going live on Facebook, featuring @NMAtweets, @MollyRingwald and other advocates. Learn how you can help protect your teens from meningococcal #meningitis. RSVP here: www.facebook.com/events/292008832756559?sf249283236=1 #the16vaccine
-
Sanofi US
@SanofiUS
For many men, living with #prostatecancer is a shared experience with a caregiver, and may affect the entire family. If you’ve been a caregiver, what’s one piece of advice you would give to the caregiver of a prostate cancer patient?
-
Sanofi US
@SanofiUS
If you're fighting multiple myeloma and may need a transplant of your own stem cells like Danielle, you’re not alone. This #bloodcancerawarenessmonth, we want people to know our Journey Partners will share their personal stories. Learn more: www.mmjourneypartners.com?sf249260274=1
-
Sanofi US
@SanofiUS
September is #prostatecancer Awareness Month. DYK approximately 1 in 8 men will be diagnosed with prostate cancer during his lifetime? Learn more about the signs and symptoms of prostate cancer: www.cancer.org/cancer/prostate-cancer/detection-diagnosis…
-
Sanofi US
@SanofiUS
Education is critical to helping protect health early on. In his latest piece, Dr. Corey Robertson discusses how early education about vaccines can help people make the most of public health resources and help protect their futures. #niam21 #ivax2protect
-
Sanofi US
@SanofiUS
We all have a responsibility to help protect public health. In honor of #niam21, Sanofi’s @greenbergepi emphasizes that routine vaccination and catch-up are more important than ever. Learn more. #niam2021 #ivax2protect
-
Sanofi US
@SanofiUS
With @Regeneron, we’re announcing positive Phase 3 results from our pivotal trial in children 6 months to 5 years old with moderate-to-severe #atopicdermatitis. Read more:
www.news.sanofi.us/press-releases?item=137328&sf249001232=1 -
Sanofi US
@SanofiUS
Join us for the virtual 2021 #torchawards on August 26 at 7 p.m. ET to recognize the contributions of visionary individuals working to have a positive impact on the #raredisease community. www.youtube.com/watch?v=XpcFw82_5fU&sf248929270=1
-
Sanofi US
@SanofiUS
Want to make the world a greener place? So does Lisa Moher. Her team has been researching sustainable packaging methods and found Bioffex™, a new material we're now using to ship medicines that can be composted and broken down in just 4 weeks. #iamsanofi www.sanofi.us/en/about-us/our-stories/making-a-difference…
-
Sanofi US
@SanofiUS
The best defense against meningococcal disease, a rare but potentially fatal disease, is keeping up to date with immunizations. To learn more about the @CDCgov recommended second dose of the MenACWY meningitis vaccine at age 16, visit the16vaccine.org?sf248428100=1 #niam21 #niam202
-
Sanofi US
@SanofiUS
Attention parents! Help make sure your children are protected from vaccine-preventable diseases like meningococcal disease. Talk to your teen’s doctor about the CDC recommended second dose of the MenACWY meningitis vaccine at age 16. #niam21 #niam2021 the16vaccine.org?sf248428037=1
-
Sanofi US
@SanofiUS
Small changes. Big impacts. By modifying the packaging materials we use to ship medicines, we’re helping to make the world both a healthier and greener place. #sustainability
-
Sanofi US
@SanofiUS
Developing a new #raredisease treatment is an exciting moment – but not the end of the road. Read Dr. Kelly George and Dr. Kristina An Haack’s stories about driving research.
-
Sanofi US
@SanofiUS
More diverse perspectives lead to better thinking and better patient outcomes. Read Rogelio's interview with @PharmExec to see his perspective on how pharma can improve Latinx representation and empower a future generation of leaders.
-
Sanofi US
@SanofiUS
Vaccines can help protect against vaccine-preventable diseases. This National #immunization Awareness Month, let’s help get kids caught up on routine vaccinations before they return to in-person learning. Learn more: www.cdc.gov/vaccines/parents/visit/vaccination-during-COV… #ivax2protect #niam21 #niam2021
-
Sanofi US
@SanofiUS
Learn about our new treatment for late-onset #pompe disease from a clinical trial investigator and patient: www.sanofi.us/en/media/fda-approves-nexviazyme-avalglucos…
Sanofi
@sanofi
Today the @US_FDA approved our therapy for late-onset #pompe disease, a progressive and debilitating #raredisease that damages muscle cells:
-
Sanofi US
@SanofiUS
Teens are at increased risk for meningococcal #meningitis. Together with @MollyRingwald & @NMAtweets, we’re rallying parents to talk to their teen’s doctor about the potentially life-saving second dose of the MenACWY vaccine. Learn more: the16vaccine.org?sf248268246=1 #niam21
-
Sanofi US
@SanofiUS
Patients often don't see everyone behind their care. In 22 years, Damon Griggs hasn't met the patients he helps, but his role has been key in their care. #iamsanofi #patienthero
-
Sanofi US
@SanofiUS
Chief of the Neuromuscular Division at @KUMedCenter, Dr. Mazen Dimachkie, describes the importance of advancing care for those living with #pompe disease, a #raredisease and debilitating condition. www.news.sanofi.us/2021-08-06-FDA-approves-Nexviazyme-R-a…
-
Sanofi US
@SanofiUS
#dyk that while anyone can get meningococcal disease, teens are among those at the highest risk for the infection? Talk to your teen’s doctor about the @CDCgov recommended second dose of the MenACWY meningitis vaccine they need at age 16. #niam21 #niam2021 the16vaccine.org?sf248268219=1
-
Sanofi US
@SanofiUS
Today with @Regeneron, we announced positive Phase 3 data for our #immunotherapy plus chemotherapy in first-line advanced #nonsmallcelllungcancer (#nsclc). Learn more: www.news.sanofi.us/2021-08-05-Phase-3-trial-of-Libtayo-R-…
Sanofi US
@SanofiUS
The trial met its primary endpoint, and the data will form the basis of regulatory submissions.
-
Sanofi US reposted
Sanofi
@sanofi
Sanofi CEO Paul Hudson: "Today’s acquisition adds mRNA technology & capabilities, advancing our ability to explore the promise of this technology to develop best-in-class vaccines and therapeutics".
Read the press release: www.sanofi.com/en/media-room/press-releases/2021/2021-08-…
$SAN $SNY $TBIO -
Sanofi US
@SanofiUS
As a co-lead of the VETS Employee Resource Group and the wife of a veteran, Francie devotes her work to lift up all of our veteran employees. Learn more about how we support our veterans: sanofi.jobs/veterans/?sf248010894=1 #iamsanofi
-
Sanofi US
@SanofiUS
A virtual internship with a lifelong impact. Thank you to our @INROADS intern Serenity, and to all of our incredible interns for their work in shaping the future of our company. #nationalinternday
-
Sanofi US reposted
Sanofi
@sanofi
[#sanofiresults] Our Q2 financial results are now available. Read the press release: www.sanofi.com/en/media-room/press-releases/2021/2021-07-… $SAN $SNY
-
Sanofi US
@SanofiUS
With @Regeneron, we’re announcing positive topline results from our pivotal trial in people with a chronic, inflammatory skin condition called chronic spontaneous urticaria. Read more: www.news.sanofi.us/2021-07-29-Dupixent-R-dupilumab-signif…
-
Sanofi US
@SanofiUS
Save the date! We are honoring the significant contributions & resiliency of #raredisease advocates. Join our annual 2021 virtual #torchawards on August 26: www.facebook.com/login/?next=https%3A%2F%2Fwww.facebook.c…
-
Sanofi US
@SanofiUS
Congrats to our #proteinsciences team for their extraordinary work advocating for immunizations and educating representatives on our innovative flu vaccine technology! #wwfh2021
We Work For Health
@weworkforhealth
Today, we recognize the incredible recipients of the 2021 WWFH Employee Champion Award. In the midst of a global pandemic, each Champion has demonstrated commitment and resiliency that goes above and beyond expectation. Meet our Champions! youtu.be/_8O3XCPVEIk
-
Sanofi US
@SanofiUS
Tune in on Thursday 7/29 at 6:30 PM PT for this live chat hosted by @33rdPTA, featuring @MollyRingwald and other advocates. Learn why vaccination for meningococcal #meningitis is crucial to help protect teens. RSVP here: us02web.zoom.us/webinar/register/WN_7hJMCmwrQa6sYDLAeKNOqQ #the16vaccine @NMAtweets
-
Sanofi US
@SanofiUS
Striving for asthma control starts with understanding its root causes. Up to 70% of people living with asthma have type 2 inflammation, which means they have underlying inflammation even when their asthma symptoms go away. Learn more: www.thenextbreath.com
-
Sanofi US
@SanofiUS
As a mom of twins who were born 13 weeks prematurely, Jennifer Umstead knows how important research is to protecting the most vulnerable: www.sanofi.us/en/about-us/our-stories/science-and-solutio… #iamsanofi
-
Sanofi US
@SanofiUS
Disability inclusion drives #innovation. Sanofi US values all talent and we’re proud to have earned a top score on the Disability Equality Index.
-
Sanofi US
@SanofiUS
With COVID-19 impacting the number of transplants performed last year, Sanofi’s job to support this community became that much more important. Learn more: www.sanofi.us/en/about-us/our-stories/making-a-difference…
-
Sanofi US
@SanofiUS
Wishing everyone a happy and healthy Fourth of July! #independenceday
-
Sanofi US
@SanofiUS
We were named one of the 2021+ Best Companies for Multicultural Women by @Seramount for our commitment to supporting, encouraging and empowering women of all backgrounds to grow and thrive. Learn more at: seramount.com/working-mother/ #mcw2021
-
Sanofi US reposted
Sanofi
@sanofi
We are pleased to announce the launch of our mRNA Center of Excellence, bringing together ~400 dedicated employees with integrated end-to-end mRNA vaccine capabilities to work at accelerating the development and delivery of next-generation vaccines. www.sanofi.com/en/media-room/press-releases/2021/2021-06-…
-
Sanofi US
@SanofiUS
Today we announced positive topline results from a phase 2/3 trial against respiratory syncytial virus, or #rsv.
Learn more: www.news.sanofi.us/2021-06-28-Nirsevimab-shows-positive-t… -
Sanofi US
@SanofiUS
To commemorate the 100th anniversary of the discovery of insulin, we are partnering with @AmDiabetesAssn for the #letstalkinsulin campaign. Learn more here: www.diabetes.org/newsroom/press-releases/2021/ada-partner… #insulin100
-
Sanofi US
@SanofiUS
Today at #ada2021, we announced SoliMix trial data in people living with type 2 #diabetes. Learn more about our new data: www.news.sanofi.us/2021-06-28-New-Soliqua-100-33-data-sho…
-
Sanofi US reposted
Sanofi
@sanofi
Recent analysis by Sanofi teams focuses on the #covid19 pandemic’s impact on transmission of endemic diseases & circulation of other #respiratory viruses. Read more in @ScienceMagazine
#sanofiscience #sanofiacts -
Sanofi US
@SanofiUS
Today we announced the approval of a new influenza vaccine manufacturing facility in Swiftwater, PA to further expand our production and distribution capabilities. Learn more: www.news.sanofi.us/2021-06-17-Newly-licensed-US-manufactu…
-
Sanofi US
@SanofiUS
A reminder of progress. A time to reflect on struggles. A moment of acceptance. For Mark, Pride takes on many meanings. To LGBTQIA+ individuals who are celebrating living as their authentic selves and those who need more time, we are here for you today and every day. #iamsanofi
-
Sanofi US
@SanofiUS
We are working across the biopharmaceutical industry to support breakthroughs for patients. Thank you to our researchers who are speaking to representatives about how we can work together to make this happen. #phrmaflyin21
-
Sanofi US
@SanofiUS
Read the positive results from our Phase 3 CADENZA trial in #coldagglutinindisesase being presented at #eha2021.
Sanofi
@sanofi
At #eha2021, we’re presenting new data from our pivotal Phase 3 CADENZA study in #coldagglutinindisease, a chronic rare blood disorder. Read more: www.sanofi.com/en/media-room/press-releases/2021/2021-06-…
-
Sanofi US
@SanofiUS
Read our post-ASCO recap www.linkedin.com/pulse/asco-2021-gathering-insights-drivi…
-
Sanofi US
@SanofiUS
We’re committed to helping combat #healthinequities. Hear our interview with @drlauraleehall1 on how we’re working together with @SHC_tweets to support improved uptake of vaccinations in diverse communities.
-
Sanofi US
@SanofiUS
Health disparities need to be addressed, including for those seeking a transplant. Our initiative with @ASTSChimera hopes to address the issues underrepresented minorities face when in need of an organ transplant. Learn more: www.linkedin.com/pulse/addressing-disparities-transplant-…
-
Sanofi US
@SanofiUS
Empowering, comforting, freeing. Pride Month can mean a lot, and we believe in creating a space that encourages our employees to be their true selves throughout the year. See how we're supporting our LGBTQIA+ employees year-round: www.sanofi.us/en/careers/benefits?sf246487617=1 #pride #pridemonth
-
Sanofi US
@SanofiUS
We’re partnering with @BIGagainstBC, @EORTC and @alliance_trials to conduct a pivotal Phase 3 trial studying our investigational treatment for ER+ breast cancer in the adjuvant setting, an area of significant unmet need. Learn more: www.news.sanofi.us/2021-06-04-Sanofi-partnering-with-lead…
-
Sanofi US
@SanofiUS
For people living with #metastaticbreastcancer, understanding the complicated science of their disease is a necessary part of their journey. Watch to learn more about the science of #mbc.
#asco21 www.youtube.com/watch?v=LVeHGJbX3nQ&ab_channel=SanofiGenzyme -
Sanofi US
@SanofiUS
Today, in partnership with @Merck, we announce the US availability of our combination #vaccine. Read more: www.news.sanofi.us/2021-06-01-Sanofi-and-Mercks-first-and…
-
Sanofi US
@SanofiUS
It is Memorial Day, a time to remember those who have given the ultimate sacrifice for our nation. We'll be reflecting on those we have lost and keeping their memory and families in our thoughts. #memorialday
-
Sanofi US
@SanofiUS
At #asco21, we’re looking ahead to new innovations in oncology, leading with compassion and supporting the #cancer community.
Sanofi
@sanofi
#oncology is a cornerstone of transformational science at Sanofi. Ahead of #asco21, Paul Hudson shares how bringing together leading scientific minds is essential to a successful pipeline. www.linkedin.com/pulse/asco-2021-advancing-science-togeth…
-
Sanofi US reposted
Sanofi
@sanofi
#covid19vaccine candidate
Sanofi and @GSK today started a large-scale global Phase 3 clinical efficacy study, with a booster study program complementing the Phase 3 beginning in the coming weeks
www.sanofi.com/en/media-room/press-releases/2021/2021-05-…
#sanofiacts -
Sanofi US
@SanofiUS
“Quality of life” (QoL) is of most interest. If you agree, make sure to see Dr. Mahmut Gümüş’ #asco21 poster on QoL in advanced #nsclc (9078) and watch his video below. meetinglibrary.asco.org/browse-meetings/2021 ASCO Annual …
Sanofi US
@SanofiUS
In your practice, you may see patients with advanced #nonsmallcelllungcancer (#nsclc) who face a variety of challenges. Which of the below research topics would be most helpful to learn about at #asco2021?
-
Sanofi US
@SanofiUS
Honoring Asian American and Pacific Islander heritage doesn't stop at the end of May – it's a year-round celebration. And it’s one that we're proud of. www.sanofi.us/en/about-us/our-stories/inside-sanofi/aapi-… #apahm
-
Sanofi US reposted
Sanofi
@sanofi
We celebrate teamwork for International Clinical Trials Day. Every advance in healthcare is thanks to collaboration between patients, caregivers, medical professionals, scientists, technicians & regulators, who all make #clinicalresearch possible www.sanofi.com/en/science-and-innovation/stories/clinical… #ictd2021
-
Sanofi US
@SanofiUS
Exciting news: @MollyRingwald is our first-ever national spokesperson for #the16vaccine, in partnership with @NMAtweets. We're educating parents on how to help protect their teens from #meningitis. Learn more: the16vaccine.org
-
Sanofi US reposted
Sanofi
@sanofi
At #asco21 today, we’re announcing results from our Phase 1/2 trial in #metastaticbreastcancer: www.sanofi.com/en/media-room/press-releases/2021/2021-05-…
-
Sanofi US reposted
Sanofi
@sanofi
In Paul Hudson’s words, the world will never go back to the way it was before the #pandemic—and that’s a good thing. Read more about the positive impact that technology has had on #healthcare during the pandemic in @FastCompany: www.fastcompany.com/90637069/how-technology-is-making-hea…
-
Sanofi US
@SanofiUS
For Canghai Lu, Asian American and Pacific Islander Heritage Month is a time for everyone to learn about the experiences of people in the AAPI community. In May and beyond, we're committed to promoting inclusivity so everyone can share their story: www.sanofi.us/en/about-us/our-stories/inside-sanofi/aapi-… #apahm
-
Sanofi US
@SanofiUS
In your practice, you may see patients with advanced #nonsmallcelllungcancer (#nsclc) who face a variety of challenges. Which of the below research topics would be most helpful to learn about at #asco2021?
-
Sanofi US
@SanofiUS
Children living with moderate-to-severe #asthma need care that addresses their unique needs. That’s why we’re working with @Regeneron to explore ways to advance asthma care for children as young as 6 years of age. Learn more: www.news.sanofi.us/2021-05-17-Pivotal-data-at-ATS-2021-sh…
-
Sanofi US reposted
Sanofi
@sanofi
Today we announced positive results of the Phase 2 trial of our #covid19 recombinant #vaccine candidate developed with @GSK. We can now progress to Phase 3, bringing us another step us closer to protecting people against this virus. www.sanofi.com/en/media-room/press-releases/2021/2021-05-…
#sanofiacts -
Sanofi US
@SanofiUS
Asian American and Pacific Islander Heritage Month is about more than just celebrating AAPI culture. For Tracey, it’s a time to understand and establish her own identity. See what #apahm means to other leaders at Sanofi at: www.sanofi.us/en/about-us/our-stories/inside-sanofi/aapi-…
-
Sanofi US
@SanofiUS
For Jennifer Umstead, a mom of twins who were born 13 weeks early, motherhood showed her a new kind of perseverance. See how she found strength and continues to use it today: www.sanofi.us/en/about-us/our-stories/making-a-difference… #mothersday #iamsanofi
-
Sanofi US
@SanofiUS
Proud to support @MassBio in sharing such an important message. #itsourshot to help build trust within diverse communities so they are comfortable and confident in getting their #covid19 vaccination.
-
Sanofi US
@SanofiUS
We believe in creating a culture that empowers and supports our employees. For the 4th year in a row, @DiversityInc has named us one of the “Top 50 Companies for Diversity.” Learn more about our culture at: www.sanofi.us/en/corporate-responsibility/diversity-and-i… #ditop50
-
Sanofi US
@SanofiUS
In our three-year partnership with @StanfordMed, we'll be bringing together the nation's most innovative minds to advance the understanding of inflammation. Learn more about what this partnership will mean for the future of immunology: www.news.sanofi.us/2021-05-06-Sanofi-establishes-three-ye…
-
Sanofi US
@SanofiUS
We find meaning in our work. Robin is a mother of two who knows firsthand the impact #rsv (Respiratory Syncytial Virus) can have on children. Read her story. #nationalinfantimmunizationweek
-
Sanofi US reposted
Sanofi
@sanofi
Live from #sanofiresults webcast
Today, Sanofi’s top management reviewed Q1 financial results and provided a strategy update during a live video webcast with investors.
$SAN $SNY -
Sanofi US reposted
Sanofi
@sanofi
[#sanofiresults] Our Q1 Financial Results are now available. Read the press release: www.sanofi.com/en/media-room/press-releases/2021/2021-04-… $SAN $SNY
-
Sanofi US
@SanofiUS
This year, #worldimmunizationweek reminds us of the importance of #vaccines. It’s in our hands to help protect ourselves, our loved ones and our communities from devastating diseases like meningococcal meningitis. #inyourhands.
-
Sanofi US
@SanofiUS
We’re committed to improving access and affordability of our diabetes and cardiovascular medicines. Access to our savings programs will now be offered through the @GoodRx platform. Learn more: bwnews.pr/3xsMRVb
-
Sanofi US
@SanofiUS
We can’t let our guard down. Routine and childhood immunization rates have lost ground during the pandemic. Read more from Sanofi’s @greenbergepi. #worldimmunizationweek
-
Sanofi US
@SanofiUS
We’re proud to help bring and keep the pandemic under control by supporting the manufacturing of vaccines for three different companies on top of developing our own candidates. Sanofi will help produce @moderna_tx’s #covid19 vaccine starting in September.
-
Sanofi US
@SanofiUS
We are working to advance the understanding and care of uncontrolled moderate-to-severe #atopicdermatitis (AD). Our latest findings will be presented at #aadvmx2021 and #espd2021. Learn more at: www.news.sanofi.us/2021-04-23-New-Dupixent-R-dupilumab-an… @Regeneron
-
Sanofi US
@SanofiUS
After facing a crisis, we learn from it. Sanofi’s Dr. Corey Robertson is an epidemiologist who has seen firsthand the impact a meningococcal disease outbreak can have on a community. #worldmeningitisday
-
Sanofi US
@SanofiUS
Thank you @MassBio for continuing to share this important message. #itsourshot to not only address #vaccinehesitancy, but to protect ourselves and our communities – and help stop the COVID-19 pandemic.
MassBio
@MassBio
Racial disparities in science & medicine existed long before #covid19, but the pandemic has magnified them, leading to broad vaccine hesitancy. #itsourshot to help marginalized communities trust the vaccines are safe & effective: www.massbio.org/news/recent-news/itsourshot-to-address-va…
-
Sanofi US
@SanofiUS
One team, powered by experts inside and outside the lab. With years of knowledge in user experience design and digital tech, Steve is always forging new paths forward to help teams deliver better care. #iamsanofi
-
Sanofi US reposted
Sanofi
@sanofi
#attheheartofsanofi
Paul Hudson shares his vision for the future: “All of us at Sanofi will keep moving forward with a strong sense of purpose, and with the objective of doing the right thing for our people, our patients, our communities, and the planet.”
integrated-report.sanofi.com/foreword-by-paul-hudson/ -
Sanofi US
@SanofiUS
Patients are the beating heart of our commitment in #oncology. We’re proud of the recent progress we’ve made with our partner @Regeneron to bring new treatment options to patients with advanced #basalcellcarcinoma and advanced #nonsmallcelllungcancer.
-
Sanofi US
@SanofiUS
A commitment to well-being, development and being inclusive – that's the kind of support an employee needs. We provide that kind of support, and @FortuneMagazine noticed by naming us to the Best Big Companies to Work For 2021 list: www.sanofi.us/en/about-us/our-stories/inside-sanofi/fortu… #bestbigcos @GPTW_US
-
Sanofi US reposted
Sanofi
@sanofi
Announcing the acquisition of Tidal Therapeutics, a biotech company with a novel #mrna-based approach for #invivo reprogramming of immune cells. This new technology platform expands our research capabilities in both oncology and immunology. www.sanofi.com/en/media-room/press-releases/2021/2021-04-…
-
Sanofi US
@SanofiUS
Phase 3 pivotal data for our investigational therapy for #coldagglutinindisease (CAD) have been published in @NEJM. CAD is a chronic rare #blooddisorder where the body’s immune system mistakenly attacks and destroys healthy red blood cells. Read more: www.news.sanofi.us/2021-04-07-Positive-results-from-the-s…
-
Sanofi US
@SanofiUS
In her career, Kate has always put patients first and worked with advocacy groups to improve access to care. As the Head of Patient Advocacy, she uses her passion to be a champion for patients. Learn more about our team at: www.sanofi.us/en/about-us/patient-advocacy?sf244647377=1 #iamsanofi #raredisease
-
Sanofi US
@SanofiUS
Join Clint Wallace, Senior Vice President, Human Resources, Sanofi North America, to celebrate extraordinary people committed to helping students #riseup. Register here: www.bottomline.org @cw_sanofi.
Bottom Line
@BottomLineOrg
Join us for Bottom Line’s Rise UP Virtual Celebration on April 8th at 7:00 pm EST! We’re thrilled to be honoring @McCourtyTwins this year. Together we'll celebrate our students and they continue to #riseup. www.bottomline.org
-
Sanofi US
@SanofiUS
Today, the @US_FDA approved our medicine in a new indication for the treatment of adult patients with relapsed or refractory #multiplemyeloma. Learn more. #mmsm
Sanofi US
@SanofiUS
We’re proud to introduce a new treatment option for relapsed or refractory #multiplemyeloma. Click the link above to read more about the @US_FDA approval of a second indication for our therapy. #mmsm
-
Sanofi US
@SanofiUS
The urgency to ensure patient access to their medicines has never been greater. We remain committed to supporting patients experiencing unexpected financial challenges through the pandemic and beyond.
-
Sanofi US
@SanofiUS
Among her many titles, Carole is the Head of Sanofi Genzyme North America and U.S. Country Lead and knows the difficulty of balancing responsibilities. See her advice for supporting women during the pandemic, Women’s History Month and beyond: www.sanofi.us/en/about-us/our-stories/inside-sanofi/inter…
-
Sanofi US
@SanofiUS
For #womenshistorymonth we're championing women making history today. Take Kathryn Rizzo. As a scientist at Sanofi, she’s led groundbreaking studies and is currently researching the COVID-19 vaccine. In a male-dominated field, she's an innovator girls everywhere can look up to.
-
Sanofi US
@SanofiUS
Hate has no place in our society. We stand with the AAPI community both at Sanofi and beyond and are committed to creating a more inclusive and supportive world. #stopasianhate
-
Sanofi US
@SanofiUS
To help narrow #vaccination disparities, engaging local leaders in diverse communities is key. In Sanofi's latest edition of Ahead of the Curve video series, @drlauraleehall1 explains.
-
Sanofi US
@SanofiUS
Patient registries are critical to helping us understand real-life experiences. A global, voluntary registry on #fabry disease has been groundbreaking for how we understand the progression of the disease and the impact of individual characteristics: www.sanofi.us/en/sanofi-today/social-impact/rare-disease-…
-
Sanofi US reposted
Sanofi
@sanofi
As we pass the one-year anniversary of the first global lockdowns due to the Covid-19 pandemic, Paul Hudson shares with @CNBC how we can manage for the foreseeable future: www.cnbc.com/2021/03/12/op-ed-sanofi-ceo-on-navigating-co…
#1yearofcovid #covid19 -
Sanofi US
@SanofiUS
Through co-pay assistance and free medicine programs for eligible patients, we're constantly working to improve access and affordability of our medicines. Learn more: www.sanofi.us/en/corporate-responsibility/access-to-healt…
-
Sanofi US
@SanofiUS
Together with @davinciscience we are mentoring the future generation of #stem professionals. At the #wiseforum, #sanofi leaders shared experiences and offered insight into the industry for more than 400 local high school and college students.
-
Sanofi US
@SanofiUS
#tbt Dr. Ameet Nathwani, Chief Medical Officer @sanofi, shared the stage with @KreinMD at the 2018 #startuphealth Festival. We look forward to joining this transformative event again in a couple of weeks as a Lead Innovation Partner.
-
Sanofi US
@SanofiUS
Proud to welcome Rep. Leonard Lance to Sanofi US headquarters in Bridgewater, NJ, today, where he received the American Life Sciences Innovation Council’s 2018 Champion of Health Care Innovation Award. Congratulations @RepLanceNJ7!
-
Sanofi US
@SanofiUS
People of all races, religions and nationalities work at Sanofi every day to improve the lives of people around the world. While all pharmaceutical treatments have side effects, racism is not a known side effect of any Sanofi medication.
-
Sanofi US
@SanofiUS
MT @JudithLight: Excited to join @sanofipasteur & @NCOAging for 2nd year to educate adults 65+ on #flu www.paramount.com/advertising #spokesperson





















































































































































































































































































































































































































































































































































































































































































































